Microfluidic cartridge and method of making same

Information

  • Patent Grant
  • 12030050
  • Patent Number
    12,030,050
  • Date Filed
    Wednesday, November 4, 2020
    4 years ago
  • Date Issued
    Tuesday, July 9, 2024
    9 months ago
  • Inventors
  • Original Assignees
  • Examiners
    • Bhat; Narayan K
    Agents
    • Knobbe, Martens, Olson & Bear, LLP
Abstract
The present technology provides for a microfluidic substrate configured to carry out PCR on a number of polynucleotide-containing samples in parallel. The substrate can be a single-layer substrate in a microfluidic cartridge. Also provided are a method of making a microfluidic cartridge comprising such a substrate. Still further disclosed are a microfluidic valve suitable for use in isolating a PCR chamber in a microfluidic substrate, and a method of making such a valve.
Description
TECHNICAL FIELD

The technology described herein generally relates to microfluidic cartridges. The technology more particularly relates to microfluidic cartridges that are configured to carry out PCR on nucleotides of interest, particularly from several biological samples in parallel, within microfluidic channels in the cartridge, and permit detection of those nucleotides.


BACKGROUND

The medical diagnostics industry is a critical element of today's healthcare infrastructure. At present, however, diagnostic analyses no matter how routine have become a bottleneck in patient care. There are several reasons for this. First, many diagnostic analyses can only be done with highly specialist equipment that is both expensive and only operable by trained clinicians. Such equipment is found in only a few locations—often just one in any given urban area. This means that most hospitals are required to send out samples for analyses to these locations, thereby incurring shipping costs and transportation delays, and possibly even sample loss or mix-up. Second, the equipment in question is typically not available ‘on-demand’ but instead runs in batches, thereby delaying the processing time for many samples because they must wait for a machine to fill up before they can be run.


Understanding that sample flow breaks down into several key steps, it would be desirable to consider ways to automate as many of these as possible. For example, a biological sample, once extracted from a patient, must be put in a form suitable for a processing regime that typically involves using polymerase chain reaction (PCR) to amplify a vector of interest. Once amplified, the presence or absence of a nucleotide of interest from the sample needs to be determined unambiguously. Sample preparation is a process that is susceptible to automation but is also relatively routinely carried out in almost any location. By contrast, steps such as PCR and nucleotide detection have customarily only been within the compass of specially trained individuals having access to specialist equipment.


There is therefore a need for a method and apparatus of carrying out PCR on prepared biological samples and detecting amplified nucleotides, preferably with high throughput. In particular there is a need for an easy-to-use device that can deliver a diagnostic result on several samples in a short time.


The discussion of the background to the technology herein is included to explain the context of the technology. This is not to be taken as an admission that any of the material referred to was published, known, or part of the common general knowledge as at the priority date of any of the claims.


Throughout the description and claims of the specification the word “comprise” and variations thereof, such as “comprising” and “comprises”, is not intended to exclude other additives, components, integers or steps.


SUMMARY

The present technology includes methods and devices for detecting polynucleotides in samples, particularly from biological samples. In particular, the technology relates to microfluidic devices that carry out PCR on nucleotides of interest within microfluidic channels, and permit detection of those nucleotides.


In particular, the present technology provides for a microfluidic cartridge, comprising: a first PCR reaction chamber; a second PCR reaction chamber; a first inlet, in fluid communication with the first PCR reaction chamber; a second inlet, in fluid communication with the second PCR reaction chamber; a first set of microfluidic valves configured to control motion of a sample from the first inlet to the first PCR reaction chamber; and a second set of microfluidic valves configured to control motion of a sample from the second inlet to the second PCR reaction chamber.


The present technology includes a process for carrying out PCR on a plurality of polynucleotide-containing samples, the method comprising: introducing the plurality of samples into a microfluidic cartridge, wherein the cartridge has a plurality of PCR reaction chambers configured to permit thermal cycling of the plurality of samples independently of one another; moving the plurality of samples into the respective plurality of PCR reaction chambers; and amplifying polynucleotides contained with the plurality of samples, by application of successive heating and cooling cycles to the PCR reaction chambers.


The present technology further comprises a number of other embodiments, as set forth herein.


A microfluidic substrate, comprising: a first PCR reaction chamber, a second PCR reaction chamber, a first inlet, in fluid communication with the first PCR reaction chamber; a second inlet, in fluid communication with the second PCR reaction chamber; a first set of microfluidic valves configured to isolate the first reaction chamber from the first inlet; and a second set of microfluidic valves configured to isolate the second PCR reaction chamber from the second inlet.


A microfluidic substrate, comprising: a plurality of sample lanes, wherein each of the plurality of sample lanes comprises a microfluidic network having, in fluid communication with one another: an inlet; a first valve and a second valve; a first channel leading from the inlet, via the first valve, to a reaction chamber; and a second channel leading from the reaction chamber, via the second valve, to a vent.


A microfluidic cartridge having a plurality of microfluidic networks, wherein each of the microfluidic networks, including a PCR reaction chamber, an inlet hole, and the valves for isolating the PCR reaction chamber, is defined in a single substrate.


A method of carrying out PCR independently on a plurality of polynucleotide-containing samples, the method comprising: introducing the plurality of samples in to a microfluidic cartridge, wherein the cartridge has a plurality of PCR reaction chambers configured to permit thermal cycling of the plurality of samples independently of one another; moving the plurality of samples into the respective plurality of PCR reaction chambers; isolating the plurality of PCR reaction chambers; and amplifying polynucleotides contained with the plurality of samples, by application of successive heating and cooling cycles to the PCR reaction chambers.


A microfluidic valve, comprising: a first chamber, connected to a first load channel; a second chamber, connected to a second load channel; and a flow channel, wherein the first and second load channels are each connected to the flow channel, and wherein the first and second load channels each contain a thermally responsive substance that, upon actuation of the valve, flows into the flow channel thereby sealing it, and wherein the flow channel is constricted along a length either side of the first and second load channels.


A microfluidic valve, comprising: a chamber, connected to a load channel; and a flow channel, wherein the load channel is connected to the flow channel, and wherein the load channel contains a thermally responsive substance that, upon actuation of the valve, flows into the flow channel thereby sealing it, and wherein the flow channel is constricted along a length either side of the load channel.


A method of making a microfluidic valve, the method comprising: directing a dispensing head over an inlet hole in a microfluidic substrate; propelling a quantity of thermally responsive substance from the dispensing head into the inlet hole; and maintaining a temperature of the microfluidic substrate so that the thermally responsive substance flows by capillary action from the inlet hole into a microfluidic channel in communication with the inlet hole.


The microfluidic cartridge described herein can be configured for use with an apparatus comprising: a chamber configured to receive the microfluidic cartridge; at least one heat source thermally coupled to the cartridge and configured to apply heat and cooling cycles that carry out PCR on one or more microdroplets of polynucleotide-containing sample in the cartridge; a detector configured to detect presence of one or more polynucleotides in the one or more samples; and a processor coupled to the detector and the heat source, configured to control heating of one or more regions of the microfluidic cartridge.


The details of one or more embodiments of the technology are set forth in the accompanying drawings and further description herein. Other features, objects, and advantages of the technology will be apparent from the description and drawings, and from the claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a plan view of an exemplary multi-lane microfluidic cartridge;



FIG. 2A shows an exemplary multi-lane cartridge;



FIG. 2B shows a portion of an exemplary multi-lane cartridge of FIG. 2A;



FIG. 3 shows a plan of microfluidic circuitry and inlets in an exemplary multi-lane cartridge;



FIGS. 4A-4C show layer construction, and cross section of an exemplary microfluidic cartridge;



FIG. 5 shows a heater array for an exemplary highly-multiplexed microfluidic cartridge;



FIGS. 6-9 show various aspects of exemplary highly multiplexed microfluidic cartridges;



FIGS. 10A-10C show various aspects of a radially configured highly multiplexed microfluidic cartridge and associated heater array,



FIG. 11 shows an exemplary microfluidic network in a lane of a multi-lane cartridge such as that for FIG. 1 or 3;



FIGS. 12A-12C show exemplary microfluidic valves, and a gate FIG. 12D;



FIG. 13 shows an exemplary bubble vent;



FIG. 14 shows a cross-section of a portion of a microfluidic cartridge, when in contact with a heater substrate;



FIGS. 15A and 15B show a plan view of heater circuitry adjacent to a PCR reaction chamber; FIG. 15C shows an overlay of an array of heater elements on an exemplary multi-lane microfluidic cartridge, wherein various microfluidic networks are visible;



FIG. 16 shows various cut-away sections that can be used to improve cooling rates during PCR thermal cycling;



FIG. 17 shows a plot of temperature against time during a PCR process, as performed on a microfluidic cartridge as described herein;



FIG. 18 shows an exemplary assembly process for a cartridge as further described herein;



FIGS. 19A and 19B show exemplary deposition of wax droplets into microfluidic valves;



FIG. 20 shows an exemplary apparatus, a microfluidic cartridge, and a read head contains a detector, as further described herein;



FIG. 21 shows a cross-section of a pipetting head and a cartridge in position in a microfluidic apparatus;



FIG. 22 shows introduction of a PCR-ready sample into a cartridge, situated in an instrument;



FIG. 23 shows an exemplary 48-lane cartridge;



FIG. 24 shows a heater configuration used for actuating the 48-lane PCR cartridge of FIG. 23;



FIGS. 25A and 25B respectively show an exemplary cartridge and lane configuration for a cartridge that permits retrieval of amplified sample;



FIG. 26A shows components of a kit, including an exemplary cartridge and reagents; FIG. 26B shows manual action of pipetting a PCR solution into PCR lanes of the cartridge;



FIG. 27 shows an exemplary cartridge partially removed from a sealed pouch;



FIGS. 28A and 28B show exemplary apparatus for carrying out wax deposition;



FIGS. 29A-29C show an exemplary 24-lane cartridge in plan view, perspective views, and cross-section, respectively;



FIGS. 30A-30D show aspects of a 96-lane cartridge; and



FIG. 31 shows a real-time PCR trace.





DETAILED DESCRIPTION

Microfluidic Cartridge


The present technology comprises a microfluidic cartridge that is configured to carry out an amplification, such as by PCR, of one or more polynucleotides from one or more samples. It is to be understood that, unless specifically made clear to the contrary, where the term PCR is used herein, any variant of PCR including but not limited to real-time and quantitative, and any other form of polynucleotide amplification is intended to be encompassed. The microfluidic cartridge need not be self-contained and can be designed so that it receives thermal energy from one or more heating elements present in an external apparatus with which the cartridge is in thermal communication. An exemplary such apparatus is further described herein; additional embodiments of such a system are found in U.S. patent application Ser. No. 11/985,577, entitled “Microfluidic System for Amplifying and Detecting Polynucleotides in Parallel”, and filed on even date herewith, the specification of which is incorporated herein by reference.


By cartridge is meant a unit that may be disposable, or reusable in whole or in part, and that is configured to be used in conjunction with some other apparatus that has been suitably and complementarily configured to receive and operate on (such as deliver energy to) the cartridge.


By microfluidic, as used herein, is meant that volumes of sample, and/or reagent, and/or amplified polynucleotide are from about 0.1 μl to about 999 μl, such as from 1-100 μl, or from 2-25 μl. Similarly, as applied to a cartridge, the term microfluidic means that various components and channels of the cartridge, as further described herein, are configured to accept, and/or retain, and/or facilitate passage of microfluidic volumes of sample, reagent, or amplified polynucleotide. Certain embodiments herein can also function with nanoliter volumes (in the range of 10-500 nanoliters, such as 100 nanoliters).


One aspect of the present technology relates to a microfluidic cartridge having two or more sample lanes arranged so that analyses can be carried out in two or more of the lanes in parallel, for example simultaneously, and wherein each lane is independently associated with a given sample.


A sample lane is an independently controllable set of elements by which a sample can be analyzed, according to methods described herein as well as others known in the art. A sample lane comprises at least a sample inlet, and a microfluidic network having one or more microfluidic components, as further described herein.


In various embodiments, a sample lane can include a sample inlet port or valve, and a microfluidic network that comprises, in fluidic communication one or more components selected from the group consisting of: at least one thermally actuated valve, a bubble removal vent, at least one thermally actuated pump, a gate, mixing channel, positioning element, microreactor, a downstream thermally actuated valve, and a PCR reaction chamber. The sample inlet valve can be configured to accept a sample at a pressure differential compared to ambient pressure of between about 70 and 100 kilopascals.


The cartridge can therefore include a plurality of microfluidic networks, each network having various components, and each network configured to carry out PCR on a sample in which the presence or absence of one or more polynucleotides is to be determined.


A multi-lane cartridge is configured to accept a number of samples in series or in parallel, simultaneously or consecutively, in particular embodiments 12 samples, wherein the samples include at least a first sample and a second sample, wherein the first sample and the second sample each contain one or more polynucleotides in a form suitable for amplification. The polynucleotides in question may be the same as, or different from one another, in different samples and hence in different lanes of the cartridge. The cartridge typically processes each sample by increasing the concentration of a polynucleotide to be determined and/or by reducing the concentration of inhibitors relative to the concentration of polynucleotide to be determined.


The multi-lane cartridge comprises at least a first sample lane having a first microfluidic network and a second lane having a second microfluidic network, wherein each of the first microfluidic network and the second microfluidic network is as elsewhere described herein, and wherein the first microfluidic network is configured to amplify polynucleotides in the first sample, and wherein the second microfluidic network is configured to amplify polynucleotides in the second sample.


In various embodiments, the microfluidic network can be configured to couple heat from an external heat source to a sample mixture comprising PCR reagent and neutralized polynucleotide sample under thermal cycling conditions suitable for creating PCR amplicons from the neutralized polynucleotide sample.


At least the external heat source may operate under control of a computer processor, configured to execute computer readable instructions for operating one or more components of each sample lane, independently of one another, and for receiving signals from a detector that measures fluorescence from one or more of the PCR reaction chambers.


For example, FIG. 1 shows a plan view of a microfluidic cartridge 100 containing twelve independent sample lanes 101 capable of simultaneous or successive processing. The microfluidic network in each lane is typically configured to carry out amplification, such as by PCR, on a PCR-ready sample, such as one containing nucleic acid extracted from a sample using other methods as further described herein. A PCR-ready sample is thus typically a mixture comprising the PCR reagents and the neutralized polynucleotide sample, suitable for subjecting to thermal cycling conditions that create PCR amplicons from the neutralized polynucleotide sample. For example, a PCR-ready sample can include a PCR reagent mixture comprising a polymerase enzyme, a positive control plasmid, a fluorogenic hybridization probe selective for at least a portion of the plasmid and a plurality of nucleotides, and at least one probe that is selective for a polynucleotide sequence. Exemplary probes are further described herein. Typically, the microfluidic network is configured to couple heat from an external heat source with the mixture comprising the PCR reagent and the neutralized polynucleotide sample under thermal cycling conditions suitable for creating PCR amplicons from the neutralized polynucleotide sample.


In various embodiments, the PCR reagent mixture can include a positive control plasmid and a plasmid fluorogenic hybridization probe selective for at least a portion of the plasmid, and the microfluidic cartridge can be configured to allow independent optical detection of the fluorogenic hybridization probe and the plasmid fluorogenic hybridization probe.


In various embodiments, the microfluidic cartridge can accommodate a negative control polynucleotide, wherein the microfluidic network can be configured to independently carry out PCR on each of a neutralized polynucleotide sample and a negative control polynucleotide with the PCR reagent mixture under thermal cycling conditions suitable for independently creating PCR amplicons of the neutralized polynucleotide sample and PCR amplicons of the negative control polynucleotide. Each lane of a multi-lane cartridge as described herein can perform two reactions when used in conjunction with two fluorescence detection systems per lane. A variety of combinations of reactions can be performed in the cartridge, such as two sample reactions in one lane, a positive control and a negative control in two other lanes; or a sample reaction and an internal control in one lane and a negative control in a separate lane.



FIG. 2A shows a perspective view of a portion of an exemplary microfluidic cartridge 200 according to the present technology. FIG. 2B shows a close-up view of a portion of the cartridge 200 of FIG. 2A illustrating various representative components. The cartridge 200 may be referred to as a multi-lane PCR cartridge with dedicated sample inlets 202. For example sample inlet 202 is configured to accept a liquid transfer member (not shown) such as a syringe, a pipette, or a PCR tube containing a PCR ready sample. More than one inlet 202 is shown in FIGS. 2A, 2B, wherein one inlet operates in conjunction with a single sample lane. Various components of microfluidic circuitry in each lane are also visible. For example, microvalves 204, and 206, and hydrophobic vents 208 for removing air bubbles, are parts of microfluidic circuitry in a given lane. Also shown is an ultrafast PCR reactor 210, which, as further described herein, is a microfluidic channel in a given sample lane that is long enough to permit PCR to amplify polynucleotides present in a sample. Above each PCR reactor 210 is a window 212 that permits detection of fluorescence from a fluorescent substance in PCR reactor 210 when a detector is situated above window 212. It is to be understood that other configurations of windows are possible including, but not limited to, a single window that straddles each PCR reactor across the width of cartridge 200.


In preferred embodiments, the multi-sample cartridge has a size substantially the same as that of a 96-well plate as is customarily used in the art. Advantageously, then, such a cartridge may be used with plate handlers used elsewhere in the art.


The sample inlets of adjacent lanes are reasonably spaced apart from one another to prevent any contamination of one sample inlet from another sample when a user introduces a sample into any one cartridge. In an embodiment, the sample inlets are configured so as to prevent subsequent inadvertent introduction of sample into a given lane after a sample has already been introduced into that lane. In certain embodiments, the multi-sample cartridge is designed so that a spacing between the centroids of sample inlets is 9 mm, which is an industry-recognized standard. This means that, in certain embodiments the center-to-center distance between inlet holes in the cartridge that accept samples from PCR tubes, as further described herein, is 9 mm. The inlet holes can be manufactured conical in shape with an appropriate conical angle so that industry-standard pipette tips (2 μl, 20 μl, 200 μl, volumes, etc.) fit snugly therein. The cartridge herein may be adapted to suit other, later-arising, industry standards not otherwise described herein, as would be understood by one of ordinary skill in the art.



FIG. 3 shows a plan view of an exemplary microfluidic cartridge 300 having 12 sample lanes. The inlet ports 302 in this embodiment have a 6 mm spacing, so that, when used in conjunction with an automated sample loader having 4 heads, spaced equidistantly at 18 mm apart, the inlets can be loaded in three batches of four inlets: e.g., inlets 1, 4, 7, and 10 together, followed by 2, 5, 8, and 11, then finally 3, 6, 9, and 12, wherein the 12 inlets are numbered consecutively from one side of the cartridge to the other as shown.


A microfluidic cartridge as used herein may be constructed from a number of layers. Accordingly, one aspect of the present technology relates to a microfluidic cartridge that comprises a first, second, third, fourth, and fifth layers wherein one or more layers define a plurality of microfluidic networks, each network having various components configured to carry out PCR on a sample in which the presence or absence of one or more polynucleotides is to be determined. In various embodiments, one or more such layers are optional.



FIGS. 4A-C show various views of a layer structure of an exemplary microfluidic cartridge comprising a number of layers, as further described herein. FIG. 4A shows an exploded view; FIG. 4B shows a perspective view; and FIG. 4C shows a cross-sectional view of a sample lane in the exemplary cartridge. Referring to FIGS. 4A-C, an exemplary microfluidic cartridge 400 includes first 420, second 422, third 424, fourth 426, and fifth layers in two non-contiguous parts 428, 430 (as shown) that enclose a microfluidic network having various components configured to process multiple samples in parallel that include one or more polynucleotides to be determined.


Microfluidic cartridge 400 can be fabricated as desired. The cartridge can include a microfluidic substrate layer 424, typically injection molded out of a plastic, such as a zeonor plastic (cyclic olefin polymer), having a PCR channel and valve channels on a first side and vent channels and various inlet holes, including wax loading holes and liquid inlet holes, on a second side (disposed toward hydrophobic vent membrane 426). It is advantageous that all the microfluidic network defining structures, such as PCR reactors, valves, inlet holes, and air vents, are defined on the same single substrate 424. This attribute facilitates manufacture and assembly of the cartridge. Additionally, the material from which this substrate is formed is rigid or non-deformable, non-venting to air and other gases, and has a low autofluorescence to facilitate detection of polynucleotides during an amplification reaction performed in the microfluidic circuitry defined therein. Rigidity is advantageous because it facilitates effective and uniform contact with a heat unit as further described herein. Use of a non-venting material is also advantageous because it reduces the likelihood that the concentration of various species in liquid form will change during analysis. Use of a material having low auto-fluorescence is also important so that background fluorescence does not detract from measurement of fluorescence from the analyte of interest.


The cartridge can further include, disposed on top of the substrate 424, an oleophobic/hydrophobic vent membrane layer 426 of a porous material, such as 0.2 to 1.0 micron pore-size membrane of modified polytetrafluorethylene, the membrane being typically between about 25 and about 100 microns thick, and configured to cover the vent channels of microfluidic substrate 424, and attached thereto using, for example, heat bonding.


Typically, the microfluidic cartridge further includes a layer 428, 430 of polypropylene or other plastic label with pressure sensitive adhesive (typically between about 50 and 150 microns thick) configured to seal the wax loading holes of the valves in substrate 424, trap air used for valve actuation, and serve as a location for operator markings. In FIG. 4A, this layer is shown in two separate pieces, 428,430, though it would be understood by one of ordinary skill in the art that a single piece layer would be appropriate.


In various embodiments, the label is a computer-readable label. For example, the label can include a bar code, a radio frequency tag or one or more computer-readable characters. The label can be formed of a mechanically compliant material. For example, the mechanically compliant material of the label can have a thickness of between about 0.05 and about 2 millimeters and a Shore hardness of between about 25 and about 100. The label can be positioned such that it can be read by a sample identification verifier as further described herein.


The cartridge can further include a heat sealable laminate layer 422 (typically between about 100 and about 125 microns thick) attached to the bottom surface of the microfluidic substrate 424 using, for example, heat bonding. This layer serves to seal the PCR channels and vent channels in substrate 424. The cartridge can further include a thermal interface material layer 420 (typically about 125 microns thick), attached to the bottom of the heat sealable laminate layer using, for example, pressure sensitive adhesive. The layer 420 can be compressible and have a higher thermal conductivity than common plastics, thereby serving to transfer heat across the laminate more efficiently. Typically, however, layer 420 is not present.


The application of pressure to contact the cartridge to the heater of an instrument that receives the cartridge generally assists in achieving better thermal contact between the heater and the heat-receivable parts of the cartridge, and also prevents the bottom laminate structure from expanding, as would happen if the PCR channel was only partially filled with liquid and the air entrapped therein would be thermally expanded during thermocycling.


In use, cartridge 400 is typically thermally associated with an array of heat sources configured to operate the components (e.g., valves, gates, actuators, and processing region 410) of the device. Exemplary such heater arrays are further described herein. Additional embodiments of heater arrays are described in U.S. patent application Ser. No. 11/940,315, entitled “Heater Unit for Microfluidic Diagnostic System” and filed on even date herewith, the specification of which is incorporated herein by reference in its entirety. In some embodiments, the heat sources are controlled by a computer processor and actuated according to a desired protocol. Processors configured to operate microfluidic devices are described in, e.g., U.S. application Ser. No. 09/819,105, filed Mar. 28, 2001, which application is incorporated herein by reference.


In various embodiments, during transport and storage, the microfluidic cartridge can be further surrounded by a sealed pouch. The microfluidic cartridge can be sealed in the pouch with an inert gas. The microfluidic cartridge can be disposable for example after one or more of its sample lanes have been used.


Highly Multiplexed Embodiments


Embodiments of the cartridge described herein may be constructed that have high-density microfluidic circuitry on a single cartridge that thereby permit processing of multiple samples in parallel, or in sequence, on a single cartridge. Preferred numbers of such multiple samples include 20, 24, 36, 40, 48, 50, 60, 64, 72, 80, 84, 96, and 100, but it would be understood that still other numbers are consistent with the apparatus and cartridge herein, where deemed convenient and practical.


Accordingly, different configurations of lanes, sample inlets, and associated heater networks than those explicitly depicted in the FIGs and examples that can facilitate processing such numbers of samples on a single cartridge are within the scope of the instant disclosure. Similarly, alternative configurations of detectors and heating elements for use in conjunction with such a highly multiplexed cartridge are also within the scope of the description herein.


It is also to be understood that the microfluidic cartridges described herein are not to be limited to rectangular shapes, but can include cartridges having circular, elliptical, triangular, rhombohedral, square, and other shapes. Such shapes may also be adapted to include some irregularity, such as a cut-out, to facilitate placement in a complementary apparatus as further described herein.


In an exemplary embodiment, a highly multiplexed cartridge has 48 sample lanes, and permits independent control of each valve in each lane by suitably configured heater circuitry, with 2 banks of thermocycling protocols per lane, as shown in FIG. 5. In the embodiment in FIG. 5, the heaters (shown superimposed on the lanes) are arranged in three arrays 502, 504, with 506, and 508. The heaters are themselves disposed within one or more substrates. Heater arrays 502, 508 in two separate glass regions only apply heat to valves in the microfluidic networks in each lane. Because of the low thermal conductivity of glass, the individual valves may be heated separately from one another. This permits samples to be loaded into the cartridge at different times, and passed to the PCR reaction chambers independently of one another. The PCR heaters 504, 506 are mounted on a silicon substrate—and are not readily heated individually, but thereby permit batch processing of PCR samples, where multiple samples from different lanes are amplified by the same set of heating/cooling cycles. It is preferable for the PCR heaters to be arranged in 2 banks (the heater arrays 506 on the left and right 508 are not in electrical communication with one another), thereby permitting a separate degree of sample control.



FIG. 6 shows a representative 48-sample cartridge 600 compatible with the heater arrays of FIG. 5, and having a configuration of inlets 602 different to that depicted o other cartridges herein. The inlet configuration is exemplary and has been designed to maximize efficiency of space usage on the cartridge. The inlet configuration can be compatible with an automatic pipetting machine that has dispensing heads situated at a 9 mm spacing. For example, such a machine having 4 heads can load 4 inlets at once, in 12 discrete steps, for the cartridge of FIG. 6. Other configurations of inlets though not explicitly described or depicted are compatible with the technology described herein.



FIG. 7 shows, in close up, an exemplary spacing of valves 702, channels 704, and vents 706, in adjacent lanes 708 of a multi-sample microfluidic cartridge for example as shown in FIG. 6.



FIGS. 8 and 9 show close-ups of, respectively, heater arrays 804 compatible with, and inlets 902 on, the exemplary cartridge shown in FIG. 7.



FIGS. 10A and 10B show various views of an embodiment of a radially-configured highly-multiplexed cartridge, having a number of inlets 1002, microfluidic lanes 1004, valves 1005, and PCR reaction chambers 1006. FIG. 10C shows an array of heater elements 1008 compatible with the cartridge layout of FIG. 10A.


The various embodiments shown in FIGS. 5-10C are compatible with liquid dispensers, receiving bays, and detectors that are configured differently from the other specific examples described herein.


During the design and manufacture of highly multiplexed cartridges, photolithographic processing steps such as etching, hole drilling/photo-chemical drilling/sand-blasting/ion-milling processes should be optimized to give well defined holes and microchannel pattern. Proper distances between channels should be identified and maintained to obtain good bonding between the microchannel substrate and the heat conducting substrate layer. In particular, it is desirable that minimal distances are maintained between pairs of adjacent microchannels to promote, reliable bonding of the laminate in between the channels.


The fabrication by injection molding of these complicated microfluidic structures having multiple channels and multiple inlet holes entails proper consideration of dimensional repeatability of these structures over multiple shots from the injection molding master pattern. Proper consideration is also attached to the placement of ejector pins to push out the structure from the mold without causing warp, bend or stretching of it. For example, impression of the ejector pins on the microfluidic substrate should not sink into the substrate thereby preventing planarity of the surface of the cartridge. The accurate placement of various inlet holes (such as sample inlet holes, valve inlet holes and vent holes) relative to adjacent microfluidic channels is also important because the presence of these holes can cause knit-lines to form that might cause unintended leak from a hole to a microchannel. Highly multiplexed microfluidic substrates may be fabricated in other materials such as glass, silicon.


The size of the substrate relative to the number of holes is also factor during fabrication because it is easy to make a substrate having just a simple microfluidic network with a few holes (may be fewer than 10 holes) and a few microchannels, but making a substrate having over 24, or over 48, or over 72 holes, etc., is more difficult.


Microfluidic Networks


Particular components of exemplary microfluidic networks are further described herein.


Channels of a microfluidic network in a lane of cartridge typically have at least one sub-millimeter cross-sectional dimension. For example, channels of such a network may have a width and/or a depth of about 1 mm or less (e.g., about 750 microns or less, about 500 microns, or less, about 250 microns or less).



FIG. 11 shows a plan view of a representative microfluidic circuit found in one lane of a multi-lane cartridge such as shown in FIGS. 2A and 2B. It would be understood by one skilled in the art that other configurations of microfluidic network would be consistent with the function of the cartridges and apparatus described herein. In operation of the cartridge, in sequence, sample is introduced through liquid inlet 202, optionally flows into a bubble removal vent channel 208 (which permits adventitious air bubbles introduced into the sample during entry, to escape), and continues along a channel 216. Typically, when using a robotic dispenser of liquid sample, the volume is dispensed accurately enough that formation of bubbles is not a significant problem, and the presence of vent channel 208 is not necessary. Thus, in certain embodiments, the bubble removal vent channel 208 is not present and sample flows directly into channel 216. Throughout the operation of cartridge 200, the fluid is manipulated as a microdroplet (not shown in FIG. 11). Valves 204 and 206 are initially both open, so that a microdroplet of sample-containing fluid can be pumped into PCR reactor channel 210 from inlet hole 202 under influence of force from the sample injection operation. Upon initiating of processing, the detector present on top of the PCR reactor 210 checks for the presence of liquid in the PCR channel, and then valves 204 and 206 are closed to isolate the PCR reaction mix from the outside. In one embodiment, the checking of the presence of liquid in the PCR channel is by measuring the heat ramp rate, such as by one or more temperature sensors in the heating unit. A channel with liquid absent will heat up faster than one in which, e.g., a sample, is present.


Both valves 204 and 206 are closed prior to thermocycling to prevent or reduce any evaporation of liquid, bubble generation, or movement of fluid from the PCR reactor. End vent 214 is configured to prevent a user from introducing an excess amount of liquid into the microfluidic cartridge, as well as playing a role of containing any sample from spilling over to unintended parts of the cartridge. A user may input sample volumes as small as an amount to fill the region from the bubble removal vent (if present) to the middle of the microreactor, or up to valve 204 or beyond valve 204. The use of microvalves prevents both loss of liquid or vapor thereby enabling even a partially filled reactor to successfully complete a PCR thermocycling reaction.


The reactor 210 is a microfluidic channel that is heated through a series of cycles to carry out amplification of nucleotides in the sample, as further described herein, and according to amplification protocols known to those of ordinary skill in the art. The inside walls of the channel in the PCR reactor are typically made very smooth and polished to a shiny finish (for example, using a polish selected from SPI A1, SPI A2, SPI A3, SPI B1, or SPI B2) during manufacture. This is in order to minimize any microscopic quantities of air trapped in the surface of the PCR channel, which would causing bubbling during the thermocycling steps. The presence of bubbles especially in the detection region of the PCR channel could also cause a false or inaccurate reading while monitoring progress of the PCR. Additionally, the PCR channel can be made shallow such that the temperature gradient across the depth of the channel is minimized.


The region of the cartridge 212 above PCR reactor 210 is a thinned down section to reduce thermal mass and autofluorescence from plastic in the cartridge. It permits a detector to more reliably monitor progress of the reaction and also to detect fluorescence from a probe that binds to a quantity of amplified nucleotide. Exemplary probes are further described herein. The region 212 can be made of thinner material than the rest of the cartridge so as to permit the PCR channel to be more responsive to a heating cycle (for example, to rapidly heat and cool between temperatures appropriate for denaturing and annealing steps), and so as to reduce glare, autofluorescence, and undue absorption of fluorescence.


After PCR has been carried out on a sample, and presence or absence of a polynucleotide of interest has been determined, it is preferred that the amplified sample remains in the cartridge and that the cartridge is either used again (if one or more lanes remain unused), or disposed of. Should a user wish to run a post amplification analysis, such as gel electrophoresis, the user may pierce a hole through the laminate of the cartridge, and recover an amount—typically about 1.5 microliter—of PCR product. The user may also place the individual PCR lane on a special narrow heated plate, maintained at a temperature to melt the wax in the valve, and then aspirate the reacted sample from the inlet hole of that PCR lane.


In various embodiments, the microfluidic network can optionally include at least one reservoir configured to contain waste.


Table 1 outlines typical volumes, pumping pressures, and operation times associated with various components of a microfluidic cartridge described herein.












TABLE 1








Pumping
Displacement
Time of


Operation
Pressure
Volume
Operation





Moving valve
~1-2 psi
<1 μl
5-15 seconds


wax plugs





Operation
Pump Used
Pump Design
Pump Actuation





Moving valve
Thermopneumatic
1 μl of trapped
Heat trapped air


wax plugs
pump
air
to ~70-90° C.










Valves


A valve (sometimes referred to herein as a microvalve) is a component in communication with a channel, such that the valve has a normally open state allowing material to pass along a channel from a position on one side of the valve (e.g., upstream of the valve) to a position on the other side of the valve (e.g., downstream of the valve). Upon actuation of the valve, the valve transitions to a closed state that prevents material from passing along the channel from one side of the valve to the other. For example, in one embodiment, a valve can include a mass of a thermally responsive substance (TRS) that is relatively immobile at a first temperature and more mobile at a second temperature. The first and second temperatures are insufficiently high to damage materials, such as polymer layers of a microfluidic cartridge in which the valve is situated. A mass of TRS can be an essentially solid mass or an agglomeration of smaller particles that cooperate to obstruct the passage when the valve is closed. Examples of TRS's include a eutectic alloy (e.g., a solder), wax (e.g., an olefin), polymers, plastics, and combinations thereof. The TRS can also be a blend of variety of materials, such as an emulsion of thermoelastic polymer blended with air microbubbles (to enable higher thermal expansion, as well as reversible expansion and contraction), polymer blended with expancel material (offering higher thermal expansion), polymer blended with heat conducting microspheres (offering faster heat conduction and hence, faster melting profiles), or a polymer blended with magnetic microspheres (to permit magnetic actuation of the melted thermoresponsive material).


Generally, for such a valve, the second temperature is less than about 90° C. and the first temperature is less than the second temperature (e.g., about 70° C. or less). Typically, a chamber is in gaseous communication with the mass of TRS. The valve is in communication with a source of heat that can be selectively applied to the chamber of air and to the TRS. Upon heating gas (e.g., air) in the chamber and heating the mass of TRS to the second temperature, gas pressure within the chamber due to expansion of the volume of gas, forces the mass to move into the channel, thereby obstructing material from passing therealong.


An exemplary valve is shown in FIG. 12A. The valve of FIG. 12A has two chambers of air 1203, 1205 in contact with, respectively, each of two channels 1207, 1208 containing TRS. The air chambers also serve as loading ports for TRS during manufacture of the valve, as further described herein. In order to make the valve sealing very robust and reliable, the flow channel 1201 (along which, e.g., sample passes) at the valve junction is made narrow (typically 150 μm wide, and 150 μm deep or narrower), and the constricted portion of the flow channel is made at least 0.5 or 1 mm long such that the TRS seals up a long narrow channel thereby reducing any leakage through the walls of the channel. In the case of a bad seal, there may be leakage of fluid around walls of channel, past the TRS, when the valve is in the closed state. In order to minimize this, the flow channel is narrowed and elongated as much as possible. In order to accommodate such a length of channel on a cartridge where space may be at a premium, the flow channel can incorporate one or more curves 1209 as shown in FIG. 12A. The valve operates by heating air in the TRS-loading port, which forces the TRS forwards into the flow-channel in a manner so that it does not come back to its original position. In this way, both air and TRS are heated during operation.


In various other embodiments, a valve for use with a microfluidic network in a microfluidic cartridge herein can be a bent valve as shown in FIG. 12B. Such a configuration reduces the footprint of the valve and hence reduces cost per part for highly dense microfluidic cartridges. A single valve loading hole 1211 is positioned in the center, that serves as an inlet for thermally responsive substance. The leftmost vent 1213 can be configured to be an inlet for, e.g., sample, and the rightmost vent 1215 acts as an exit for, e.g., air. This configuration can be used as a prototype for testing such attributes as valve and channel geometry and materials.


In various other embodiments, a valve for use with a microfluidic network can include a curved valve as shown in FIG. 12C, in order to reduce the effective cross-section of the valve, thereby enabling manufacture of cheaper dense microfluidic devices. Such a valve can function with a single valve loading hole and air chamber 1221 instead of a pair as shown in FIG. 12A.


Gates



FIG. 12D shows an exemplary gate as may optionally be used in a microfluidic network herein. A gate can be a component that can have a closed state that does not allow material to pass along a channel from a position on one side of the gate to another side of the gate, and an open state that does allow material to pass along a channel from a position on one side of the gate to another side of the gate. Actuation of an open gate can transition the gate to a closed state in which material is not permitted to pass from one side of the gate (e.g., upstream of the gate) to the other side of the gate (e.g., downstream of the gate). Upon actuation, a closed gate can transition to an open state in which material is permitted to pass from one side of the gate (e.g., upstream of the gate) to the other side of the gate (e.g., downstream of the gate).


In various embodiments, a microfluidic network can include a narrow gate 380 as shown in FIG. 12D where a gate loading channel 382 used for loading wax from a wax loading hole 384 to a gate junction 386 can be narrower (e.g., approximately 150 μm wide and 100 microns deep). An upstream channel 388 as well as a downstream channel 390 of the gate junction 386 can be made wide (e.g., ˜500 μm) and deep (e.g., ˜500 μm) to help ensure the wax stops at the gate junction 386. The amount of gate material melted and moved out of the gate junction 386 may be minimized for optimal gate 380 opening. As an off-cartridge heater may be used to melt the thermally responsive substance in gate 380, a misalignment of the heater could cause the wax in the gate loading channel 382 to be melted as well. Therefore, narrowing the dimension of the loading channel may increase reliability of gate opening. In the case of excessive amounts of wax melted at the gate junction 386 and gate loading channel 382, the increased cross-sectional area of the downstream channel 390 adjacent to the gate junction 386 can prevent wax from clogging the downstream channel 390 during gate 380 opening. The dimensions of the upstream channel 388 at the gate junction 386 can be made similar to the downstream channel 390 to ensure correct wax loading during gate fabrication.


In various embodiments, the gate can be configured to minimize the effective area or footprint of the gate within the network and thus bent gate configurations, although not shown herein are consistent with the foregoing description.


Vents


In various embodiments, the microfluidic network can include at least one hydrophobic vent in addition to an end vent. A vent is a general outlet (hole) that may or may not be covered with a hydrophobic membrane. An exit hole is an example of a vent that need not be covered by a membrane.


A hydrophobic vent (e.g., a vent in FIG. 13) is a structure that permits gas to exit a channel while limiting (e.g., preventing) quantities of liquid from exiting the channel. Typically, hydrophobic vents include a layer of porous hydrophobic material (e.g., a porous filter such as a porous hydrophobic membrane from GE Osmonics, Minnetonka, MN) that defines a wall of the channel. As described elsewhere herein, hydrophobic vents can be used to position a microdroplet of sample at a desired location within a microfluidic network.


The hydrophobic vents of the present technology are preferably constructed so that the amount of air that escapes through them is maximized while minimizing the volume of the channel below the vent surface. Accordingly, it is preferable that the vent is constructed so as to have a hydrophobic membrane 1303 of large surface area and a shallow cross section of the microchannel below the vent surface.


Hydrophobic vents are useful for bubble removal and typically have a length of at least about 2.5 mm (e.g., at least about 5 mm, at least about 7.5 mm) along a channel 1305 (see FIG. 13). The length of the hydrophobic vent is typically at least about 5 times (e.g., at least about 10 times, at least about 20 times) larger than a depth of the channel within the hydrophobic vent. For example, in some embodiments, the channel depth within the hydrophobic vent is about 300 microns or less (e.g., about 250 microns or less, about 200 microns or less, about 150 microns or less).


The depth of the channel within the hydrophobic vent is typically about 75% or less (e.g., about 65% or less, about 60% or less) of the depth of the channel upstream 1301 and downstream (not shown) of the hydrophobic vent. For example, in some embodiments the channel depth within the hydrophobic vent is about 150 microns and the channel depth upstream and downstream of the hydrophobic vent is about 250 microns. Other dimensions are consistent with the description herein.


A width of the channel within the hydrophobic vent is typically at least about 25% wider (e.g., at least about 50% wider) than a width of the channel upstream from the vent and downstream from the vent. For example, in an exemplary embodiment, the width of the channel within the hydrophobic vent is about 400 microns, and the width of the channel upstream and downstream from the vent is about 250 microns. Other dimensions are consistent with the description herein.


The vent in FIG. 13 is shown in a linear configuration though it would be understood that it need not be so. A bent, kinked, curved, S-shaped, V-shaped, or U-shaped (as in item 208FIG. 11) vent is also consistent with the manner of construction and operation described herein.


Heater Configurations to Ensure Uniform Heating of a Region


The microfluidic cartridges described herein are configured to position in a complementary receiving bay in an apparatus that contains a heater unit. The heater unit is configured to deliver heat to specific regions of the cartridge, including but not limited to one or more microfluidic components, at specific times. For example, the heat source is configured so that particular heating elements are situated adjacent to specific components of the microfluidic network of the cartridge. In certain embodiments, the apparatus uniformly controls the heating of a region of a microfluidic network. In an exemplary embodiment, multiple heaters can be configured to simultaneously and uniformly heat a single region, such as the PCR reaction chamber, of the microfluidic cartridge. In other embodiments, portions of different sample lanes are heated simultaneously and independently of one another.



FIG. 14 shows a cross-sectional view of an exemplary microfluidic cartridge to show the location of a PCR channel in relation to various heaters when the cartridge is placed in a suitable apparatus. The view in FIG. 14 is also referred to as a sectional-isometric view of the cartridge lying over a heater wafer. A window 903 above the PCR channel in the cartridge is shown in perspective view. PCR channel 901 (for example, 150μ deep×700μ wide), is shown in an upper layer of the cartridge. A laminate layer 905 of the cartridge (for example, 125μ thick) is directly under the PCR channel 901. As depicted, an optional further layer of thermal interface laminate 907 on the cartridge (for example, 125μ thick) lies directly under the laminate layer 905. Heaters 909, 911 are situated in a heater substrate layer 913 directly under the thermal interface laminate, shown in cross-section. In one embodiment the heaters are photolithographically defined and etched metal layers of gold (typically about 3,000 Å thick). Layers of 400 Å of TiW (not shown) are deposited on top and bottom of the gold layer to serve as an adhesion layer. The substrate 913 used is glass, fused silica or a quartz wafer having a thickness of 0.4 mm, 0.5 mm, 0.7 mm, or 1 mm. A thin electrically-insulative layer of 2 μm silicon oxide serves as an insulative layer on top of the metal layer. Additional thin electrically insulative layers such as 2-4 μm of Parylene may also be deposited on top of the silicon oxide surface. Two long heaters 909 and 911, as further described herein, run alongside the PCR channel.


An exemplary heater array is shown in FIGS. 15A and 15B. Additional embodiments of heater arrays are described in U.S. patent application Ser. No. 11/940,315, entitled “Heater Unit for Microfluidic Diagnostic System” and filed on even date herewith, the specification of which is incorporated herein by reference in its entirety.


Referring to FIGS. 15A and 15B, an exemplary PCR reaction chamber 1501, typically having a volume ˜1.6 μl, is configured with a long side and a short side, each with an associated heating element. The heater substrate therefore includes four heaters disposed along the sides of, and configured to heat, the PCR reaction chamber, as shown in the exemplary embodiment of FIG. 15A: long top heater 1505, long bottom heater 1503, short left heater 1507, and short right heater 1509. The small gap between long top heater 1505 and long bottom heater 1503 results in a negligible temperature gradient (less than 1° C. difference across the width of the PCR channel at any point along the length of the PCR reaction chamber) and therefore an effectively uniform temperature throughout the PCR reaction chamber. The heaters on the short edges of the PCR reactor provide heat to counteract the gradient created by the two long heaters from the center of the reactor to the edge of the reactor. It would be understood by one of ordinary skill in the art that still other configurations of one or more heater(s) situated about a PCR reaction chamber are consistent with the methods and apparatus described herein. For example, a ‘long’ side of the reaction chamber can be configured to be heated by two or more heaters. Specific orientations and configurations of heaters are used to create uniform zones of heating even on substrates having poor thermal conductivity because the poor thermal conductivity of glass, or quartz, polyimide, FR4, ceramic, or fused silica substrates is utilized to help in the independent operation of various microfluidic components such as valves and independent operation of the various PCR lanes. In FIG. 15B, various aspects of fine structure of heater elements are shown in inserts.


Generally, the heating of microfluidic components, such as a PCR reaction chamber, is controlled by passing currents through suitably configured microfabricated heaters. Under control of suitable circuitry, the lanes of a multi-lane cartridge can then be controlled independently of one another. This can lead to a greater energy efficiency of the apparatus, because not all heaters are heating at the same time, and a given heater is receiving current for only that fraction of the time when it is required to heat. Control systems and methods of controllably heating various heating elements are further described in U.S. patent application Ser. No. 11/940,315, filed Nov. 14, 2007 and entitled “Heater Unit for Microfluidic Diagnostic System”.


The configuration for uniform heating, shown in FIG. 15A for a single PCR reaction chamber, can be applied to a multi-lane PCR cartridge in which multiple independent PCR reactions occur. See, e.g., FIG. 15C, which shows an array of heater elements suitable to heat the cartridge of FIG. 1.


In other embodiments, as further described in U.S. patent application Ser. No. 11/940,315, filed Nov. 14, 2007 and entitled “Heater Unit for Microfluidic Diagnostic System”, the heaters may have an associated temperature sensor, or may themselves function as sensors.


Use of Cutaways in Cartridge and Substrate to Improve Rate of Cooling During PCR Cycling


During a PCR amplification of a nucleotide sample, a number of thermal cycles are carried out. For improved efficiency, the cooling between each application of heat is preferably as rapid as possible. Improved rate of cooling can be achieved with various modifications to the heating substrate and/or the cartridge, as shown in FIG. 16.


One way to achieve rapid cooling is to cutaway portions of the microfluidic cartridge substrate, as shown in FIG. 16. The upper panel of FIG. 16 is a cross-section of an exemplary microfluidic cartridge taken along the dashed line A-A′ as marked on the lower panel of FIG. 16. PCR reaction chamber 1601, and representative heaters 1603 are shown. Also shown are two cutaway portions, one of which labeled 1601, that are situated alongside the heaters that are positioned along the long side of the PCR reaction chamber. Cutaway portions such as 1601 reduce the thermal mass of the cartridge, and also permit air to circulate within the cutaway portions. Both of these aspects permit heat to be conducted away quickly from the immediate vicinity of the PCR reaction chamber. Other configurations of cutouts, such as in shape, position, and number, are consistent with the present technology.


Another way to achieve rapid cooling is to cutaway portions of the heater substrate, and also to use ambient air cooling, as further described in U.S. patent application Ser. No. 11/940,315, filed Nov. 14, 2007 and entitled “Heater Unit for Microfluidic Diagnostic System”.


An example of thermal cycling performance in a PCR reaction chamber obtained with a configuration as described herein, is shown in FIG. 17 for a protocol that is set to heat up the reaction mixture to 92° C., and maintain the temperature for 1 second, then cool to 62° C., and stay for 10 seconds. The cycle time shown is about 29 seconds, with 8 seconds required to heat from 62° C. and stabilize at 92° C., and 10 seconds required to cool from 92° C., and stabilize at 62° C. To minimize the overall time required for a PCR effective to produce detectable quantities of amplified material, it is important to minimize the time required for each cycle. Cycle times in the range 15-30 s, such as 18-25 s, and 20-22 s, are desirable. In general, an average PCR cycle time of 25 seconds as well as cycle times as low as 20 seconds are typical with the technology described herein. Using reaction volumes less than a microliter (such as a few hundred nanoliters or less) permits use of an associated smaller PCR chamber, and enables cycle times as low as 15 seconds.


Manufacturing Process for Cartridge



FIG. 18 shows a flow-chart 1800 for an embodiment of an assembly process for an exemplary cartridge as shown in FIG. 4A herein. It would be understood by one of ordinary skill in the art, both that various steps may be performed in a different order from the order set forth in FIG. 18, and additionally that any given step may be carried out by alternative methods to those described in the figure. It would also be understood that, where separate serial steps are illustrated for carrying out two or more functions, such functions may be performed synchronously and combined into single steps and remain consistent with the overall process described herein.


At 1802, a laminate layer is applied to a microfluidic substrate that has previously been engineered, for example by injection molding, to have a microfluidic network constructed in it; edges are trimmed from the laminate where they spill over the bounds of the substrate.


At 1804, wax is dispensed and loaded into the microvalves of the microfluidic network in the microfluidic substrate. An exemplary process for carrying this out is further described herein.


At 1806, the substrate is inspected to ensure that wax from step 1804 is loaded properly and that the laminate from step 1802 adheres properly to it. If a substrate does not satisfy either or both of these tests, it is usually discarded. If substrates repeatedly fail either or both of these tests, then the wax dispensing, or laminate application steps, as applicable, are reviewed.


At 1808, a hydrophobic vent membrane is applied to, and heat bonded to, the top of the microfluidic substrate covering at least the one or more vent holes, and on the opposite face of the substrate from the laminate. Edges of the membrane that are in excess of the boundary of the substrate are trimmed.


At 1810, the assembly is inspected to ensure that the hydrophobic vent membrane is bonded well to the microfluidic substrate without heat-clogging the microfluidic channels. If any of the channels is blocked, or if the bond between the membrane and the substrate is imperfect, the assembly is discarded, and, in the case of repeated discard events, the foregoing process step 1808 is reviewed.


At 1812, optionally, a thermally conductive pad layer is applied to the bottom laminate of the cartridge.


At 1814, two label strips are applied to the top of the microfluidic substrate, one to cover the valves, and a second to protect the vent membranes. It would be understood that a single label strip may be devised to fulfill both of these roles.


At 1816, additional labels are printed or applied to show identifying characteristics, such as a barcode #, lot # and expiry date on the cartridge. Preferably one or more of these labels has a space and a writable surface that permits a user to make an identifying annotation on the label, by hand.


Optionally, at 1818, to facilitate transport and delivery to a customer, assembled and labeled cartridges are stacked, and cartridges packed into groups, such as groups of 25, or groups of 10, or groups of 20, or groups of 48 or 50. Preferably the packaging is via an inert and/or moisture-free medium.


Wax Loading in Valves


In general, a valve as shown in, e.g., FIGS. 12A-C, is constructed by depositing a precisely controlled amount of a TRS (such as wax) into a loading inlet machined in the microfluidic substrate. FIGS. 19A and 19B show how a combination of controlled hot drop dispensing into a heated microchannel device of the right dimensions and geometry is used to accurately load wax into a microchannel of a microfluidic cartridge to form a valve. The top of FIG. 19A shows a plan view of a valve inlet 1901 and loading channel 1902, connecting to a flow channel 1904. The lower portions of FIG. 19A show the progression of a dispensed wax droplet 1906 (having a volume of 75 nl+15 nl) through the inlet 1901 and into the loading channel 1902.


To accomplish those steps, a heated dispenser head can be accurately positioned over the inlet hole of the microchannel in the microfluidic device, and can dispense molten wax drops in volumes as small as 75 nanoliters with an accuracy of 20%. A suitable dispenser is also one that can deposit amounts smaller than 100 nl with a precision of +/−20%. The dispenser should also be capable of heating and maintaining the dispensing temperature of the TRS to be dispensed. For example, it may have a reservoir to hold the solution of TRS. It is also desirable that the dispense head can have freedom of movement at least in a horizontal (x−y) plane so that it can easily move to various locations of a microfluidic substrate and dispense volumes of TRS into valve inlets at such locations without having to be re-set, repositioned manually, or recalibrated in between each dispense operation.


The inlet hole of the microfluidic cartridge, or other microchannel device, is dimensioned in such a way that the droplet of 75 nl can be accurately propelled to the bottom of the inlet hole using, for example, compressed air, or in a manner similar to an inkjet printing method. The microfluidic cartridge is maintained at a temperature above the melting point of the wax thereby permitting the wax to stay in a molten state immediately after it is dispensed. After the drop falls to the bottom of the inlet hole 1901, the molten wax is drawn into the narrow channel by capillary action, as shown in the sequence of views in FIG. 19B. A shoulder between the inlet hole 1901 and the loading channel can facilitate motion of the TRS. The volume of the narrow section can be designed to be approximately equal to a maximum typical amount that is dispensed into the inlet hole. The narrow section can also be designed so that even though the wax dispensed may vary considerably between a minimum and a maximum shot size, the wax always fills up to, and stops at, the microchannel junction 1907 because the T-junction provides a higher cross section than that of the narrow section and thus reduces the capillary forces. Dimensions shown in FIG. 19A are exemplary.


PCR Reagent Mixtures


In various embodiments, the sample for introduction into a lane of the microfluidic cartridge can include a PCR reagent mixture comprising a polymerase enzyme and a plurality of nucleotides.


In various embodiments, preparation of a PCR-ready sample for use with an apparatus and cartridge as described herein can include contacting a neutralized polynucleotide sample with a PCR reagent mixture comprising a polymerase enzyme and a plurality of nucleotides (in some embodiments, the PCR reagent mixture can further include a positive control plasmid and a fluorogenic hybridization probe selective for at least a portion of the plasmid).


The PCR-ready sample can be prepared, for example, using the following steps: (1) collect sample in sample collection buffer, (2) transfer entire sample to lysis tube, mix, heat, and incubate for seven minutes, (3) place on magnetic rack, allow beads to separate, aspirate supernatant, (4) add 100 μl of Buffer 1, mix, place on magnetic rack, allow beads to separate, aspirate supernatant, (5) add 10 μl of Buffer 2, mix, place in high temperature heat block for 3 minutes, place on magnetic rack, allow beads to separate, transfer 5 μl supernatant, and (6) Add 5μ of Buffer 3, transfer 1 to 10 μl of supernatant for PCR amplification and detection.


The PCR reagent mixture can be in the form of one or more lyophilized pellets and the steps by which the PCR-ready sample is prepared can involve reconstituting the PCR pellet by contacting it with liquid to create a PCR reagent mixture solution. In yet another embodiment, each of the PCR lanes may have dried down or lyophilized ASR reagents preloaded such that the user only needs to input prepared polynucleotide sample into the PCR. In another embodiment, the PCR lanes may have only the application-specific probes and primers pre-measured and pre-loaded, and the user inputs a sample mixed with the PCR reagents.


In various embodiments, the PCR-ready sample can include at least one probe that can be selective for a polynucleotide sequence, wherein the steps by which the PCR-ready sample is prepared involve contacting the neutralized polynucleotide sample or a PCR amplicon thereof with the probe. The probe can be a fluorogenic hybridization probe. The fluorogenic hybridization probe can include a polynucleotide sequence coupled to a fluorescent reporter dye and a fluorescence quencher dye.


In various embodiments, the PCR-ready sample further includes a sample buffer.


In various embodiments, the PCR-ready sample includes at least one probe that is selective for a polynucleotide sequence, e.g., the polynucleotide sequence that is characteristic of a pathogen selected from the group consisting of gram positive bacteria, gram negative bacteria, yeast, fungi, protozoa, and viruses.


In various embodiments, the PCR reagent mixture can further include a polymerase enzyme, a positive control plasmid and a fluorogenic hybridization probe selective for at least a portion of the plasmid.


In various embodiments, the probe can be selective for a polynucleotide sequence that is characteristic of an organism, for example any organism that employs deoxyribonucleic acid or ribonucleic acid polynucleotides. Thus, the probe can be selective for any organism. Suitable organisms include mammals (including humans), birds, reptiles, amphibians, fish, domesticated animals, wild animals, extinct organisms, bacteria, fungi, viruses, plants, and the like. The probe can also be selective for components of organisms that employ their own polynucleotides, for example mitochondria. In some embodiments, the probe is selective for microorganisms, for example, organisms used in food production (for example, yeasts employed in fermented products, molds or bacteria employed in cheeses, and the like) or pathogens (e.g., of humans, domesticated or wild mammals, domesticated or wild birds, and the like). In some embodiments, the probe is selective for organisms selected from the group consisting of gram positive bacteria, gram negative bacteria, yeast, fungi, protozoa, and viruses.


In various embodiments, the probe can be selective for a polynucleotide sequence that is characteristic of an organism selected from the group consisting of Staphylococcus spp., e.g., S. epidernmidis, S. aureus, Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Staphylococcus; Streptococcus(e.g., α, β or γ-hemolytic, Group A, B, C, D or G) such as S. pyogenes, S. agalactiae; E. faecalis, E. durans, and E. faecium (formerly S. faecalis, S. durans, S. faecium); nonenterococcal group D streptococci, e.g., S. bovis and S. equines; Streptococci viridans, e.g., S. mutans, S. sanguis, S. salivarius, S. mitior, A. milleri, S. constellatus, S. intermedius, and S. anginosus; S. iniae; S. pneumoniae; Neisseria, e.g., N. meningitides, N. gonorrhoeae, saprophytic Neisseria sp; Erysipelothrix, e.g., E. rhusiopathiae; Listeria spp., e.g., L. monocytogenes, rarely L. ivanovii and L. seeligeri; Bacillus, e.g., B. anthracis, B. cereus, B. subtilis, B. subtilus niger, B. thuringiensis; Nocardia asteroids; Legionella, e.g., L. pneumonophilia, Pneumocystis, e.g., P. carinii; Enterobacteriaceae such as Salmonella, Shigella, Escherichia (e.g., E. coli, E. coli O157:H7); Klebsiella, Enterobacter, Serratia, Proteus, Morganella, Providencia, Yersinia, and the like, e.g., Salmonella, e.g., S. typhi S. paratyphi A, B (S. schottmuelleri), and C (S. hirschfeldii), S. dublin S. choleraesuis, S. enteritidis, S. typhimurium, S. heidelberg, S. newport, S. infantis, S. agona, S. montevideo, and S. saint-paul; Shigella e.g., subgroups: A, B, C, and D, such as S. flexneri, S. sonnei, S. boydii, S. dysenteriae; Proteus (P. mirabilis, P. vulgaris, and P. myxofaciens), Morganella (M. morganii); Providencia (P. rettgeri, P. alcalifaciens, and P. stuartii); Yersinia, e.g., Y. pestis, Y. enterocolitica; Haemophilus, e.g., H. influenzae, H. parainfluenzae H. aphrophilus, H. ducreyi; Brucella, e.g., B. abortus, B. melitensis, B. suis, B. canis; Francisella, e.g., F. tularensis; Pseudomonas, e.g., P. aeruginosa, P. paucimobilis, P. putida, P. fluorescens, P. acidovorans, Burkholderia (Pseudomonas) pseudomallei, Burkholderia mallei, Burkholderia cepacia and Stenotrophomonas maltophilia; Campylobacter, e.g., C. fetus fetus, C. jejuni, C. pylori (Helicobacter pylori); Vibrio, e.g., V. cholerae, V. parahaemolyticus, V. mimicus, V. alginolyticus, V. hollisae, V. vulnificus, and the nonagglutinable vibrios; Clostridia, e.g., C. perfringens, C. tetani, C. difficile, C. botulinum; Actinomyces, e.g., A. israelii; Bacteroides, e.g., B. fragilis, B. thetaiotaomicron, B. distasonis, B. vulgatus, B. ovatus, B. caccae, and B. merdae; Prevotella, e.g., P. melaninogenica; genus Fusobacterium; Treponema, e.g. T. pallidum subspecies endemicum, T. pallidum subspecies pertenue, T. carateum, and T. pallidum subspecies pallidum; genus Borrelia, e.g., B. burgdorferi; genus Leptospira; Streptobacillus, e.g., S. moniliformis; Spirillum, e.g., S. minus; Mycobacterium, e.g., M. tuberculosis, M. bovis, M. africanum, M. avium M. intracellulare, M. kansasii, M. xenopi, M. marinum, M. ulcerans, the M. fortuitum complex (M. fortuitum and M. chelonei), M. leprae, M. asiaticum, M. chelonei subsp. abscessus, M. fallax, M. fortuitum, M. malmoense, M. shimoidei, M. simiae, M. szulgai, M. xenopi; Mycoplasma, e.g., M. hominis, M. orale, M. salivarium, M. fermentans, M. pneumoniae, M. bovis, M. tuberculosis, M. avium, M. leprae; Mycoplasma, e.g., M. genitalium; Ureaplasma, e.g., U. urealyticum; Trichomonas, e.g., T. vaginalis; Cryptococcus, e.g., C. neoformans; Histoplasma, e.g., H. capsulatum; Candida, e.g., C. albicans; Aspergillus sp; Coccidioides, e.g., C. immitis; Blastomyces, e.g. B. dermatitidis; Paracoccidioides, e.g., P. brasiliensis; Penicillium, e.g., P. marneffei; Sporothrix, e.g., S. schenckii; Rhizopus, Rhizomucor, Absidia, and Basidiobolus; diseases caused by Bipolaris, Cladophialophora, Cladosporium, Drechslera, Exophiala, Fonsecaea, Phialophora, Xylohypha, Ochroconis, Rhinocladiella, Scolecobasidium, and Wangiella; Trichosporon, e.g., T. beigelii; Blastoschizomyces, e.g., B. capitatus; Plasmodium, e.g., P. falciparum, P. vivax, P. ovale, and P. malariae; Babesia sp; protozoa of the genus Trypanosoma, e.g., T. cruzi; Leishmania, e.g., L. donovani, L. major L. tropica, L. mexicana, L. braziliensis, L. viannia braziliensis; Toxoplasma, e.g., T. gondii; Amoebas of the genera Naegleria or Acanthamoeba; Entamoeba histolytica; Giardia lamblia; genus Cryptosporidium, e.g., C. parvum; Isospora belli; Cyclospora cayetanensis; Ascaris lumbricoides; Trichuris trichiura; Ancylostoma duodenale or Necator americanus; Strongyloides stercoralis Toxocara, e.g., T. canis, T. cati; Baylisascaris, e.g., B. procyonis; Trichinella, e.g., T. spiralis; Dracunculus, e.g., D. medinensis; genus Filarioidea; Wuchereria bancrofti; Brugia, e.g., B. malayi, or B. timori; Onchocerca volvulus; Loa loa; Dirofilaria immitis; genus Schistosoma, e.g., S. japonicum, S. mansoni, S. mekongi, S. intercalatum, S. haematobium; Paragonimus, e.g., P. Westermani, P. Skriabini; Clonorchis sinensis; Fasciola hepatica; Opisthorchis sp; Fasciolopsis buski; Diphyllobothrium latum; Taenia, e.g., T. saginata, T. solium; Echinococcus, e.g., E. granulosus, E. multilocularis; Picornaviruses, rhinoviruses echoviruses, coxsackieviruses, influenza virus; paramyxoviruses, e.g., types 1, 2, 3, and 4; adnoviruses; Herpesviruses, e.g., HSV-1 and HSV-2; varicella-zoster virus; human T-lymphotrophic virus (type I and type II); Arboviruses and Arenaviruses; Togaviridae, Flaviviridae, Bunyaviridae, Reoviridae; Flavivirus; Hantavirus; Viral encephalitis (alphaviruses [e.g., Venezuelan equine encephalitis, eastern equine encephalitis, western equine encephalitis]); Viral hemorrhagic fevers (filoviruses [e.g., Ebola, Marburg] and arenaviruses [e.g., Lassa, Machupo]); Smallpox (variola); retroviruses e.g., human immunodeficiency viruses 1 and 2; human papillomavirus [HPV] types 6, 11, 16, 18, 31, 33, and 35.


In various embodiments, the probe can be selective for a polynucleotide sequence that is characteristic of an organisms selected from the group consisting of Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella oxytoca, Klebsiella pneumoniae, Escherichia coli, Acinetobacter Baumannii, Serratia marcescens, Enterobacter aerogenes, Enterococcus faecium, vancomycin-resistant enterococcus (VRE), Staphylococcus aureus, methecillin-resistant Staphylococcus aureus(MRSA), Streptococcus viridans, Listeria monocytogenes, Enterococcus spp., Streptococcus Group B, Streptococcus Group C, Streptococcus Group G, Streptococcus Group F, Enterococcus faecalis, Streptococcus pneumoniae, Staphylococcus epidermidis, Gardenerella vaginalis, Micrococcus sps., Haemophilus influenzae, Neisseria gonorrhoeee, Moraxella catarrahlis, Salmonella sps., Chlamydia trachomatis, Peptostreptococcus productus, Peptostreptococcus anaerobius, Lactobacillus fermentum, Eubacterium lentum, Candida glabrata, Candida albicans, Chlamydia spp., Camplobacter spp., Salmonella spp., smallpox (variola major), Yersina pestis, Herpes Simplex Virus I (HSV I), and Herpes Simplex Virus II (HSV II).


In various embodiments, the probe can be selective for a polynucleotide sequence that is characteristic of Group B Streptococcus.


In various embodiments, a method of carrying out PCR on a sample can further include one or more of the following steps: heating the biological sample in the microfluidic cartridge; pressurizing the biological sample in the microfluidic cartridge at a pressure differential compared to ambient pressure of between about 20 kilopascals and 200 kilopascals, or in some embodiments, between about 70 kilopascals and 110 kilopascals.


In some embodiments, the method for sampling a polynucleotide can include the steps of: placing a microfluidic cartridge containing a PCR-ready sample in a receiving bay of a suitably configured apparatus; carrying out PCR on the sample under thermal cycling conditions suitable for creating PCR amplicons from the neutralized polynucleotide in the sample, the PCR-ready sample comprising a polymerase enzyme, a positive control plasmid, a fluorogenic hybridization probe selective for at least a portion of the plasmid, and a plurality of nucleotides; contacting the neutralized polynucleotide sample or a PCR amplicon thereof with the at least one fluorogenic probe that is selective for a polynucleotide sequence, wherein the probe is selective for a polynucleotide sequence that is characteristic of an organism selected from the group consisting of gram positive bacteria, gram negative bacteria, yeast, fungi, protozoa, and viruses; and detecting the fluorogenic probe, the presence of the organism for which the one fluorogenic probe is selective is determined.


Carrying out PCR on a PCR-ready sample can additionally include: independently contacting each of the neutralized polynucleotide sample and a negative control polynucleotide with the PCR reagent mixture under thermal cycling conditions suitable for independently creating PCR amplicons of the neutralized polynucleotide sample and PCR amplicons of the negative control polynucleotide; and/or contacting the neutralized polynucleotide sample or a PCR amplicon thereof and the negative control polynucleotide or a PCR amplicon thereof with at least one probe that is selective for a polynucleotide sequence.


In various embodiments, a method of using the apparatus and cartridge described herein can further include one or more of the following steps: determining the presence of a polynucleotide sequence in the biological sample, the polynucleotide sequence corresponding to the probe, if the probe is detected in the neutralized polynucleotide sample or a PCR amplicon thereof; determining that the sample was contaminated if the probe is detected in the negative control polynucleotide or a PCR amplicon thereof; and/or in some embodiments, wherein the PCR reagent mixture further comprises a positive control plasmid and a plasmid probe selective for at least a portion of the plasmid, the method further including determining that a PCR amplification has occurred if the plasmid probe is detected.


Kit


In various embodiments, the microfluidic cartridge as described herein can be provided in the form of a kit, wherein the kit can include a microfluidic cartridge, and a liquid transfer member (such as a syringe or a pipette). In various embodiments, the kit can further include instructions to employ the liquid transfer member to transfer a sample containing extracted nucleic acid from a sample container via a sample inlet to the microfluidic network on the microfluidic cartridge. In some embodiments, the microfluidic cartridge and the liquid transfer member can be sealed in a pouch with an inert gas.


Typically when transferring a sample from liquid dispenser, such as a pipette tip, to an inlet on the microfluidic cartridge, a volume of air is simultaneously introduced into the microfluidic network, the volume of air being between about 0.5 mL and about 5 mL. Presence of air in the microfluidic network, however, is not essential to operation of the cartridge described herein.


In various embodiments, the kit can further include at least one computer-readable label on the cartridge. The label can include, for example, a bar code, a radio frequency tag or one or more computer-readable characters. When used in conjunction with a similar computer-readable label on a sample container, such as a vial or a pouch, matching of diagnostic results with sample is thereby facilitated.


In some embodiments, a sample identifier of the apparatus described elsewhere herein is employed to read a label on the microfluidic cartridge and/or a label on the biological sample.


Overview of an Apparatus for Receiving a Microfluidic Cartridge


The present technology relates to a cartridge, complementary apparatus, and related methods for amplifying, and carrying out diagnostic analyses on, nucleotides from biological samples. The technology includes a disposable or reusable microfluidic cartridge containing multiple sample lanes capable of processing samples in parallel as described elsewhere herein, and a reusable apparatus that is configured to selectively actuate on-cartridge operations, to detect and analyze the products of the PCR amplification in each of the lanes separately, in all simultaneously, or in groups simultaneously, and, optionally, can display the progression of analyses and results thereof on a graphical user interface. Such a reusable apparatus is further described in U.S. patent application Ser. No. 11/985,577, entitled “Microfluidic System for Amplifying and Detecting Polynucleotides in Parallel” and filed on Nov. 14, 2007, and which is incorporated herein by reference in its entirety.



FIG. 20 shows a perspective view of an exemplary apparatus 2000 consistent with those described herein, as well as various components thereof, such as exemplary cartridge 2010 that contains multiple sample lanes, and exemplary read head 2020 that contains detection apparatus for reading signals from cartridge 2010. The apparatus 2000 of FIG. 20 is able to carry out real-time PCR on a number of samples in cartridge 2010 simultaneously or serially. Preferably the number of samples is 12 samples, as illustrated with exemplary cartridge 2010, though other numbers of samples such as 4, 8, 10, 16, 20, 24, 25, 30, 32, 36, 40, and 48 are within the scope of the present description. In preferred operation of the apparatus, a PCR-ready solution containing the sample, and, optionally, one or more analyte-specific reagents (ASR's) is prepared, as further described elsewhere (see, e.g., U.S. patent application publication 2006-0166233, incorporated herein by reference), prior to introduction into cartridge 200.


In some embodiments, an apparatus includes: a receiving bay configured to selectively receive a microfluidic cartridge as described herein; at least one heat source thermally coupled to the receiving bay; and a processor coupled to the heat source, wherein the heat source is configured to selectively heat individual regions of individual sample lanes in the cartridge, and the processor is configured to control application of heat to the individual sample lanes, separately, in all simultaneously, or in groups simultaneously; at least one detector configured to detect one or more polynucleotides or a probe thereof in a sample in one or more of the individual sample lanes, separately or simultaneously; and a processor coupled to the detector to control the detector and to receive signals from the detector.



FIG. 21 shows a schematic cross-sectional view of a part of an apparatus as described herein, showing input of sample into a cartridge 2100 via a pipette 10 (such as a disposable pipette) and an inlet 202. Cartridge 2100 is situated in a suitably configured receiving bay 2112. Inlet 2102 is preferably configured to receive a pipette or the bottom end of a PCR tube and thereby accept sample for analysis with minimum waste, and with minimum introduction of air. Cartridge 2100 is disposed on top of and in contact with a heater substrate 2140. Read head 2130 is positioned above cartridge 2100 and a cover for optics 2131 restricts the amount of ambient light that can be detected by the read head.



FIG. 22 shows an example of 4-pipette head used for attaching disposable pipette tips, prior to dispensing PCR-ready sample into a cartridge as further described herein.


The receiving bay is a portion of the apparatus that is configured to selectively receive the microfluidic cartridge. For example, the receiving bay and the microfluidic cartridge can be complementary in shape so that the microfluidic cartridge is selectively received in, e.g., a single orientation. The microfluidic cartridge can have a registration member that fits into a complementary feature of the receiving bay. The registration member can be, for example, a cut-out on an edge of the cartridge, such as a corner that is cut-off, or one or more notches or grooves that are made on one or more of the sides in a distinctive pattern that prevents a cartridge from being loaded into the bay in more than one distinct orientation. By selectively receiving the cartridge, the receiving bay can help a user to place the cartridge so that the apparatus can properly operate on the cartridge. The cartridge can be designed to be slightly smaller than the dimensions of the receiving bay, for example by approximately 200-300 microns, for easy placement and removal of the cartridge.


The receiving bay can also be configured so that various components of the apparatus that operate on the microfluidic cartridge (heat sources, detectors, force members, and the like) are positioned to properly operate thereon. For example, a contact heat source can be positioned in the receiving bay such that it can be thermally coupled to one or more distinct locations on a microfluidic cartridge that is selectively received in the bay. Microheaters in the heater module as further described elsewhere herein were aligned with corresponding heat-requiring microcomponents (such as valves, pumps, gates, reaction chambers, etc). The microheaters can be designed to be slightly bigger than the heat requiring microfluidic components so that even though the cartridge may be off-centered from the heater, the individual components can still function effectively.


As further described elsewhere herein, the lower surface of the cartridge can have a layer of mechanically compliant heat transfer laminate that can enable thermal contact between the microfluidic substrate and the microheater substrate of the heater module. A minimal pressure of 1 psi can be employed for reliable operation of the thermal valves, gates and pumps present in the microfluidic cartridge.


In various embodiments of the apparatus, the apparatus can further include a sensor coupled to the processor, the sensor configured to sense whether the microfluidic cartridge is selectively received.


The heat source can be, for example, a heat source such as a resistive heater or network of resistive heaters. In preferred embodiments, the at least one heat source can be a contact heat source selected from a resistive heater (or network thereof), a radiator, a fluidic heat exchanger and a Peltier device. The contact heat source can be configured at the receiving bay to be thermally coupled to one or more distinct locations of a microfluidic cartridge received in the receiving bay, whereby the distinct locations are selectively heated. The contact heat source typically includes a plurality of contact heat sources, each configured at the receiving bay to be independently thermally coupled to a different distinct location in a microfluidic cartridge received therein, whereby the distinct locations are independently heated. The contact heat sources can be configured to be in direct physical contact with one or more distinct locations of a microfluidic cartridge received in the bay. In various embodiments, each contact source heater can be configured to heat a distinct location having an average diameter in 2 dimensions from about 1 millimeter (mm) to about 15 mm (typically about 1 mm to about 10 mm), or a distinct location having a surface area of between about 1 mm2 about 225 mm2 (typically between about 1 mm2 and about 100 mm2, or in some embodiments between about 5 mm2 and about 50 mm2). Various configurations of heat sources are further described in U.S. patent application Ser. No. 11/940,315, entitled “Heater Unit for Microfluidic Diagnostic System” and filed on even date herewith.


In various embodiments, the heat source is disposed in a heating module that is configured to be removable from the apparatus.


In various embodiments, the apparatus can include a compliant layer at the contact heat source configured to thermally couple the contact heat source with at least a portion of a microfluidic cartridge received in the receiving bay. The compliant layer can have a thickness of between about 0.05 and about 2 millimeters and a Shore hardness of between about 25 and about 100. Such a compliant layer may not be required if the instrument is able to reliably press the cartridge over the heater surface with a minimum contact pressure of say 1 psi over the entirety of the cartridge.


The detector can be, for example, an optical detector. For example, the detector can include a light source that selectively emits light in an absorption band of a fluorescent dye, and a light detector that selectively detects light in an emission band of the fluorescent dye, wherein the fluorescent dye corresponds to a fluorescent polynucleotide probe or a fragment thereof. Alternatively, for example, the optical detector can include a bandpass-filtered diode that selectively emits light in the absorption band of the fluorescent dye and a bandpass filtered photodiode that selectively detects light in the emission band of the fluorescent dye; or for example, the optical detector can be configured to independently detect a plurality of fluorescent dyes having different fluorescent emission spectra, wherein each fluorescent dye corresponds to a fluorescent polynucleotide probe or a fragment thereof; or for example, the optical detector can be configured to independently detect a plurality of fluorescent dyes at a plurality of different locations on a microfluidic cartridge, wherein each fluorescent dye corresponds to a fluorescent polynucleotide probe or a fragment thereof in a different sample. The detector can also be configured to detect the presence or absence of sample in a PCR reaction chamber in a given sample lane, and to condition initiation of thermocycling upon affirmative detection of presence of the sample. Further description of suitably configured detectors are described in U.S. patent application Ser. No. 11/940,321, filed on Nov. 14, 2007 and entitled “Fluorescence Detector for Microfluidic Diagnostic System”, incorporated herein by reference.


Although the various depictions therein show a heater substrate disposed underneath a microfluidic substrate, and a detector disposed on top of it, it would be understood that an inverted arrangement would work equally as well. In such an embodiment, the heater would be forced down onto the microfluidic substrate, making contact therewith, and the detector would be mounted underneath the substrate, disposed to collect light directed downwards towards it.


In another preferred embodiment (not shown in the FIGs. herein), a cartridge and apparatus are configured so that the read-head does not cover the sample inlets, thereby permitting loading of separate samples while other samples are undergoing PCR thermocycling.


In various embodiments, the apparatus can further include an analysis port. The analysis port can be configured to allow an external sample analyzer to analyze a sample in the microfluidic cartridge. For example, the analysis port can be a hole or window in the apparatus which can accept an optical detection probe that can analyze a sample or progress of PCR in situ in the microfluidic cartridge. In some embodiments, the analysis port can be configured to direct a sample from the microfluidic cartridge to an external sample analyzer; for example, the analysis port can include a conduit in fluid communication with the microfluidic cartridge that directs a liquid sample containing an amplified polynucleotide to a chromatography apparatus, an optical spectrometer, a mass spectrometer, or the like.


In various embodiments, the apparatus can further include one or more force members configured to apply force to at least a portion of a microfluidic cartridge received in the receiving bay. The one or more force members are configured to apply force to thermally couple the at least one heat source to at least a portion of the microfluidic cartridge. The application of force is important to ensure consistent thermal contact between the heater wafer and the PCR reactor and microvalves in the microfluidic cartridge.


The apparatus preferably also includes a processor, comprising microprocessor circuitry, in communication with, for example, the input device and a display, that accepts a user's instructions and controls analysis of samples.


In various embodiments, the apparatus can further include a lid at the receiving bay, the lid being operable to at least partially exclude ambient light from the receiving bay.


In various embodiments, the apparatus can further include at least one input device coupled to the processor, the input device being selected from the group consisting of a keyboard, a touch-sensitive surface, a microphone, and a mouse.


In various embodiments, the apparatus can further include at least one sample identifier coupled to the processor, the sample identifier being selected from an optical scanner such as an optical character reader, a bar code reader, or a radio frequency tag reader. For example, the sample identifier can be a handheld bar code reader.


In various embodiments, the apparatus can further include at least one data storage medium coupled to the processor, the medium selected from: a hard disk drive, an optical disk drive, or one or more removable storage media such as a CD-R, CD-RW, USB-drive, or flash memory card.


In various embodiments, the apparatus can further include at least one output coupled to the processor, the output being selected from a display, a printer, and a speaker, the coupling being either directly through a directly dedicated printer cable, or wirelessly, or via a network connection.


The apparatus further optionally comprises a display that communicates information to a user of the system. Such information includes but is not limited to: the current status of the system; progress of PCR thermocycling; and a warning message in case of malfunction of either system or cartridge. The display is preferably used in conjunction with an external input device as elsewhere described herein, through which a user may communicate instructions to apparatus 100. A suitable input device may further comprise a reader of formatted electronic media, such as, but not limited to, a flash memory card, memory stick, USB-stick, CD, or floppy diskette. An input device may further comprise a security feature such as a fingerprint reader, retinal scanner, magnetic strip reader, or barcode reader, for ensuring that a user of the system is in fact authorized to do so, according to pre-loaded identifying characteristics of authorized users. An input device may additionally—and simultaneously—function as an output device for writing data in connection with sample analysis. For example, if an input device is a reader of formatted electronic media, it may also be a writer of such media. Data that may be written to such media by such a device includes, but is not limited to, environmental information, such as temperature or humidity, pertaining to an analysis, as well as a diagnostic result, and identifying data for the sample in question.


The apparatus may further include a computer network connection that permits extraction of data to a remote location, such as a personal computer, personal digital assistant, or network storage device such as computer server or disk farm. The network connection can be a communications interface selected from the group consisting of: a serial connection, a parallel connection, a wireless network connection, and a wired network connection such as an ethernet or cable connection, wherein the communications interface is in communication with at least the processor. The computer network connection may utilize, e.g., ethernet, firewire, or USB connectivity. The apparatus may further be configured to permit a user to e-mail results of an analysis directly to some other party, such as a healthcare provider, or a diagnostic facility, or a patient.


In various embodiments, there is an associated computer program product includes computer readable instructions thereon for operating the apparatus and for accepting instructions from a user.


In various embodiments, the computer program product can include one or more instructions to cause the system to: output an indicator of the placement of the microfluidic cartridge in the receiving bay; read a sample label or a microfluidic cartridge label; output directions for a user to input a sample identifier; output directions for a user to load a sample transfer member with the PCR-ready sample; output directions for a user to introduce the PCR-ready sample into the microfluidic cartridge; output directions for a user to place the microfluidic cartridge in the receiving bay; output directions for a user to close the lid to operate the force member; output directions for a user to pressurize the PCR-ready sample in the microfluidic cartridge by injecting the PCR-ready sample with a volume of air between about 0.5 mL and about 5 mL; and output status information for sample progress from one or more lanes of the cartridge.


In various embodiments, the computer program product can include one or more instructions to cause the system to: heat the PCR ready-sample under thermal cycling conditions suitable for creating PCR amplicons from the neutralized polynucleotide; contact the neutralized polynucleotide sample or a PCR amplicon thereof with at least one probe that is selective for a polynucleotide sequence; independently contact each of the neutralized polynucleotide sample and a negative control polynucleotide with the PCR reagent mixture under thermal cycling conditions suitable for independently creating PCR amplicons of the neutralized polynucleotide sample and PCR amplicons of the negative control polynucleotide; contact the neutralized polynucleotide sample or a PCR amplicon thereof and the negative control polynucleotide or a PCR amplicon thereof with at least one probe that is selective for a polynucleotide sequence; output a determination of the presence of a polynucleotide sequence in the biological sample, the polynucleotide sequence corresponding to the probe, if the probe is detected in the neutralized polynucleotide sample or a PCR amplicon thereof; and/or output a determination of a contaminated result if the probe is detected in the negative control polynucleotide or a PCR amplicon thereof.


Apparatus 100 may optionally comprise one or more stabilizing feet that cause the body of the device to be elevated above a surface on which system 100 is disposed, thereby permitting ventilation underneath system 100, and also providing a user with an improved ability to lift system 100.


EXAMPLES
Example 1: 48 Lane Cartridge


FIG. 23 shows an exemplary 48-lane cartridge for carrying out PCR independently on 48 samples, and with a reaction volume of 10 microliter each. The area occupied by the entire cartridge is approximately 3.5 inches (8.9 cm) by 4.25 inches (10.8 cm). The sample lanes are organized as two groups of 24 each. The adjacent sample lanes in each of the two rows of 24 are spaced apart 4 mm (center-to-center). Trenches between the PCR lanes may be cut in order to isolate the heating of each PCR channel from those adjacent to it. This may be accomplished by etching, milling, controlled cutting, etc., during fabrication of the cartridge.



FIG. 24 shows a heater design used for actuating the 48 lane PCR cartridge of FIG. 23. The heating of each sample lane can be independently controlled.


Example 2: PCR Cartridge with Post-PCR Retrieval Capability

Many applications such as genotyping, sequencing, multiple analyte detection (microarray, electrochemical sensing) require post-PCR sample retrieval and subsequent analysis of the retrieved sample in a different instrument. The cartridge of this example, of which a 24 lane embodiment is shown in FIG. 25A, with a sample lane layout illustrated in FIG. 25B, accommodates such a retrieval capability. Each lane in the cartridge of FIG. 25A independently permits sample retrieval. The configuration of the lane of FIG. 25B is different from that of, e.g., FIG. 6 at least because of the presence of 2 gates and the alternative channel from the reactor, via Gate 1, to the inlet. Such features permit effective sample retrieval.


Sample DNA mixed with PCR enzymes is input into a sample lane 2501 through the inlet hole 2502 in the microfluidic network described below. The valves 2506, 2504 (valves 1 and 2) are initially open while the gates 2522, 2520 (gates 1 and 2) are closed, enabling the reaction mix to fill up the PCR reactor 2510 with the excess air venting out through vent hole 1 (label 2514). The valves 1 and 2 are then closed to seal off the reaction mixture. Thermocycling is initiated to conduct the PCR reaction within the PCR reactor. After the reaction is completed, a pipette is mechanically interfaced with the inlet hole 2502 and suction force applied to the pipette. Gates 1 and 2 are opened to enable the reacted sample to exit the PCR reactor and enter the pipette. This controlled opening of the PCR device will also prevent post-PCR contamination of the apparatus in which the cartridge resides as there is minimal exposure of the PCR product with the atmosphere.


It will be understood that reactions other than PCR can easily be performed in the cartridge of this example.


Example 3: 12-Lane Cartridge

The 12 channel cartridge of this example is the same basic design that is described and shown in FIG. 3, with the following modifications: the volume of the PCR reactor is increased from 2 μl to 4.5 μl, leading to an increase in the acceptable input volume from 4 μl to 6 μl. Increasing the reaction volume facilitates detection from even dilute samples (wherein the target DNA concentration may be low). In order to detect DNA in a reactor of say 1 microliter volume, there should be a minimum of 1-2 copies of the DNA in the 1 microliter for positive identification, i.e., the concentration should not be less than around 1-2 copies/microliter. Increasing the reaction volume to say 5 microliters will reduce the minimum acceptable starting DNA concentration by 5 fold. The inlet holes are moved a few millimeters away from the edge of the cartridge to allow room for a 2 mm alignment ledge in the cartridge. A similar alignment ledge is also included on the other edge of the cartridge. The alignment ledge permits the cartridges to be stacked during storage (or within a multi-cartridge spring-loader) without the hydrophobic vent of one cartridge coming into contact with a surface of an adjacent cartridge.


Example 4: 24-Lane Cartridge

This 24-lane cartridge has two rows of 12 sample lanes. Each lane has: a liquid inlet port, that interfaces with a disposable pipette; a 4 microliter PCR reaction chamber (1.5 mm wide, 300 microns deep and approximately 10 mm long), and two microvalves on either side of the PCR reactor and outlet vent. Microvalves are normally open, and close the channel on actuation. The outlet holes enable extra liquid (˜1 μl) to be contained in the fluidic channel in case more than 6 μl of fluid is dispensed into the cartridge. Thus, the cartridge of this example does not require a bubble vent as it will be used in an automated PCR machine having a reliable, precision liquid dispenser.


The inlet holes of the cartridge of this example are made conical in shape and have a diameter of 3-6 mm at the top to ensure that pipette tips can be easily landed by an automated fluid dispensing head into the conical hole, with some tolerance. There is also an optional raised annulus around the top of the holes. Once the pipette tip lands within the cone, the conical shape guides the pipette and mechanically seals to provide error free dispensing into, or withdrawal of fluid from, the cartridge. The bigger the holes, the better it is to align with the pipette, however, given the opposing need to maximize the number of inlet ports within the width of the cartridge as well as to maintain the pitch between holes compatible with the inter-pipette distance, the holes cannot be too big. In this design, the inter-pipette tip distance is 18 mm and the distance between the loading holes in the cartridge is 6 mm. So lanes 1, 4, 7, 11 are pipetted into during one dispensing operation that utilizes four pipette tips; lanes 2, 5, 8 and 12 in the next, and so on and so forth.


The height of the conical holes is kept lower than the height of the ledges on the edges of the cartridge to ensure the cartridges can be stacked on the ledges. The ledges on the two long edges of the cartridge enable stacking of the cartridges with minimal surface contact between two stacked cartridges and also help guide the cartridge into the reader from a spring-loader, where used.


Example 5: 12-Lane Cartridge

This 12-lane cartridge has 12 sample lanes in parallel, as shown in FIG. 1. Each lane has: a liquid inlet port that interfaces with a disposable pipette; a bubble vent; a PCR reaction chamber, and two microvalves on either side of the PCR reactor and outlet vent. Microvalves are normally open, and close the channel on actuation. The reaction volume is in the range 1-10 μl so that the number of copies of DNA will be sufficient for detection. Such a volume also permits the PCR reaction volume to be similar to release volume from a sample preparation procedure.


Example 6: Kit


FIG. 26 shows a representative sample kit 2610 that includes a microfluidic cartridge 2612 with a barcode label 2632, and one or more sample containers 2614 each also optionally having a barcode label.



FIG. 27 shows that one or more components of the sample kit, for example, microfluidic cartridge 2612, can be packaged in a sealed pouch 2624. The pouch can be hermetically sealed with an inert gas such as argon, nitrogen, or others.


The barcode labels of both cartridge and sample container can be read with a bar code reader prior to use.


Example 7: Apparatus and Process for Wax Loading of Valves

Exemplary Wax-Deposition Process


Deposition of wax in valves of the microfluidic network, as at step 1804 of FIG. 18 may be carried out with the exemplary equipment shown in FIGS. 28A and 28B. The DispenseJet Series DJ-9000 (available from Asymtek, Carlsbad, CA) is a non-contact dispenser suitable for this purpose that provides rapid delivery and high-precision volumetric control for various fluids, including surface mount adhesive, underfill, encapsulants, conformal coating, UW adhesives, and silver epoxy. The DJ-9000 jets in tight spaces as small as 200 micrometers and creates fillet wet-out widths as small as 300 micrometers on the dispensed side of a substrate such as a die. It dispenses fluid either as discrete dots or a rapid succession of dots to form a 100-micron (4 mil) diameter stream of fluid from the nozzle. It is fully compatible with other commercially available dispensing systems such as the Asymtek Century C-718/C-720, Millennium M-2000, and Axiom X-1000 Series Dispensing Systems.


A DJ-9000 is manufactured under quality control standards that aim to provide precise and reliable performance. Representative specifications of the apparatus are as follows.













Characteristic
Specification







Size
Width: 35 mm



Height: 110 mm



Depth: 100 mm


Weight
400 grams-dry


Feed Tube Assembly
Nylon-Fitting



Polyurethane-Tube


Fluid Chamber
Type 303 Stainless Steel


Seat and Nozzle
300/400 Series S/S, Carbide


Needle Assembly
52100 Bearing Steel-Shaft



Hard Chrome Plate



Carbide-Tip


Fluid Seal
PEEK/Stainless Steel


Fluid Chamber 0-Ring
Ethylene Propylene


Jet Body
6061-T6 Aluminum



Nickel Plated


Needle Assembly Bearings
PEEK


Thermal Control Body
6061-T6 Aluminum



Nickel Plated


Reservoir Holder
Acetyl


Reservoir Size
5, 10, or 30 cc (0.17, 0.34, or 1.0 oz)


Feed Tube Assembly Fitting
Female Luer per ANSI/HIMA



MD70.1-1983


Maximum Cycle Frequency
200 Hz.


Minimum Valve Air Pressure
5.5 bar (80 psi)


Operating Noise Level
70 db*


Solenoid
24 VDC, 12.7 Watts


Thermal Control Heater
24 VDC, 14.7 Watts, 40 ohms


Thermal Control RTD
100 ohm, platinum


Maximum Heater Set Point
80° C.





*At Maximum Cycle Rate






An exploded view of this apparatus is shown in FIG. 28B.


Theory of Operation of DJ-9000


The DJ-9000 has a normally closed, air-actuated, spring-return mechanism, which uses momentum transfer principles to expel precise volumes of material. Pressurized air is regulated by a high-speed solenoid to retract a needle assembly from the seat. Fluid, fed into the fluid chamber, flows over the seat. When the air is exhausted, the needle travels rapidly to the closed position, displacing fluid through the seat and nozzle in the form of a droplet. Multiple droplets fired in succession can be used to form larger dispense volumes and lines when combined with the motion of a dispenser robot.


The equipment has various adjustable features: The following features affect performance of the DJ-9000 and are typically adjusted to fit specific process conditions.


Fluid Pressure should be set so that fluid fills to the seat, but should not be influential in pushing the fluid through the seat and nozzle. In general, higher fluid pressure results in a larger volume of material jetted.


The Stroke Adjustment controls the travel distance of the Needle Assembly. The control is turned counterclockwise to increase needle assembly travel, or turned clockwise to decrease travel. An increase of travel distance will often result in a larger volume of material jetted.


The Solenoid Valve controls the valve operation. When energized, it allows air in the jet air chamber to compress a spring and thereby raise the Needle Assembly. When de-energized, the air is released and the spring forces the piston down so that the needle tip contacts the seat.


The seat and nozzle geometry are typically the main factors controlling dispensed material volume. The seat and nozzle size are determined based on the application and fluid properties. Other parameters are adjusted in accordance with seat and nozzle choices. Available seat and nozzle sizes are listed in the table hereinbelow.


Thermal Control Assembly: Fluid temperature often influences fluid viscosity and flow characteristics. The DJ-9000 is equipped with a Thermal Control Assembly that assures a constant fluid temperature.


Dot and Line Parameters: In addition to the DJ-9000 hardware configuration and settings, Dot and Line Parameters are set in a software program (referred to as FmNT) to control the size and quality of dots and lines dispensed.


Example 7: 24-Lane Cartridge


FIGS. 29A-29C show an exemplary 24-lane cartridge having three layers in its construction in which there is no hydrophobic membrane, and no thermally compliant layer. The three layers are a laminate 2922, a microfluidic substrate 2924, and a label 2926. A typical reaction vol. is 4.5 μl in each lane from 2 rows of 12 lanes. No bubble-removal vents are utilized and instead of a hydrophobic end vent, there is just a hole. This is consistent with use of an accurate pipetting system. There is no thermally compliant/conductive layer for situations where enough pressure can be reliably applied to the cartridge that effective thermal contact with the microfluidic substrate can be made without requiring the additional layer. The absence of two layers from the construction saves manufacturing costs.


Example 8: 96-Lane Cartridge


FIGS. 30A-D show aspects of a 96-lane cartridge design, including complementary heater configurations. (FIG. 30A shows cartridge design; 30B shows heater design in a single metal layer; 30C shows individual PCR channels overlaid with heater configurations; 30D shows individual PCR lanes.) In the embodiment shown, liquid sample is loaded without air bubbles as the lanes do not have any vents. Two or more Mux can be utilized for controlling all 96 PCR channels.


Such an arrangement lends itself to whole area imaging (e.g., by a CCD) for detection instead of optical based methods using diodes and lenses.


Example 9: Real-time PCR


FIG. 31 shows a trace of real-time PCR carried out on multiple samples in parallel with an apparatus and microfluidic network as described herein. The PCR curves are standard plots that are representative of fluorescence from 12 different PCR lanes as a function of cycle number.


The foregoing description is intended to illustrate various aspects of the present technology. It is not intended that the examples presented herein limit the scope of the present technology. The technology now being fully described, it will be apparent to one of ordinary skill in the art that many changes and modifications can be made thereto without departing from the spirit or scope of the appended claims.

Claims
  • 1. A method of isolating a plurality of polynucleotide-containing samples on a microfluidic cartridge, the method comprising: introducing a first polynucleotide-containing sample into a first reaction chamber via a first inlet, the first inlet in fluid communication with the first reaction chamber;introducing a second polynucleotide-containing sample into a second reaction chamber via a second inlet, the second inlet in fluid communication with the second reaction chamber, wherein the first polynucleotide-containing sample is different than the second polynucleotide-containing sample;isolating the first polynucleotide-containing sample within the first reaction chamber, wherein a first set of microfluidic valves is closed;independent of isolating the first polynucleotide-containing sample, isolating the second polynucleotide-containing sample within the second reaction chamber, wherein a second set of valves is closed; andapplying a minimum contact pressure of at least 1 psi over the microfluidic cartridge to contact the microfluidic cartridge to a heater of an instrument to assist in achieving better thermal contact between the heater of the instrument and heat-receivable parts of the microfluidic cartridge.
  • 2. The method of claim 1, wherein applying the minimum contact pressure comprises contacting a laminate on a lower surface of the microfluidic cartridge with the heater of the instrument.
  • 3. The method claim 1, further comprising amplifying one or more polynucleotides in the first reaction chamber independently of amplifying one or more polynucleotides in the second reaction chamber.
  • 4. The method claim 3, further comprising detecting amplified polynucleotides.
  • 5. The method claim 4, wherein detecting amplified polynucleotides comprises use of an optical detector comprising a light source that selectively emits light in an absorption band of a fluorescent dye and a light detector that selectively detects light in an emission band of the fluorescent dye, wherein the fluorescent dye corresponds to a fluorescent polynucleotide probe or a fragment thereof.
  • 6. The method claim 1, wherein the heater of the instrument is configured to heat the first reaction chamber.
  • 7. The method claim 1, further comprising selectively receiving the microfluidic cartridge in a bay.
  • 8. The method claim 1, further comprising fitting a registration member of the microfluidic cartridge into a complementary feature.
  • 9. The method of claim 1, wherein the heater of the instrument is selected from a resistive heater, a radiator, a fluidic heat exchanger, and a Peltier device.
  • 10. A method of isolating a plurality of polynucleotide-containing samples on a microfluidic cartridge, the method comprising: providing the microfluidic cartridge comprising a plurality of sample lanes, wherein each of the plurality of sample lanes comprises a microfluidic network having, in fluid communication with one another: a first valve;a second valve;a reaction chamber,a first channel leading, via the first valve, to the reaction chamber; anda second channel leading, via the second valve, from the reaction chamber;introducing a first polynucleotide-containing sample into a first reaction chamber in a first microfluidic network and introducing a second polynucleotide-containing sample into a second reaction chamber in a second microfluidic network, wherein the first polynucleotide-containing sample is different than the second polynucleotide-containing sample;isolating the first polynucleotide-containing sample to prevent movement into or out of the first reaction chamber, wherein the first valve and the second valve of the first microfluidic network are closed when the first polynucleotide-containing sample is isolated;isolating the second polynucleotide-containing sample to prevent movement into or out of the second reaction chamber, wherein the first valve and the second valve of the second microfluidic network are closed when the second polynucleotide-containing sample is isolated; andapplying a contact pressure of at least 1 psi to the microfluidic cartridge to thermally couple at least one heat source to one or more distinct locations on the microfluidic cartridge.
  • 11. The method claim 10, wherein the contact pressure is applied to the microfluidic cartridge using a force member.
  • 12. The method of claim 10, further comprising amplifying one or more polynucleotides in the first reaction chamber independently of amplifying one or more polynucleotides in the second reaction chamber.
  • 13. The method of claim 10, wherein isolating the first polynucleotide-containing sample and isolating the second polynucleotide-containing sample comprises closing the first valve in the first microfluidic network independent of closing the first valve in the second microfluidic network.
  • 14. The method claim 10, further comprising detecting amplified nucleotides with an optical detector comprising a light source that selectively emits light in an absorption band of a fluorescent dye and a light detector that selectively detects light in an emission band of the fluorescent dye, wherein the fluorescent dye corresponds to a fluorescent polynucleotide probe or a fragment thereof.
  • 15. The method of claim 10, wherein the at least one heat source is disposed underneath the microfluidic cartridge and a detector is disposed over the microfluidic cartridge.
  • 16. A method of isolating a plurality of polynucleotide-containing samples on a microfluidic cartridge, the method comprising: providing the microfluidic cartridge comprising a plurality of sample lanes, wherein each of the plurality of sample lanes comprises a microfluidic network having, in fluid communication with one another: a first valve;a second valve;a reaction chamber,a first channel leading, via the first valve, to the reaction chamber; anda second channel leading, via the second valve, from the reaction chamber;introducing a first polynucleotide-containing sample into a first reaction chamber in a first microfluidic network and introducing a second polynucleotide-containing sample into a second reaction chamber in a second microfluidic network, wherein the first polynucleotide-containing sample is different than the second polynucleotide-containing sample;isolating the first polynucleotide-containing sample in the first reaction chamber;isolating the second polynucleotide-containing sample in the second reaction chamber,amplifying the first polynucleotide-containing sample in the first reaction chamber;amplifying the second polynucleotide-containing sample in the second reaction chamber;applying contact force of at least 1 psi by a contact force member to press the microfluidic cartridge over heaters so that the first reaction chamber and the second reaction chamber of the microfluidic cartridge make thermal contact with the heaters for amplification.
  • 17. The method claim 16, further comprising detecting amplified nucleotides with an optical detector comprising a light source that selectively emits light in an absorption band of a fluorescent dye and a light detector that selectively detects light in an emission band of the fluorescent dye, wherein the fluorescent dye corresponds to a fluorescent polynucleotide probe or a fragment thereof.
  • 18. The method of claim 16, further comprising amplifying one or more polynucleotides in the first reaction chamber independently of amplifying one or more polynucleotides in the second reaction chamber.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/809,248, filed Nov. 10, 2017, which is a continuation of U.S. patent application Ser. No. 14/263,208, filed Apr. 28, 2014 and issued as U.S. Pat. No. 9,815,057 on Nov. 14, 2017, which is a continuation of U.S. patent application Ser. No. 11/940,310, filed Nov. 14, 2007 and issued as U.S. Pat. No. 8,709,787 on Apr. 29, 2014, which claims the benefit of U.S. Provisional Patent Application No. 60/859,284, filed Nov. 14, 2006, and U.S. Provisional Patent Application No. 60/959,437, filed Jul. 13, 2007. The disclosures of all the above-referenced prior applications, publications, and patents are considered part of the disclosure of this application, and are incorporated by reference herein in their entirety.

US Referenced Citations (1131)
Number Name Date Kind
D189404 Nicolle Dec 1960 S
3050239 Williams Aug 1962 A
3444742 Ellis et al. May 1969 A
3905772 Hartnett et al. Sep 1975 A
3985649 Eddelman Oct 1976 A
4018089 Dzula et al. Apr 1977 A
4018652 Lanham et al. Apr 1977 A
4038192 Serur Jul 1977 A
4055395 Honkawa et al. Oct 1977 A
D249706 Adamski Sep 1978 S
4139005 Dickey Feb 1979 A
D252157 Kronish et al. Jun 1979 S
D252341 Thomas Jul 1979 S
D254687 Fadler et al. Apr 1980 S
4212744 Oota Jul 1980 A
D261033 Armbruster Sep 1981 S
D261173 Armbruster Oct 1981 S
4301412 Hill et al. Nov 1981 A
4439526 Columbus Mar 1984 A
4457329 Werley et al. Jul 1984 A
4466740 Kano et al. Aug 1984 A
4472357 Levy et al. Sep 1984 A
4504582 Swann Mar 1985 A
4522786 Ebersole Jun 1985 A
D279817 Chen et al. Jul 1985 S
D282208 Lowry Jan 1986 S
4599315 Terasaki et al. Jul 1986 A
4612873 Eberle Sep 1986 A
4612959 Costello Sep 1986 A
D288478 Carlson et al. Feb 1987 S
4647432 Wakatake Mar 1987 A
4654127 Baker et al. Mar 1987 A
4673657 Christian Jun 1987 A
4678752 Thorne et al. Jul 1987 A
4683195 Mullis et al. Jul 1987 A
4683202 Mullis Jul 1987 A
4698302 Whitehead et al. Oct 1987 A
D292735 Lovborg Nov 1987 S
4720374 Ramachandran Jan 1988 A
4724207 Hou et al. Feb 1988 A
4795698 Owen et al. Jan 1989 A
4798693 Mase et al. Jan 1989 A
4800022 Leonard Jan 1989 A
4827944 Nugent May 1989 A
4841786 Schulz Jun 1989 A
D302294 Hillman Jul 1989 S
4855110 Marker et al. Aug 1989 A
4871779 Killat et al. Oct 1989 A
4889818 Gelfand et al. Dec 1989 A
4895650 Wang Jan 1990 A
4902624 Columbus et al. Feb 1990 A
4914710 Ward et al. Apr 1990 A
4919829 Gates et al. Apr 1990 A
4921809 Schiff et al. May 1990 A
4935342 Seligson et al. Jun 1990 A
4946562 Guruswamy Aug 1990 A
4948561 Hinckley et al. Aug 1990 A
4949742 Rando et al. Aug 1990 A
D310413 Bigler et al. Sep 1990 S
4963498 Hillman Oct 1990 A
4965188 Mullis et al. Oct 1990 A
4967950 Legg et al. Nov 1990 A
D312692 Bradley Dec 1990 S
4978502 Dole et al. Dec 1990 A
4978622 Mishell et al. Dec 1990 A
4989626 Takagi et al. Feb 1991 A
4994373 Stavrianopoulos et al. Feb 1991 A
4997772 Sutton et al. Mar 1991 A
5001417 Pumphrey et al. Mar 1991 A
5004583 Guruswamy et al. Apr 1991 A
5048554 Kremer Sep 1991 A
5053199 Keiser et al. Oct 1991 A
5060823 Perlman Oct 1991 A
5061336 Soane Oct 1991 A
5064618 Baker et al. Nov 1991 A
5071531 Soane Dec 1991 A
5089233 DeVaney, Jr. et al. Feb 1992 A
5091328 Miller Feb 1992 A
D324426 Fan et al. Mar 1992 S
5096669 Lauks et al. Mar 1992 A
5098663 Berthold et al. Mar 1992 A
D325638 Sloat et al. Apr 1992 S
5126002 Iwata et al. Jun 1992 A
5126022 Soane et al. Jun 1992 A
D328135 Fan et al. Jul 1992 S
D328794 Frenkel et al. Aug 1992 S
5135627 Soane Aug 1992 A
5135872 Pouletty et al. Aug 1992 A
5147606 Charlton et al. Sep 1992 A
5147777 Sutton et al. Sep 1992 A
5155166 Danielson et al. Oct 1992 A
5169512 Wiedenmann et al. Dec 1992 A
5173269 Mon et al. Dec 1992 A
D333522 Gianino Feb 1993 S
5186339 Heissler Feb 1993 A
5192507 Taylor et al. Mar 1993 A
5208163 Charlton et al. May 1993 A
5217694 Gibler et al. Jun 1993 A
5223226 Wittmer et al. Jun 1993 A
5229297 Schnipelsky et al. Jul 1993 A
5231015 Cummins et al. Jul 1993 A
D338275 Fischer et al. Aug 1993 S
5234809 Boom et al. Aug 1993 A
5250263 Manz Oct 1993 A
5252743 Barrett et al. Oct 1993 A
5256376 Callan et al. Oct 1993 A
5273716 Northrup et al. Dec 1993 A
5275787 Yuguchi et al. Jan 1994 A
5282950 Dietze et al. Feb 1994 A
5296375 Kricka et al. Mar 1994 A
5304477 Nagoh et al. Apr 1994 A
5304487 Wilding et al. Apr 1994 A
D347478 Pinkney May 1994 S
5311896 Kaartinen et al. May 1994 A
5311996 Duffy et al. May 1994 A
5316727 Suzuki et al. May 1994 A
5327038 Culp Jul 1994 A
5334499 Burdick et al. Aug 1994 A
5338671 Scalice et al. Aug 1994 A
5339486 Persic, Jr. Aug 1994 A
D351475 Gerber Oct 1994 S
D351913 Hieb et al. Oct 1994 S
5364591 Green et al. Nov 1994 A
5372946 Cusak et al. Dec 1994 A
5374395 Robinson Dec 1994 A
5384499 Pedersen et al. Jan 1995 A
5389339 Petschek et al. Feb 1995 A
D356232 Armstrong et al. Mar 1995 S
5397709 Berndt Mar 1995 A
5401465 Smethers et al. Mar 1995 A
5411708 Moscetta et al. May 1995 A
5414245 Hackleman May 1995 A
5415839 Zaun et al. May 1995 A
5416000 Allen et al. May 1995 A
5422271 Chen et al. Jun 1995 A
5422284 Lau Jun 1995 A
5427946 Kricka et al. Jun 1995 A
5443791 Cathcart et al. Aug 1995 A
5466574 Liberti et al. Nov 1995 A
5474796 Brennan Dec 1995 A
5475487 Mariella, Jr. et al. Dec 1995 A
D366116 Biskupski Jan 1996 S
5486335 Wilding et al. Jan 1996 A
5494639 Grzegorzewski Feb 1996 A
5498392 Wilding et al. Mar 1996 A
5503803 Brown Apr 1996 A
5516410 Schneider et al. May 1996 A
5519635 Miyake et al. May 1996 A
5529677 Schneider et al. Jun 1996 A
5559432 Logue Sep 1996 A
5565171 Dovichi et al. Oct 1996 A
5569364 Hooper et al. Oct 1996 A
5576218 Zurek et al. Nov 1996 A
5578270 Reichler et al. Nov 1996 A
5578818 Kain et al. Nov 1996 A
5579928 Anukwuem Dec 1996 A
5580523 Bard Dec 1996 A
5582884 Ball et al. Dec 1996 A
5582988 Backus et al. Dec 1996 A
5585069 Zanucchi et al. Dec 1996 A
5585089 Queen et al. Dec 1996 A
5585242 Bouma et al. Dec 1996 A
5587128 Wilding et al. Dec 1996 A
5589136 Northrup et al. Dec 1996 A
5593838 Zanzucchi et al. Jan 1997 A
5595708 Berndt Jan 1997 A
5599432 Manz et al. Feb 1997 A
5599503 Manz et al. Feb 1997 A
5599667 Arnold, Jr. et al. Feb 1997 A
5601727 Bormann et al. Feb 1997 A
5603351 Cherukuri et al. Feb 1997 A
5605662 Heller et al. Feb 1997 A
5609910 Hackleman Mar 1997 A
D378782 LaBarbera et al. Apr 1997 S
5628890 Carter et al. May 1997 A
5630920 Friese et al. May 1997 A
5631337 Sassi et al. May 1997 A
5632876 Zanzucchi et al. May 1997 A
5632957 Heller et al. May 1997 A
5635358 Wilding et al. Jun 1997 A
5637469 Wilding et al. Jun 1997 A
5639423 Northrup et al. Jun 1997 A
5639428 Cottingham Jun 1997 A
5643738 Zanzucchi et al. Jul 1997 A
5645801 Bouma et al. Jul 1997 A
5646039 Northrup et al. Jul 1997 A
5646049 Tayi Jul 1997 A
5647994 Tuunanen et al. Jul 1997 A
5651839 Rauf Jul 1997 A
5652141 Henco et al. Jul 1997 A
5652149 Mileaf et al. Jul 1997 A
D382346 Buhler et al. Aug 1997 S
D382647 Staples et al. Aug 1997 S
5654141 Mariani et al. Aug 1997 A
5658515 Lee et al. Aug 1997 A
5667976 Van Ness et al. Sep 1997 A
5671303 Shieh et al. Sep 1997 A
5674394 Whitmore Oct 1997 A
5674742 Northrup et al. Oct 1997 A
5681484 Zanzucchi et al. Oct 1997 A
5681529 Taguchi et al. Oct 1997 A
5683657 Mian Nov 1997 A
5683659 Hovatter Nov 1997 A
5699157 Parce et al. Dec 1997 A
5700429 Bühler et al. Dec 1997 A
5700637 Southern Dec 1997 A
5705610 Zuckermann et al. Jan 1998 A
5705813 Apffel et al. Jan 1998 A
5720923 Haff et al. Feb 1998 A
5721136 Finney et al. Feb 1998 A
5725831 Reichler et al. Mar 1998 A
5726026 Wilding et al. Mar 1998 A
5726404 Brody Mar 1998 A
5726944 Pelley et al. Mar 1998 A
5731212 Gavin et al. Mar 1998 A
5744366 Kricka et al. Apr 1998 A
5746978 Bienhaus et al. May 1998 A
5747666 Willis May 1998 A
5750015 Soane et al. May 1998 A
5755942 Zanzucchi et al. May 1998 A
5762874 Seaton et al. Jun 1998 A
5763262 Wong et al. Jun 1998 A
5770029 Nelson et al. Jun 1998 A
5770388 Vorpahl Jun 1998 A
5772966 Maracas et al. Jun 1998 A
5779868 Parce et al. Jul 1998 A
5783148 Cottingham et al. Jul 1998 A
5787032 Heller et al. Jul 1998 A
5788814 Sun et al. Aug 1998 A
5800600 Lima-Marques et al. Sep 1998 A
5800690 Chow et al. Sep 1998 A
5804436 Okun et al. Sep 1998 A
D399959 Prokop et al. Oct 1998 S
5819749 Lee et al. Oct 1998 A
5827481 Bente et al. Oct 1998 A
5842106 Thaler et al. Nov 1998 A
5842787 Kopf-Sill et al. Dec 1998 A
5846396 Zanzucchi et al. Dec 1998 A
5846493 Bankier et al. Dec 1998 A
5849208 Hayes et al. Dec 1998 A
5849486 Heller et al. Dec 1998 A
5849489 Heller Dec 1998 A
5849598 Wilson et al. Dec 1998 A
5851492 Blattner Dec 1998 A
5852495 Parce Dec 1998 A
5856174 Lipshutz et al. Jan 1999 A
5858187 Ramsey et al. Jan 1999 A
5858188 Soane et al. Jan 1999 A
5863502 Southgate et al. Jan 1999 A
5863708 Zanzucchi et al. Jan 1999 A
5863801 Southgate et al. Jan 1999 A
5866345 Wilding et al. Feb 1999 A
5869004 Parce et al. Feb 1999 A
5869244 Martin et al. Feb 1999 A
5872010 Karger et al. Feb 1999 A
5872623 Stabile et al. Feb 1999 A
5874046 Megerle Feb 1999 A
5876675 Kennedy Mar 1999 A
5880071 Parce et al. Mar 1999 A
5882465 McReynolds Mar 1999 A
5883211 Sassi et al. Mar 1999 A
5885432 Hooper et al. Mar 1999 A
5885470 Parce et al. Mar 1999 A
5895762 Greenfield et al. Apr 1999 A
5900130 Benvegnu et al. May 1999 A
5911737 Lee et al. Jun 1999 A
5912124 Kumar Jun 1999 A
5912134 Shartle Jun 1999 A
5914229 Loewy Jun 1999 A
5916522 Boyd et al. Jun 1999 A
5916776 Kumar Jun 1999 A
5919646 Okun et al. Jul 1999 A
5919711 Boyd et al. Jul 1999 A
5922289 Wong Jul 1999 A
5922591 Anderson et al. Jul 1999 A
5927547 Papen et al. Jul 1999 A
5928161 Krulevitch et al. Jul 1999 A
5928880 Wilding et al. Jul 1999 A
5929208 Heller et al. Jul 1999 A
D413391 Lapeus et al. Aug 1999 S
5932799 Moles Aug 1999 A
5935401 Amigo Aug 1999 A
5939291 Loewy et al. Aug 1999 A
5939312 Baier et al. Aug 1999 A
5942443 Parce et al. Aug 1999 A
5944717 Lee et al. Aug 1999 A
D413677 Dumitrescu et al. Sep 1999 S
D414271 Mendoza Sep 1999 S
5948227 Dubrow Sep 1999 A
5948363 Gaillard Sep 1999 A
5948673 Cottingham Sep 1999 A
5955028 Chow Sep 1999 A
5955029 Wilding et al. Sep 1999 A
5957579 Kopf-Sill et al. Sep 1999 A
5958203 Parce et al. Sep 1999 A
5958349 Petersen et al. Sep 1999 A
5958694 Nikiforov Sep 1999 A
5959221 Boyd et al. Sep 1999 A
5959291 Jensen Sep 1999 A
5935522 Swerdlow et al. Oct 1999 A
5964995 Nikiforov et al. Oct 1999 A
5964997 McBride Oct 1999 A
5965001 Chow et al. Oct 1999 A
5965410 Chow et al. Oct 1999 A
5965886 Sauer et al. Oct 1999 A
5968745 Thorp et al. Oct 1999 A
5972187 Parce et al. Oct 1999 A
5973138 Collis Oct 1999 A
D417009 Boyd Nov 1999 S
5976336 Dubrow et al. Nov 1999 A
5980704 Cherukuri et al. Nov 1999 A
5980719 Cherukuri et al. Nov 1999 A
5981735 Thatcher et al. Nov 1999 A
5985651 Hunicke-Smith Nov 1999 A
5989402 Chow et al. Nov 1999 A
5992820 Fare et al. Nov 1999 A
5993611 Moroney, III et al. Nov 1999 A
5993750 Ghosh et al. Nov 1999 A
5997708 Craig Dec 1999 A
6001229 Ramsey Dec 1999 A
6001231 Kopf-Sill Dec 1999 A
6001307 Naka et al. Dec 1999 A
6004450 Northrup et al. Dec 1999 A
6004515 Parce et al. Dec 1999 A
6007690 Nelson et al. Dec 1999 A
6010607 Ramsey Jan 2000 A
6010608 Ramsey Jan 2000 A
6010627 Hood, III Jan 2000 A
6012902 Parce Jan 2000 A
D420747 Dumitrescu et al. Feb 2000 S
D421130 Cohen et al. Feb 2000 S
6024920 Cunanan Feb 2000 A
D421653 Purcell Mar 2000 S
6033546 Ramsey Mar 2000 A
6033880 Haff et al. Mar 2000 A
6043080 Lipshutz et al. Mar 2000 A
6043880 Andrews et al. Mar 2000 A
6046056 Parce et al. Apr 2000 A
6048734 Burns et al. Apr 2000 A
6054034 Soane et al. Apr 2000 A
6054277 Furcht et al. Apr 2000 A
6056860 Amigo et al. May 2000 A
6057149 Burns et al. May 2000 A
6062261 Jacobson et al. May 2000 A
6063341 Fassbind et al. May 2000 A
6063589 Kellogg et al. May 2000 A
6066300 Carey et al. May 2000 A
6068751 Neukermans May 2000 A
6068752 Dubrow et al. May 2000 A
6071478 Chow Jun 2000 A
6074725 Kennedy Jun 2000 A
6074827 Nelson et al. Jun 2000 A
D428497 Lapeus et al. Jul 2000 S
6086740 Kennedy Jul 2000 A
6096509 Okun et al. Aug 2000 A
6100541 Nagle et al. Aug 2000 A
6102897 Lang Aug 2000 A
6103537 Ullman et al. Aug 2000 A
6106685 McBride et al. Aug 2000 A
6110343 Ramsey et al. Aug 2000 A
6117398 Bienhaus et al. Sep 2000 A
6123205 Dumitrescu et al. Sep 2000 A
6123798 Gandhi et al. Sep 2000 A
6130098 Handique et al. Oct 2000 A
6132580 Mathies et al. Oct 2000 A
6132684 Marino Oct 2000 A
6133436 Koster et al. Oct 2000 A
D433759 Mathis et al. Nov 2000 S
6143250 Tajima Nov 2000 A
6143547 Hsu Nov 2000 A
6149787 Chow et al. Nov 2000 A
6149872 Mack et al. Nov 2000 A
6156199 Zuk, Jr. Dec 2000 A
6158269 Dorenkott et al. Dec 2000 A
6167910 Chow Jan 2001 B1
6168948 Anderson et al. Jan 2001 B1
6171850 Nagle et al. Jan 2001 B1
6174675 Chow et al. Jan 2001 B1
6180950 Olsen Jan 2001 B1
D438311 Yamanishi et al. Feb 2001 S
6190619 Kilcoin et al. Feb 2001 B1
6194563 Cruickshank Feb 2001 B1
D438632 Miller Mar 2001 S
D438633 Miller Mar 2001 S
D439673 Brophy et al. Mar 2001 S
6197595 Anderson et al. Mar 2001 B1
6203759 Pelc et al. Mar 2001 B1
6211989 Wulf et al. Apr 2001 B1
6213151 Jacobson et al. Apr 2001 B1
6221600 MacLeod et al. Apr 2001 B1
6228635 Armstrong et al. May 2001 B1
6232072 Fisher May 2001 B1
6235175 Dubrow et al. May 2001 B1
6235313 Mathiowitz et al. May 2001 B1
6235471 Knapp et al. May 2001 B1
6236456 Giebeler et al. May 2001 B1
6236581 Foss et al. May 2001 B1
6238626 Higuchi et al. May 2001 B1
6251343 Dubrow et al. Jun 2001 B1
6254826 Acosta et al. Jul 2001 B1
6259635 Khouri et al. Jul 2001 B1
6261431 Mathies et al. Jul 2001 B1
6267858 Parce et al. Jul 2001 B1
D446306 Ochi et al. Aug 2001 S
6271021 Burns et al. Aug 2001 B1
6274089 Chow et al. Aug 2001 B1
6280967 Ransom et al. Aug 2001 B1
6281008 Komai et al. Aug 2001 B1
6284113 Bjornson et al. Sep 2001 B1
6284470 Bitner et al. Sep 2001 B1
6287254 Dodds Sep 2001 B1
6287774 Nikiforov Sep 2001 B1
6291248 Haj-Ahmad Sep 2001 B1
6294063 Becker et al. Sep 2001 B1
6300124 Blumenfeld et al. Oct 2001 B1
6302134 Kellogg et al. Oct 2001 B1
6302304 Spencer Oct 2001 B1
6303343 Kopf-sill Oct 2001 B1
6306273 Wainright et al. Oct 2001 B1
6306590 Mehta et al. Oct 2001 B1
6310199 Smith et al. Oct 2001 B1
6316774 Giebeler et al. Nov 2001 B1
6319469 Mian et al. Nov 2001 B1
6319474 Krulevitch et al. Nov 2001 B1
6322683 Wolk et al. Nov 2001 B1
6326083 Yang et al. Dec 2001 B1
6326147 Oldham et al. Dec 2001 B1
6326211 Anderson et al. Dec 2001 B1
6334980 Hayes et al. Jan 2002 B1
6337435 Chu et al. Jan 2002 B1
6352673 Rainin et al. Mar 2002 B1
6353475 Jensen et al. Mar 2002 B1
6358387 Kopf-sill et al. Mar 2002 B1
6366924 Parce Apr 2002 B1
6368561 Rutishauser et al. Apr 2002 B1
6368871 Christel et al. Apr 2002 B1
6370206 Schenk Apr 2002 B1
6375185 Lin Apr 2002 B1
6375901 Robotti et al. Apr 2002 B1
6379884 Wada et al. Apr 2002 B2
6379929 Burns et al. Apr 2002 B1
6379974 Parce et al. Apr 2002 B1
6382254 Yang et al. May 2002 B1
6391541 Petersen et al. May 2002 B1
6391623 Besemer et al. May 2002 B1
6395161 Schneider et al. May 2002 B1
6398956 Coville et al. Jun 2002 B1
6399025 Chow Jun 2002 B1
6399389 Parce et al. Jun 2002 B1
6399952 Maher et al. Jun 2002 B1
6401552 Elkins Jun 2002 B1
6403338 Knapp et al. Jun 2002 B1
6408878 Unger et al. Jun 2002 B2
6413401 Chow et al. Jul 2002 B1
6416642 Alajoki et al. Jul 2002 B1
6420143 Kopf-sill Jul 2002 B1
6425972 McReynolds Jul 2002 B1
D461906 Pham Aug 2002 S
6428987 Franzen Aug 2002 B2
6430512 Gallagher Aug 2002 B1
6432366 Ruediger et al. Aug 2002 B2
6440725 Pourahmadi et al. Aug 2002 B1
D463031 Slomski et al. Sep 2002 S
6444461 Knapp et al. Sep 2002 B1
6447661 Chow et al. Sep 2002 B1
6447727 Parce et al. Sep 2002 B1
6448047 Dattagupta et al. Sep 2002 B2
6448064 Vo-Dinh et al. Sep 2002 B1
6453928 Kaplan et al. Sep 2002 B1
6458259 Parce et al. Oct 2002 B1
6461570 Ishihara et al. Oct 2002 B2
6465257 Parce et al. Oct 2002 B1
6468761 Yang et al. Oct 2002 B2
6472141 Nikiforov Oct 2002 B2
D466219 Wynschenk et al. Nov 2002 S
6475364 Dubrow et al. Nov 2002 B1
D467348 McMichael et al. Dec 2002 S
D467349 Niedbala et al. Dec 2002 S
6488897 Dubrow et al. Dec 2002 B2
6495104 Unno et al. Dec 2002 B1
6498497 Chow et al. Dec 2002 B1
6500323 Chow et al. Dec 2002 B1
6500390 Boulton et al. Dec 2002 B1
D468437 McMenamy et al. Jan 2003 S
6506609 Wada et al. Jan 2003 B1
6509186 Zou et al. Jan 2003 B1
6509193 Tajima Jan 2003 B1
6511853 Kopf-sill et al. Jan 2003 B1
D470595 Crisanti et al. Feb 2003 S
6515753 Maher Feb 2003 B2
6517783 Horner et al. Feb 2003 B2
6520197 Deshmukh et al. Feb 2003 B2
6521181 Northrup et al. Feb 2003 B1
6521188 Webster Feb 2003 B1
6524456 Ramsey et al. Feb 2003 B1
6524532 Northrup Feb 2003 B1
6524790 Kopf-sill et al. Feb 2003 B1
D472324 Rumore et al. Mar 2003 S
6534295 Tai et al. Mar 2003 B2
6537432 Schneider et al. Mar 2003 B1
6537771 Farinas et al. Mar 2003 B1
6540896 Manz et al. Apr 2003 B1
6544734 Briscoe et al. Apr 2003 B1
6547942 Parce et al. Apr 2003 B1
6555389 Ullman et al. Apr 2003 B1
6556923 Gallagher et al. Apr 2003 B2
D474279 Mayer et al. May 2003 S
D474280 Niedbala et al. May 2003 S
6558916 Veerapandian et al. May 2003 B2
6558945 Kao May 2003 B1
6565815 Chang et al. May 2003 B1
6569607 McReynolds May 2003 B2
6572830 Burdon et al. Jun 2003 B1
6575188 Parunak Jun 2003 B2
6576459 Miles et al. Jun 2003 B2
6579453 Bächler et al. Jun 2003 B1
6589729 Chan et al. Jul 2003 B2
6592821 Wada et al. Jul 2003 B1
6597450 Andrews et al. Jul 2003 B1
6602474 Tajima Aug 2003 B1
6605475 Taylor et al. Aug 2003 B1
6613211 Mccormick et al. Sep 2003 B1
6613512 Kopf-sill et al. Sep 2003 B1
6613580 Chow et al. Sep 2003 B1
6613581 Wada et al. Sep 2003 B1
6614030 Maher et al. Sep 2003 B2
6620625 Wolk et al. Sep 2003 B2
6623860 Hu et al. Sep 2003 B2
6627406 Singh et al. Sep 2003 B1
D480814 Lafferty et al. Oct 2003 S
6632655 Mehta et al. Oct 2003 B1
6633785 Kasahara et al. Oct 2003 B1
D482796 Oyama et al. Nov 2003 S
6640981 Lafond et al. Nov 2003 B2
6649358 Parce et al. Nov 2003 B1
6664104 Pourahmadi et al. Dec 2003 B2
6669831 Chow et al. Dec 2003 B2
6670133 Knapp et al. Dec 2003 B2
6670153 Stern Dec 2003 B2
D484989 Gebrian Jan 2004 S
6672458 Hansen et al. Jan 2004 B2
6681616 Spaid et al. Jan 2004 B2
6681788 Parce et al. Jan 2004 B2
6685813 Williams et al. Feb 2004 B2
6692700 Handique Feb 2004 B2
6695009 Chien et al. Feb 2004 B2
6699713 Benett et al. Mar 2004 B2
6706519 Kellogg et al. Mar 2004 B1
6720148 Nikiforov Apr 2004 B1
6730206 Ricco et al. May 2004 B2
6733645 Chow May 2004 B1
6734401 Bedingham et al. May 2004 B2
6737026 Bergh et al. May 2004 B1
6740518 Duong et al. May 2004 B1
D491272 Alden et al. Jun 2004 S
D491273 Biegler et al. Jun 2004 S
D491276 Langille Jun 2004 S
6750661 Brooks et al. Jun 2004 B2
6752966 Chazan Jun 2004 B1
6756019 Dubrow et al. Jun 2004 B1
6762049 Zou et al. Jul 2004 B2
6764859 Kreuwel et al. Jul 2004 B1
6766817 Dias da Silva Jul 2004 B2
6773567 Wolk Aug 2004 B1
6777184 Nikiforov et al. Aug 2004 B2
6783962 Olander et al. Aug 2004 B1
D495805 Lea et al. Sep 2004 S
6787015 Lackritz et al. Sep 2004 B2
6787016 Tan et al. Sep 2004 B2
6787111 Roach et al. Sep 2004 B2
6790328 Jacobson et al. Sep 2004 B2
6790330 Gascoyne et al. Sep 2004 B2
6811668 Berndt et al. Nov 2004 B1
6818113 Williams et al. Nov 2004 B2
6819027 Saraf Nov 2004 B2
6824663 Boone Nov 2004 B1
D499813 Wu Dec 2004 S
D500142 Crisanti et al. Dec 2004 S
D500363 Fanning et al. Dec 2004 S
6827831 Chow et al. Dec 2004 B1
6827906 Björnson et al. Dec 2004 B1
6838156 Neyer et al. Jan 2005 B1
6838680 Maher et al. Jan 2005 B2
6852287 Ganesan Feb 2005 B2
6858185 Kopf-sill et al. Feb 2005 B1
6859698 Schmeisser Feb 2005 B2
6861035 Pham et al. Mar 2005 B2
6878540 Pourahmadi et al. Apr 2005 B2
6878755 Singh et al. Apr 2005 B2
6884628 Hubbell et al. Apr 2005 B2
6887693 McMillan et al. May 2005 B2
6893879 Petersen et al. May 2005 B2
6900889 Bjornson et al. May 2005 B2
6905583 Wainright et al. Jun 2005 B2
6905612 Dorian et al. Jun 2005 B2
6906797 Kao et al. Jun 2005 B1
6908594 Schaevitz et al. Jun 2005 B1
6911183 Handique et al. Jun 2005 B1
6914137 Baker Jul 2005 B2
6915679 Chien et al. Jul 2005 B2
6918404 Dias da Silva Jul 2005 B2
D508999 Fanning et al. Aug 2005 S
6939451 Zhao et al. Sep 2005 B2
6940598 Christel et al. Sep 2005 B2
6942771 Kayyem Sep 2005 B1
6951632 Unger et al. Oct 2005 B2
6958392 Fomovskaia et al. Oct 2005 B2
D512155 Matsumoto Nov 2005 S
6964747 Banerjee et al. Nov 2005 B2
6969835 Rushbrooke et al. Nov 2005 B1
6977163 Mehta Dec 2005 B1
6979424 Northrup et al. Dec 2005 B2
6984516 Briscoe et al. Jan 2006 B2
D515707 Sinohara et al. Feb 2006 S
D516221 Wohlstadter et al. Feb 2006 S
7001853 Brown et al. Feb 2006 B1
7004184 Handique et al. Feb 2006 B2
D517554 Yanagisawa et al. Mar 2006 S
7010391 Handique et al. Mar 2006 B2
7023007 Gallagher Apr 2006 B2
7024281 Unno Apr 2006 B1
7036667 Greenstein et al. May 2006 B2
7037416 Parce et al. May 2006 B2
7038472 Chien May 2006 B1
7039527 Tripathi et al. May 2006 B2
7040144 Spaid et al. May 2006 B2
7041258 Desmond et al. May 2006 B2
7049558 Baer et al. May 2006 B2
D523153 Akashi et al. Jun 2006 S
7055695 Greenstein et al. Jun 2006 B2
7060171 Nikiforov et al. Jun 2006 B1
7066586 Dias da Silva Jun 2006 B2
7069952 McReynolds et al. Jul 2006 B1
7072036 Jones et al. Jul 2006 B2
7099778 Chien Aug 2006 B2
D528215 Malmsater Sep 2006 S
7101467 Spaid Sep 2006 B2
7105304 Nikiforov et al. Sep 2006 B1
D531321 Godfrey et al. Oct 2006 S
7118892 Ammann et al. Oct 2006 B2
7118910 Unger et al. Oct 2006 B2
7122799 Hsieh et al. Oct 2006 B2
7135144 Christel et al. Nov 2006 B2
7138032 Gandhi et al. Nov 2006 B2
D534280 Gomm et al. Dec 2006 S
7150814 Parce et al. Dec 2006 B1
7150999 Shuck Dec 2006 B1
D535403 Isozaki et al. Jan 2007 S
7160423 Chien et al. Jan 2007 B2
7161356 Chien Jan 2007 B1
7169277 Ausserer et al. Jan 2007 B2
7169601 Northrup et al. Jan 2007 B1
7169618 Skold Jan 2007 B2
D537951 Okamoto et al. Mar 2007 S
D538436 Patadia et al. Mar 2007 S
7188001 Young et al. Mar 2007 B2
7192557 Wu et al. Mar 2007 B2
7195986 Bousse et al. Mar 2007 B1
7205154 Corson Apr 2007 B2
7208125 Dong Apr 2007 B1
7235406 Woudenberg et al. Jun 2007 B1
7247274 Chow Jul 2007 B1
D548841 Brownell et al. Aug 2007 S
D549827 Maeno et al. Aug 2007 S
7252928 Hafeman et al. Aug 2007 B1
7255833 Chang et al. Aug 2007 B2
7270786 Parunak et al. Sep 2007 B2
D554069 Bolotin et al. Oct 2007 S
D554070 Bolotin et al. Oct 2007 S
7276208 Sevigny et al. Oct 2007 B2
7276330 Chow et al. Oct 2007 B2
7288228 Lefebvre Oct 2007 B2
7297313 Northrup et al. Nov 2007 B1
D556914 Okamoto et al. Dec 2007 S
7303727 Dubrow et al. Dec 2007 B1
D559995 Handique et al. Jan 2008 S
7315376 Bickmore et al. Jan 2008 B2
7323140 Handique et al. Jan 2008 B2
7332130 Handique Feb 2008 B2
7338760 Gong et al. Mar 2008 B2
D566291 Parunak et al. Apr 2008 S
7351377 Chazan et al. Apr 2008 B2
D569526 Duffy et al. May 2008 S
7374949 Kuriger May 2008 B2
7390460 Osawa et al. Jun 2008 B2
7419784 Dubrow et al. Sep 2008 B2
7422669 Jacobson et al. Sep 2008 B2
7440684 Spaid et al. Oct 2008 B2
7476313 Siddiqi Jan 2009 B2
7480042 Phillips et al. Jan 2009 B1
7494577 Williams et al. Feb 2009 B2
7494770 Wilding et al. Feb 2009 B2
7514046 Kechagia et al. Apr 2009 B2
7518726 Rulison et al. Apr 2009 B2
7521186 Burd Mehta Apr 2009 B2
7527769 Bunch et al. May 2009 B2
D595423 Johansson et al. Jun 2009 S
7553671 Sinclair et al. Jun 2009 B2
D596312 Giraud et al. Jul 2009 S
D598566 Allaer Aug 2009 S
7578976 Northrup et al. Aug 2009 B1
D599234 Ito Sep 2009 S
7595197 Brasseur Sep 2009 B2
7604938 Takahashi et al. Oct 2009 B2
7622296 Joseph et al. Nov 2009 B2
7628902 Knowlton et al. Dec 2009 B2
7633606 Northrup et al. Dec 2009 B2
7635588 King et al. Dec 2009 B2
7645581 Knapp et al. Jan 2010 B2
7670559 Chien et al. Mar 2010 B2
7674431 Ganesan Mar 2010 B2
7689022 Weiner et al. Mar 2010 B2
7704735 Facer et al. Apr 2010 B2
7705739 Northrup et al. Apr 2010 B2
7723123 Murphy et al. May 2010 B1
D618820 Wilson et al. Jun 2010 S
7727371 Kennedy et al. Jun 2010 B2
7727477 Boronkay et al. Jun 2010 B2
7744817 Bui Jun 2010 B2
D621060 Handique Aug 2010 S
7785868 Yuan et al. Aug 2010 B2
D628305 Gorrec et al. Nov 2010 S
7829025 Ganesan et al. Nov 2010 B2
7858366 Northrup et al. Dec 2010 B2
7867776 Kennedy et al. Jan 2011 B2
7892819 Wilding et al. Feb 2011 B2
D637737 Wilson et al. May 2011 S
7955864 Cox et al. Jun 2011 B2
7987022 Handique et al. Jul 2011 B2
7998708 Handique et al. Aug 2011 B2
8053214 Northrup Nov 2011 B2
8071056 Burns et al. Dec 2011 B2
8088616 Handique Jan 2012 B2
8105783 Handique Jan 2012 B2
8110158 Handique Feb 2012 B2
8133671 Williams et al. Mar 2012 B2
8182763 Duffy et al. May 2012 B2
8232900 Takeda Jul 2012 B2
8246919 Herchenbach et al. Aug 2012 B2
8273308 Handique et al. Sep 2012 B2
D669597 Cavada et al. Oct 2012 S
8287820 Williams et al. Oct 2012 B2
8323584 Ganesan Dec 2012 B2
8323900 Handique et al. Dec 2012 B2
8324372 Brahmasandra et al. Dec 2012 B2
8415103 Handique Apr 2013 B2
8420015 Ganesan et al. Apr 2013 B2
8440149 Handique May 2013 B2
8470586 Wu et al. Jun 2013 B2
8473104 Handique et al. Jun 2013 B2
D686749 Trump Jul 2013 S
D687567 Jungheim et al. Aug 2013 S
D692162 Lentz et al. Oct 2013 S
8592157 Petersen et al. Nov 2013 B2
8679831 Handique et al. Mar 2014 B2
D702854 Nakahana et al. Apr 2014 S
8685341 Ganesan Apr 2014 B2
8703069 Handique et al. Apr 2014 B2
8709787 Handique Apr 2014 B2
8710211 Brahmasandra et al. Apr 2014 B2
8734733 Handique May 2014 B2
D710024 Guo Jul 2014 S
8765076 Handique et al. Jul 2014 B2
8765454 Zhou et al. Jul 2014 B2
8768517 Handique et al. Jul 2014 B2
8852862 Wu et al. Oct 2014 B2
8883490 Handique et al. Nov 2014 B2
8894947 Ganesan et al. Nov 2014 B2
8895311 Handique et al. Nov 2014 B1
D729404 Teich et al. May 2015 S
9028773 Ganesan May 2015 B2
9040288 Handique et al. May 2015 B2
9051604 Handique Jun 2015 B2
9080207 Handique et al. Jul 2015 B2
D742027 Lentz et al. Oct 2015 S
9186677 Williams et al. Nov 2015 B2
9217143 Brahmasandra et al. Dec 2015 B2
9222954 Lentz et al. Dec 2015 B2
9234236 Thomas et al. Jan 2016 B2
9238223 Handique Jan 2016 B2
9259734 Williams et al. Feb 2016 B2
9259735 Handique et al. Feb 2016 B2
9347586 Williams et al. May 2016 B2
9480983 Lentz et al. Nov 2016 B2
9528142 Handique Dec 2016 B2
9618139 Handique Apr 2017 B2
D787087 Duffy et al. Jun 2017 S
9670528 Handique et al. Jun 2017 B2
9677121 Ganesan et al. Jun 2017 B2
9701957 Wilson et al. Jul 2017 B2
9745623 Steel Aug 2017 B2
9765389 Gubatayao et al. Sep 2017 B2
9789481 Petersen et al. Oct 2017 B2
9802199 Handique et al. Oct 2017 B2
9815057 Handique Nov 2017 B2
9958466 Dalbert et al. May 2018 B2
10065185 Handique Sep 2018 B2
10071376 Williams et al. Sep 2018 B2
10076754 Lentz et al. Sep 2018 B2
10100302 Brahmasandra et al. Oct 2018 B2
10139012 Handique Nov 2018 B2
10179910 Duffy et al. Jan 2019 B2
10234474 Williams et al. Mar 2019 B2
10351901 Ganesan et al. Jul 2019 B2
10364456 Wu et al. Jul 2019 B2
10443088 Wu et al. Oct 2019 B1
10494663 Wu et al. Dec 2019 B1
10571935 Handique et al. Feb 2020 B2
10590410 Brahmasandra et al. Mar 2020 B2
10604788 Wu et al. Mar 2020 B2
10619191 Ganesan et al. Apr 2020 B2
10625261 Williams et al. Apr 2020 B2
10625262 Williams et al. Apr 2020 B2
10632466 Williams et al. Apr 2020 B1
10695764 Handique et al. Jun 2020 B2
10710069 Handique et al. Jul 2020 B2
10717085 Williams et al. Jul 2020 B2
10731201 Handique et al. Aug 2020 B2
10781482 Gubatayao et al. Sep 2020 B2
10799862 Handique et al. Oct 2020 B2
10821436 Handique et al. Nov 2020 B2
10821446 Handique et al. Nov 2020 B1
10822644 Steel et al. Nov 2020 B2
10843188 Handique et al. Nov 2020 B2
10844368 Duffy et al. Nov 2020 B2
10857535 Handique et al. Dec 2020 B2
10865437 Handique et al. Dec 2020 B2
10875022 Williams et al. Dec 2020 B2
10900066 Handique et al. Jan 2021 B2
10913061 Handique et al. Feb 2021 B2
11060082 Brahmasandra et al. Jul 2021 B2
11078523 Handique et al. Aug 2021 B2
11085069 Handique et al. Aug 2021 B2
11141734 Handique et al. Oct 2021 B2
11142785 Handique et al. Oct 2021 B2
11254927 Brahmasandra et al. Feb 2022 B2
11266987 Handique Mar 2022 B2
11441171 Wu et al. Sep 2022 B2
11453906 Handique Sep 2022 B2
11466263 Duffy et al. Sep 2022 B2
11549959 Williams et al. Jan 2023 B2
20010005489 Roach et al. Jun 2001 A1
20010012492 Acosta et al. Aug 2001 A1
20010016358 Osawa et al. Aug 2001 A1
20010018513 Baker Aug 2001 A1
20010021355 Baugh et al. Sep 2001 A1
20010023848 Gjerde et al. Sep 2001 A1
20010038450 McCaffrey et al. Nov 2001 A1
20010045358 Kopf-Sill et al. Nov 2001 A1
20010046702 Schembri Nov 2001 A1
20010048899 Marouiss et al. Dec 2001 A1
20010051340 Singh et al. Dec 2001 A1
20010055765 O'Keefe et al. Dec 2001 A1
20020001848 Bedingham et al. Jan 2002 A1
20020008053 Hansen et al. Jan 2002 A1
20020009015 Laugharn, Jr. et al. Jan 2002 A1
20020014443 Hansen et al. Feb 2002 A1
20020015667 Chow Feb 2002 A1
20020021983 Comte et al. Feb 2002 A1
20020022261 Anderson et al. Feb 2002 A1
20020037499 Quake et al. Mar 2002 A1
20020039783 McMillan et al. Apr 2002 A1
20020047003 Bedingham et al. Apr 2002 A1
20020053399 Soane et al. May 2002 A1
20020054835 Robotti et al. May 2002 A1
20020055167 Pourahmadi et al. May 2002 A1
20020058332 Quake et al. May 2002 A1
20020060156 Mathies et al. May 2002 A1
20020068357 Mathies et al. Jun 2002 A1
20020068821 Gundling Jun 2002 A1
20020086443 Bamdad Jul 2002 A1
20020090320 Burow et al. Jul 2002 A1
20020092767 Bjornson et al. Jul 2002 A1
20020094303 Yamamoto et al. Jul 2002 A1
20020131903 Ingenhoven et al. Sep 2002 A1
20020141903 Parunak et al. Oct 2002 A1
20020143297 Francavilla et al. Oct 2002 A1
20020155010 Karp et al. Oct 2002 A1
20020155477 Ito Oct 2002 A1
20020169518 Luoma et al. Nov 2002 A1
20020173032 Zou et al. Nov 2002 A1
20020176804 Strand et al. Nov 2002 A1
20020187557 Hobbs et al. Dec 2002 A1
20020192808 Gambini et al. Dec 2002 A1
20030008308 Enzelberger et al. Jan 2003 A1
20030008320 Baker Jan 2003 A1
20030019522 Parunak Jan 2003 A1
20030022392 Hudak Jan 2003 A1
20030036067 Schwartz Feb 2003 A1
20030049833 Chen et al. Mar 2003 A1
20030059823 Matsunaga et al. Mar 2003 A1
20030064507 Gallagher et al. Apr 2003 A1
20030072683 Stewart et al. Apr 2003 A1
20030073106 Johansen et al. Apr 2003 A1
20030073110 Aritomi et al. Apr 2003 A1
20030083686 Freeman et al. May 2003 A1
20030087300 Knapp et al. May 2003 A1
20030088657 Eggers May 2003 A1
20030096310 Hansen et al. May 2003 A1
20030099954 Miltenyi et al. May 2003 A1
20030124611 Schwartz Jul 2003 A1
20030127327 Kurnik Jul 2003 A1
20030129094 Schubert et al. Jul 2003 A1
20030134333 Dehlinger et al. Jul 2003 A1
20030136679 Bohn et al. Jul 2003 A1
20030156991 Halas et al. Aug 2003 A1
20030180192 Seippel Sep 2003 A1
20030186295 Colin et al. Oct 2003 A1
20030190608 Blackburn et al. Oct 2003 A1
20030199081 Wilding et al. Oct 2003 A1
20030211517 Carulli et al. Nov 2003 A1
20040014202 King et al. Jan 2004 A1
20040014238 Krug et al. Jan 2004 A1
20040018116 Desmond et al. Jan 2004 A1
20040018119 Massaro Jan 2004 A1
20040022689 Wulf et al. Feb 2004 A1
20040029258 Heaney et al. Feb 2004 A1
20040029260 Hansen et al. Feb 2004 A1
20040037739 McNeely et al. Feb 2004 A1
20040043479 Briscoe et al. Mar 2004 A1
20040053290 Terbrueggen et al. Mar 2004 A1
20040063217 Webster et al. Apr 2004 A1
20040065655 Brown Apr 2004 A1
20040072278 Chou et al. Apr 2004 A1
20040072375 Gjerde et al. Apr 2004 A1
20040076996 Kondo et al. Apr 2004 A1
20040086427 Childers et al. May 2004 A1
20040086956 Bachur May 2004 A1
20040132059 Scurati et al. Jul 2004 A1
20040141887 Mainquist et al. Jul 2004 A1
20040151629 Pease et al. Aug 2004 A1
20040157220 Kurnool et al. Aug 2004 A1
20040161788 Chen et al. Aug 2004 A1
20040171515 Hamers et al. Sep 2004 A1
20040189311 Glezer et al. Sep 2004 A1
20040197810 Takenaka et al. Oct 2004 A1
20040200909 McMillan et al. Oct 2004 A1
20040203173 Peck et al. Oct 2004 A1
20040209331 Ririe Oct 2004 A1
20040209354 Mathies et al. Oct 2004 A1
20040224317 Kordunsky et al. Nov 2004 A1
20040235154 Oh et al. Nov 2004 A1
20040240097 Evans Dec 2004 A1
20050009174 Nikiforov et al. Jan 2005 A1
20050013737 Chow et al. Jan 2005 A1
20050019902 Mathies et al. Jan 2005 A1
20050037471 Liu et al. Feb 2005 A1
20050041525 Pugia et al. Feb 2005 A1
20050042639 Knapp et al. Feb 2005 A1
20050048540 Inami et al. Mar 2005 A1
20050058574 Bysouth et al. Mar 2005 A1
20050058577 Micklash et al. Mar 2005 A1
20050064535 Favuzzi et al. Mar 2005 A1
20050069898 Moon et al. Mar 2005 A1
20050084424 Ganesan et al. Apr 2005 A1
20050106066 Saltsman et al. May 2005 A1
20050112754 Yoon et al. May 2005 A1
20050121324 Park et al. Jun 2005 A1
20050129580 Swinehart et al. Jun 2005 A1
20050130198 Ammann et al. Jun 2005 A1
20050133370 Park et al. Jun 2005 A1
20050135655 Kopf-sill et al. Jun 2005 A1
20050142036 Kim et al. Jun 2005 A1
20050158781 Woudenberg et al. Jul 2005 A1
20050170362 Wada et al. Aug 2005 A1
20050186585 Juncosa et al. Aug 2005 A1
20050196321 Huang Sep 2005 A1
20050202470 Sundberg et al. Sep 2005 A1
20050202489 Cho et al. Sep 2005 A1
20050202504 Anderson et al. Sep 2005 A1
20050205788 Itoh Sep 2005 A1
20050208676 Kahatt Sep 2005 A1
20050214172 Burgisser Sep 2005 A1
20050220675 Reed et al. Oct 2005 A1
20050227269 Lloyd et al. Oct 2005 A1
20050233370 Ammann et al. Oct 2005 A1
20050238545 Parce et al. Oct 2005 A1
20050239127 Ammann et al. Oct 2005 A1
20050266489 Ammann et al. Dec 2005 A1
20050276728 Muller-Cohn et al. Dec 2005 A1
20060002817 Bohm et al. Jan 2006 A1
20060003373 Ammann et al. Jan 2006 A1
20060041058 Yin et al. Feb 2006 A1
20060057039 Morse et al. Mar 2006 A1
20060057629 Kim Mar 2006 A1
20060058519 Deggerdal et al. Mar 2006 A1
20060062696 Chow et al. Mar 2006 A1
20060081539 Safar et al. Apr 2006 A1
20060094004 Nakajima et al. May 2006 A1
20060094108 Yoder et al. May 2006 A1
20060113190 Kurnik Jun 2006 A1
20060133965 Tajima et al. Jun 2006 A1
20060134790 Tanaka et al. Jun 2006 A1
20060148063 Fauzzi et al. Jul 2006 A1
20060154341 Chen Jul 2006 A1
20060165558 Witty et al. Jul 2006 A1
20060165559 Greenstein et al. Jul 2006 A1
20060177376 Tomalia et al. Aug 2006 A1
20060177855 Utermohlen et al. Aug 2006 A1
20060183216 Handique Aug 2006 A1
20060201887 Siddiqi Sep 2006 A1
20060205085 Handique Sep 2006 A1
20060207944 Siddiqi Sep 2006 A1
20060210435 Alavie et al. Sep 2006 A1
20060223169 Bedingham et al. Oct 2006 A1
20060228268 Heimberg et al. Oct 2006 A1
20060228734 Vann et al. Oct 2006 A1
20060246493 Jensen et al. Nov 2006 A1
20060246533 Fathollahi et al. Nov 2006 A1
20060269641 Atwood et al. Nov 2006 A1
20060269961 Fukushima et al. Nov 2006 A1
20070004028 Lair et al. Jan 2007 A1
20070009386 Padmanabhan et al. Jan 2007 A1
20070014695 Yue et al. Jan 2007 A1
20070020699 Carpenter et al. Jan 2007 A1
20070020764 Miller Jan 2007 A1
20070026421 Sundberg et al. Feb 2007 A1
20070042441 Masters et al. Feb 2007 A1
20070048188 Bigus Mar 2007 A1
20070054413 Aviles et al. Mar 2007 A1
20070077643 Nakamura et al. Apr 2007 A1
20070077648 Okamoto et al. Apr 2007 A1
20070092901 Ligler et al. Apr 2007 A1
20070098600 Kayyem et al. May 2007 A1
20070099200 Chow et al. May 2007 A1
20070104617 Coulling et al. May 2007 A1
20070116613 Elsener May 2007 A1
20070134808 Sullivan Jun 2007 A1
20070154895 Spaid et al. Jul 2007 A1
20070177147 Parce Aug 2007 A1
20070178603 Takii et al. Aug 2007 A1
20070178607 Prober et al. Aug 2007 A1
20070184463 Molho et al. Aug 2007 A1
20070184547 Handique et al. Aug 2007 A1
20070196237 Neuzil et al. Aug 2007 A1
20070196238 Kennedy et al. Aug 2007 A1
20070199821 Chow Aug 2007 A1
20070215554 Kreuwel et al. Sep 2007 A1
20070218459 Miller et al. Sep 2007 A1
20070231213 Prabhu et al. Oct 2007 A1
20070238161 Cerrone et al. Oct 2007 A1
20070243626 Windeyer et al. Oct 2007 A1
20070248958 Jovanovich et al. Oct 2007 A1
20070261479 Spaid et al. Nov 2007 A1
20070269861 Williams et al. Nov 2007 A1
20070292941 Handique et al. Dec 2007 A1
20080000774 Park et al. Jan 2008 A1
20080003649 Maltezos et al. Jan 2008 A1
20080017306 Liu et al. Jan 2008 A1
20080056948 Dale et al. Mar 2008 A1
20080069729 McNeely Mar 2008 A1
20080090244 Knapp et al. Apr 2008 A1
20080095673 Xu Apr 2008 A1
20080118987 Eastwood et al. May 2008 A1
20080124723 Dale et al. May 2008 A1
20080149840 Handique et al. Jun 2008 A1
20080176230 Owen et al. Jul 2008 A1
20080192254 Kim et al. Aug 2008 A1
20080226502 Jonsmann et al. Sep 2008 A1
20080240898 Manz et al. Oct 2008 A1
20080247914 Edens et al. Oct 2008 A1
20080257882 Turner Oct 2008 A1
20080280285 Chen et al. Nov 2008 A1
20080308500 Brassard Dec 2008 A1
20090047180 Kawahara Feb 2009 A1
20090066339 Glezer et al. Mar 2009 A1
20090130719 Handique May 2009 A1
20090130745 Williams et al. May 2009 A1
20090136385 Handique et al. May 2009 A1
20090148933 Battrell et al. Jun 2009 A1
20090189089 Bedingham et al. Jul 2009 A1
20090223925 Morse et al. Sep 2009 A1
20090325164 Vossenaar et al. Dec 2009 A1
20090325276 Battrell et al. Dec 2009 A1
20100009343 Fischer et al. Jan 2010 A1
20100009351 Brahmasandra et al. Jan 2010 A1
20100120129 Amshey et al. May 2010 A1
20100233763 Shigeura et al. Sep 2010 A1
20100284864 Holenstein et al. Nov 2010 A1
20110008825 Ingber et al. Jan 2011 A1
20110027151 Handique et al. Feb 2011 A1
20110060136 Matsunaga et al. Mar 2011 A1
20110097493 Kerr et al. Apr 2011 A1
20110127292 Sarofim et al. Jun 2011 A1
20110158865 Miller et al. Jun 2011 A1
20110287447 Norderhaug Nov 2011 A1
20110300033 Battisti Dec 2011 A1
20120122231 Tajima May 2012 A1
20120160826 Handique Jun 2012 A1
20120171678 Maltezos et al. Jul 2012 A1
20120258463 Duffy et al. Oct 2012 A1
20130183769 Tajima Jul 2013 A1
20130210127 Williams et al. Aug 2013 A1
20130315800 Yin et al. Nov 2013 A1
20140030798 Wu et al. Jan 2014 A1
20140120544 Brahmasandra et al. May 2014 A1
20140227710 Handique et al. Aug 2014 A1
20140329301 Handique et al. Nov 2014 A1
20150045234 Stone et al. Feb 2015 A1
20150174579 Iten et al. Jun 2015 A1
20150315631 Handique et al. Nov 2015 A1
20160038942 Roberts Feb 2016 A1
20170275702 Dahiya et al. Sep 2017 A1
20180333722 Handique Nov 2018 A1
20190054467 Handique Feb 2019 A1
20190144849 Duffy et al. May 2019 A1
20190145546 Handique May 2019 A1
20190151854 Baum et al. May 2019 A1
20190154719 LaChance et al. May 2019 A1
20190284606 Wu et al. Sep 2019 A1
20190324050 Williams et al. Oct 2019 A1
20200139363 Handique et al. May 2020 A1
20200216831 Brahmasandra et al. Jul 2020 A1
20200291388 Brahmasandra et al. Sep 2020 A1
20210001334 Handique et al. Jan 2021 A1
20210010059 Handique et al. Jan 2021 A1
20210047676 Wu et al. Feb 2021 A1
20210060565 Handique et al. Mar 2021 A1
20210071234 Gubatayao et al. Mar 2021 A1
20210087609 Handique et al. Mar 2021 A1
20210121887 Handique et al. Apr 2021 A1
20210123090 Handique et al. Apr 2021 A1
20210147923 Steel et al. May 2021 A1
20210299663 Handique Sep 2021 A1
20220010364 Handique et al. Jan 2022 A1
20220136034 Handique et al. May 2022 A1
20220170008 Brahmasandra et al. Jun 2022 A1
20220203371 Handique et al. Jun 2022 A1
20220241782 Handique et al. Aug 2022 A1
20230023741 Handique Jan 2023 A1
20230041595 Wu et al. Feb 2023 A1
Foreign Referenced Citations (252)
Number Date Country
1357102 Mar 2002 AU
3557502 Jul 2002 AU
4437602 Jul 2002 AU
4437702 Jul 2002 AU
764319 Aug 2003 AU
2574107 Sep 1998 CA
2294819 Jan 1999 CA
1934451 Mar 2007 CN
1312287 Apr 2007 CN
1942590 Apr 2007 CN
1968754 May 2007 CN
101466848 Jun 2009 CN
101522909 Sep 2009 CN
103540518 Jan 2014 CN
19755479 Jun 1999 DE
19929734 Dec 1999 DE
19833293 Jan 2000 DE
0136126 Apr 1985 EP
0365828 May 1990 EP
0483620 May 1992 EP
0402994 Nov 1994 EP
0393744 Jan 1995 EP
0688602 Dec 1995 EP
0707077 Apr 1996 EP
0698046 Mar 1997 EP
0766256 Apr 1997 EP
0772494 May 1997 EP
0810030 Dec 1997 EP
1059458 Dec 2000 EP
1064090 Jan 2001 EP
1077086 Feb 2001 EP
1346772 Sep 2003 EP
1541237 Jun 2005 EP
1574586 Sep 2005 EP
1621890 Feb 2006 EP
1745153 Jan 2007 EP
1780290 May 2007 EP
1792656 Jun 2007 EP
2372367 Oct 2011 EP
2672301 Aug 1992 FR
2795426 Dec 2000 FR
2453432 Apr 2009 GB
S50-100881 Aug 1975 JP
58212921 Dec 1983 JP
S62-119460 May 1987 JP
H01-502319 Aug 1989 JP
H03181853 Aug 1991 JP
04-053555 May 1992 JP
06-064156 Sep 1994 JP
07-020010 Jan 1995 JP
H07-290706 Nov 1995 JP
H08-122336 May 1996 JP
H08-173194 Jul 1996 JP
H08-211071 Aug 1996 JP
H08-285859 Nov 1996 JP
H08-337116 Dec 1996 JP
H09-304385 Nov 1997 JP
H09-325151 Dec 1997 JP
2001-502790 Jan 1998 JP
H01-219669 Sep 1998 JP
H10-327515 Dec 1998 JP
H11-009258 Jan 1999 JP
H11-501504 Feb 1999 JP
H11-503315 Mar 1999 JP
H11-156231 Jun 1999 JP
H11-316226 Nov 1999 JP
H11-515106 Dec 1999 JP
2000-180455 Jun 2000 JP
2000-266760 Sep 2000 JP
2000-275255 Oct 2000 JP
2000-514928 Nov 2000 JP
2001-502319 Feb 2001 JP
2001-204462 Jul 2001 JP
2001-509437 Jul 2001 JP
3191150 Jul 2001 JP
2001-515216 Sep 2001 JP
2001-523812 Nov 2001 JP
2001-527220 Dec 2001 JP
2002-503331 Jan 2002 JP
2002-085961 Mar 2002 JP
2002-517735 Jun 2002 JP
2002-215241 Jul 2002 JP
2002-540382 Nov 2002 JP
2002-544476 Dec 2002 JP
2003-500169 Jan 2003 JP
2003-500674 Jan 2003 JP
2003-047839 Feb 2003 JP
2003-047840 Feb 2003 JP
2003-516125 May 2003 JP
2003-164279 Jun 2003 JP
2003-185584 Jul 2003 JP
2003-299485 Oct 2003 JP
2003-329693 Nov 2003 JP
2003-329696 Nov 2003 JP
2003-532382 Nov 2003 JP
2004-003989 Jan 2004 JP
2004-506179 Feb 2004 JP
2004-150797 May 2004 JP
2004-283728 Oct 2004 JP
2004-531360 Oct 2004 JP
2004-533838 Nov 2004 JP
2004-534157 Nov 2004 JP
2004-361421 Dec 2004 JP
2004-536291 Dec 2004 JP
2004-536689 Dec 2004 JP
2005-009870 Jan 2005 JP
2005-010179 Jan 2005 JP
2005-511264 Apr 2005 JP
2005-514718 May 2005 JP
2005-518825 Jun 2005 JP
2005-176613 Jul 2005 JP
2005-192439 Jul 2005 JP
2005-192554 Jul 2005 JP
2005-519751 Jul 2005 JP
2005-204661 Aug 2005 JP
2005-525816 Sep 2005 JP
2005-291954 Oct 2005 JP
2005-532043 Oct 2005 JP
2005-323519 Nov 2005 JP
2005-533652 Nov 2005 JP
2005-535904 Nov 2005 JP
2006-021156 Jan 2006 JP
2006-055837 Mar 2006 JP
2006-094866 Apr 2006 JP
2006-145458 Jun 2006 JP
2006-167569 Jun 2006 JP
2006-284409 Oct 2006 JP
2007-024742 Feb 2007 JP
2007-074960 Mar 2007 JP
2007-097477 Apr 2007 JP
2007-101364 Apr 2007 JP
2007-510518 Apr 2007 JP
2007-514405 Jun 2007 JP
2007-178328 Jul 2007 JP
2007-535933 Dec 2007 JP
2009-515140 Apr 2009 JP
2009-542207 Dec 2009 JP
3193848 Oct 2014 JP
1020060044489 May 2006 KR
2418633 May 2011 RU
WO 1988006633 Sep 1988 WO
WO 1990012350 Oct 1990 WO
WO 1992005443 Apr 1992 WO
WO 1994005414 Mar 1994 WO
WO 1994011103 May 1994 WO
WO 1995033846 Dec 1995 WO
WO 1996000228 Jan 1996 WO
WO 1996004547 Feb 1996 WO
WO 1996018731 Jun 1996 WO
WO 1996039547 Dec 1996 WO
WO 1997005492 Feb 1997 WO
WO 1997016835 May 1997 WO
WO 1997021090 Jun 1997 WO
WO 1997022825 Jun 1997 WO
WO 1997027324 Jul 1997 WO
WO 1998000231 Jan 1998 WO
WO 1998007019 Feb 1998 WO
WO 1998022625 May 1998 WO
WO 1998035013 Aug 1998 WO
WO 1998038487 Sep 1998 WO
WO 1998049548 Nov 1998 WO
WO 1998050147 Nov 1998 WO
WO 1998053311 Nov 1998 WO
WO 1999001688 Jan 1999 WO
WO 1999009042 Feb 1999 WO
WO 1999012016 Mar 1999 WO
WO 1999016549 Apr 1999 WO
WO 1999017093 Apr 1999 WO
WO 1999029703 Jun 1999 WO
WO 1999033559 Jul 1999 WO
WO 1999060397 Nov 1999 WO
WO 2000022436 Apr 2000 WO
WO 2000066783 Nov 2000 WO
WO 2000073412 Dec 2000 WO
WO 2000075623 Dec 2000 WO
WO 2000078455 Dec 2000 WO
WO 2001005510 Jan 2001 WO
WO 2001014931 Mar 2001 WO
WO 2001027614 Apr 2001 WO
WO 2001028684 Apr 2001 WO
WO 2001030995 May 2001 WO
WO 2001041931 Jun 2001 WO
WO 2001046474 Jun 2001 WO
WO 2001054813 Aug 2001 WO
WO 2001089681 Nov 2001 WO
WO 2001089705 Nov 2001 WO
WO 2001092569 Dec 2001 WO
WO 2002043864 Jun 2002 WO
WO 2002048164 Jun 2002 WO
WO 2002052002 Jul 2002 WO
WO 2002072264 Sep 2002 WO
WO 2002078845 Oct 2002 WO
WO 2002086454 Oct 2002 WO
WO 2002094185 Nov 2002 WO
WO 2003007677 Jan 2003 WO
WO 2003012325 Feb 2003 WO
WO 2003012406 Feb 2003 WO
WO 2003048295 Jun 2003 WO
WO 2003055605 Jul 2003 WO
WO 2003076661 Sep 2003 WO
WO 2003078065 Sep 2003 WO
WO 2003080868 Oct 2003 WO
WO 2003087410 Oct 2003 WO
WO 2004007081 Jan 2004 WO
WO 2004010760 Feb 2004 WO
WO 2004048545 Jun 2004 WO
WO 2004055522 Jul 2004 WO
WO 2004056485 Jul 2004 WO
WO 2004074848 Sep 2004 WO
WO 2004094986 Nov 2004 WO
WO 2005008255 Jan 2005 WO
WO 2005011867 Feb 2005 WO
WO 2005030984 Apr 2005 WO
WO 2005072353 Aug 2005 WO
WO 2005094981 Oct 2005 WO
WO 2005100538 Oct 2005 WO
WO 2005107947 Nov 2005 WO
WO 2005108571 Nov 2005 WO
WO 2005108620 Nov 2005 WO
WO 2005116202 Dec 2005 WO
WO 2005118867 Dec 2005 WO
WO 2005120710 Dec 2005 WO
WO 2006010584 Feb 2006 WO
WO 2006032044 Mar 2006 WO
WO 2006035800 Apr 2006 WO
WO 2006043642 Apr 2006 WO
WO 2006066001 Jun 2006 WO
WO 2006079082 Jul 2006 WO
WO 2006081995 Aug 2006 WO
WO 2006113198 Oct 2006 WO
WO 2006118420 Nov 2006 WO
WO 2006119280 Nov 2006 WO
WO 2007044917 Apr 2007 WO
WO 2007050327 May 2007 WO
WO 2007064117 Jun 2007 WO
WO 2007075919 Jul 2007 WO
WO 2007091530 Aug 2007 WO
WO 2007112114 Oct 2007 WO
WO 2007120240 Oct 2007 WO
WO 2007120241 Oct 2007 WO
WO 2008005321 Jan 2008 WO
WO 2008030914 Mar 2008 WO
WO 2008060604 May 2008 WO
WO 2008134470 Nov 2008 WO
WO 2008149282 Dec 2008 WO
WO 2009012185 Jan 2009 WO
WO 2009054870 Apr 2009 WO
WO 2010118541 Oct 2010 WO
WO 2010130310 Nov 2010 WO
WO 2010140680 Dec 2010 WO
WO 2011009073 Jan 2011 WO
WO 2011101467 Aug 2011 WO
Non-Patent Literature Citations (449)
Entry
Yang et al, Integrated Multiprocess Microfluidic Systems for Automating Analysis, JALA, 2010, 15, 198-209 (post art) (Year: 2010).
Allemand et al., “pH-Dependent Specific Binding and Combing of DNA”, Biophys J. (1997) 73(4): 2064-2070.
Altet et al., [Eds.] “Thermal Transfer and Thermal Coupling in IC's”, Thermal Testing of Integrated Circuits; Chapter 2 (2002) Springer Science pp. 23-51.
Ateya et al., “The good, the bad, and the tiny: a review of microflow cytometry”, Anal Bioanal Chem. (2008) 391(5):1485-1498.
Auroux et al., “Miniaturised nucleic acid analysis”, Lab Chip. (2004) 4(6):534-546.
Baechi et al., “High-density microvalve arrays for sample processing in PCR chips”, Biomed Microdevices. (2001) 3(3):183-190.
Baker M., “Clever PCR: more genotyping, smaller volumes.” Nature Methods (May 2010) 70(5):351-356.
Becker H. “Fabrication of Polymer Microfluidic Devices”, in Biochip Technology (2001), Chapter 4, pp. 63-96.
Becker H., “Microfluidic Devices Fabricated by Polymer Hot Embossing,” in Integrated Microfabricated Biodevices: Advanced Technologies for Genomics, Drug Discovery, Bioanalysis, and Clinical Diagnostics (2002), Chapter 13, 32 pages.
Becker H., “Microfluidics: A Technology Coming of Age”, Med Device Technol. (2008) 19(3):21-24.
Becker et al., “Portable CE system with contactless conductivity detection in an injection molded polymer chip for on-site food analysis”, SPIE Proceedings MOEMS-MEMS 2008 Micro and Nanofabrication (2008) vol. 6886 in 8 pages.
Becker H., “Hype, hope and hubris: the quest for the killer application in microfluidics”, Lab on a Chip, The Royal Society of Chemistry (2009) 9:2119-2122.
Becker H., “Collective Wisdom”, Lab on a Chip, The Royal Society of Chemistry (2010) 10:1351-1354.
Belgrader et al., “Rapid PCR for Identity Testing Using a Battery-Powered Miniature Thermal Cycler”, J Forensic Sci. (1998) 43(2):315-319.
Belgrader et al., “A minisonicator to rapidly disrupt bacterial spores for DNA analysis.”, Anal Chem. (1999) 71(19):4232-4236.
Belgrader et al., “Real-time PCR Analysis on Nucleic Acids Purified from Plasma Using a Silicon Chip”, Micro Total Analysis Systems 2000 (pp. 525-528). Springer, Dordrecht.
Belgrader et al., “A microfluidic cartridge to prepare spores for PCR analysis”, Biosens Bioelectron. (2000) 14(10-11):849-852.
Belgrader et al., “A Battery-Powered Notebook Thermal Cycler for Rapid Multiplex Real-Time PCR Analysis”, Anal Chem. (2001) 73(2):286-289.
Belgrader et al., “Rapid and Automated Cartridge-based Extraction of Leukocytes from Whole Blood for Microsatellite DNA Analysis by Capillary Electrophoresis”, Clin Chem. (2001) 47(10):1917-1933.
Belgrader et al., “A Rapid, Flow-through, DNA Extraction Module for Integration intoMicrofluidic Systems”, Micro Total Analysis Systems (2002) pp. 697-699). Springer, Dordrecht.
Belgrader et al., “Development of a Battery-Powered Portable Instrumentation for Rapid PCR Analysis”, in Integrated Microfabricated Devices, (2002) Ch. 8, pp. 183-206, CRC Press.
Bell M., “Integrated Microsystems in Clinical Chemistry”, in Integrated Microfabricated Devices, (2002) Ch. 16, pp. 415-435, CRC Press.
Berthier et al., “Managing evaporation for more robust microscale assays Part 1. Volume loss in high throughput assays”, Lab Chip (2008) 8(6):852-859.
Berthier et al., “Managing evaporation for more robust microscale assays Part 2. Characterization of convection and diffusion for cell biology”, Lab Chip (2008) 8(6):860-864.
Berthier et al., “Microdrops,” in Microfluidics for Biotechnology (2006), Chapter 2, pp. 51-88.
Biomerieux Press Release: “bioMerieux - 2018 Financial Results,” dated Feb. 27, 2019, accessed at www.biomerieux.com, pp. 13.
Blanchard et al., “Micro structure mechanical failure characterization using rotating Couette flow in a small gap”, J Micromech Microengin. (2005) 15(4):792-801.
Blanchard et al., “Single-disk and double-disk viscous micropumps”, Sensors and Actuators A (2005) 122:149-158.
Blanchard et al., “Performance and Development of a Miniature Rotary Shaft Pump”, J Fluids Eng. (2005) 127(4):752-760.
Blanchard et al., “Single-disk and double-disk viscous micropump”, ASME 2004 Inter'l Mechanical Engineering Congress & Exposition, Nov. 13-20, 2004, Anaheim, CA, IMECE2004-61705:411-417.
Blanchard et al., “Miniature Single-Disk Viscous Pump (Single-DVP), Performance Characterization”, J Fluids Eng. (2006) 128(3):602-610.
Bollet, C. et al., “A simple method for the isolation of chromosomal DNA from Gram positive or acid-fast bacteria”, Nucleic Acids Research, vol. 19, No. 8 (1991), p. 1955.
Brahmasandra et al., On-chip DNA detection in microfabricated separation systems, SPIE Conference on Microfluidic Devices and Systems, 1998, vol. 3515, pp. 242-251, Santa Clara, CA.
Brahmasandra et al., “Microfabricated Devices for Integrated DNA Analysis”, in Biochip Technology by Cheng et al., [Eds.] (2001) pp. 229-250.
Breadmore, M.C. et al., “Microchip-Based Purification of DNA from Biological Samples”, Anal. Chem., vol. 75 (2003), pp. 1880-1886.
Brody, et al., Diffusion-Based Extraction in a Microfabricated Device, Sensors and Actuators Elsevier, 1997, vol. A58, No. 1, pp. 13-18.
Broyles et al., “Sample Filtration, Concentration, and Separation Integrated on Microfluidic Devices” Analytical Chemistry (American Chemical Society), (2003) 75(11):2761-2767.
Bu et al., “Design and theoretical evaluation of a novel microfluidic device to be used for PCR”, J Micromech Microengin. (2003) 13(4):S125-S130.
Burns et al., “An Integrated Nanoliter DNA Analysis Device”, Science 282:484-487 (1998).
Cady et al., “Real-time PCR detection of Listeria monocytogenes using an integrated microfluidics platform”, Sensors Actuat B. (2005) 107:332-341.
Carlen et al., “Paraffin Actuated Surface Micromachined Valve,” in IEEE MEMS 2000 Conference, Miyazaki, Japan, (Jan. 2000) pp. 381-385.
Carles et al., “Polymerase Chain Reaction on Microchips” in Methods in Molecular Biology—Microfluidic Techniques, Reviews & Protocols by Minteer S.D. [Ed.] Humana Press (2006), vol. 321; Chapter 11, pp. 131-140.
Chang-Yen et al., “A novel integrated optical dissolved oxygen sensor for cell culture and micro total analysis systems”, IEEE Technical Digest MEMS International Conference Jan. 24, 2002, 4 pages.
Chang-Yen et al., “A PDMS microfluidic spotter for fabrication of lipid microarrays”, IEEE 3rd EMBS Special Topic Conference May 12-15, 2005; 2 pages.
Chang-Yen et al., “Design and fabrication of a multianalyte-capable optical biosensor using a multiphysics approach”, IEEE 3rd EMBS Special Topic Conference May 12-15, 2005; 2 pages.
Chang-Yen et al., “A Novel PDMS Microfluidic Spotter for Fabrication of Protein Chips and Microarrays”, IEEE J of Microelectromech Sys. (2006) 15(5): 1145-1151.
Chang-Yen et al., “Design, fabrication, and packaging of a practical multianalyte-capable optical biosensor,” J Microlith Microfab Microsyst. (2006) 5(2):021105 in 8 pages.
Chang-Yen et al., “Spin-assembled nanofilms for gaseous oxygen sensing.” Sens Actuators B: Chemical (2007), 120(2):426-433.
Chaudhari et al., “Transient Liquid Crystal Thermometry of Microfabricated PCR Vessel Arrays”, J Microelectro Sys., (1998) 7(4):345-355.
Chen P-C., “Accelerating micro-scale PCR (polymerase chain reactor) for modular lab-on-a-chip system”, LSU Master's Theses—Digital Commons, (2006) 111 pages.
Chen et al., “Total nucleic acid analysis integrated on microfluidic devices,” Lab on a Chip. (2007) 7:1413-1423.
Cheng et al., “Biochip-Based Portable Laboratory”, Biochip Tech. (2001):269-289.
Cho et al., “A facility for characterizing the steady-state and dynamic thermal performance of microelectromechanical system thermal switches”, Rev Sci Instrum. (2008) 79(3):034901-1 to -8.
Chong et al., “Disposable Polydimethylsiloxane Package for ‘Bio-Microfluidic System’”, IEEE Proceedings Electronic Components and Technology (2005); 5 pages.
Chou et al., “A miniaturized cyclic PCR device—modeling and experiments”, Microelec Eng. (2002) 61-62:921-925.
Christel et al., “Nucleic Acid Concentration and PCR for Diagnostic Applications”, in Micro Total Analysis Systems. (1998) D.J. Harrison et al. [Eds.] pp. 277-280.
Christel et al., “Rapid, Automated Nucleic Acid Probe Assays Using Silicon Microstructures for Nucleic Acid Concentration”, J Biomech Eng. (1999) 121(1):22-27.
Christensen et al., “Characterization of interconnects used in PDMS microfluidic systems”, J Micromech Microeng. (2005) 15:928 in 8 pages.
Chung, Y. et al., “Microfluidic chip for high efficiency DNA extraction”, Miniaturisation for Chemistry, Biology & Bioengineering, vol. 4, No. 2 (Apr. 2004), pp. 141-147.
Cooley et al., “Applications of Ink-Jet Printing Technology to BioMEMS and Microfluidic Systems”, Proceedings, SPIE Conference on Microfluids and BioMEMS, (Oct. 2001), 12 pages.
Crews et al., “Rapid Prototyping of a Continuous-Flow PCR Microchip”, Proceedings of the AiChE Annual Meeting(Nov. 15, 2006) (335a) 3 pages.
Crews et al., Thermal gradient PCR in a continuous-flow microchip. In Microfluidics, BioMEMS, and Medical Microsystems V; Jan. 2007; vol. 6465, p. 646504; 12 pages.
Crews et al., “Continuous-flow thermal gradient PCR”, Biomed Microdevices. (2008) 10(2):187-195.
Cui et al., “Electrothermal modeling of silicon PCR chips”, In MEMS Design, Fabrication, Characterization, and Packaging, (Apr. 2001) (vol. 4407, pp. 275-280.
Cui et al., “Design and Experiment of Silicon PCR Chips,” Proc. SPIE 4755, Design, Test, Integration, and Packaging of MEMS/MOEMS 2002, (Apr. 19, 2002) pp. 71-76.
Danaher Press Release: “Danaher to Acquire Cepheid for $53.00 per share, or approximately $4 Billion,” dated Sep. 6, 2016, accessed at www.danaher.com, p. 3.
Demchenko A.P., “The problem of self-calibration of fluorescence signal in microscale sensor systems”, Lab Chip. (2005) 5(11):1210-1223.
Dineva et al., “Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings”, Analyst. (2007) 132(12):1193-1199.
Dishinger et al., “Multiplexed Detection and Applications for Separations on Parallel Microchips”, Electrophoresis. (2008) 29(16):3296-3305.
Dittrich et al., “Single-molecule fluorescence detection in microfluidic channels—the Holy Grail in muTAS?”, Anal Bioanal Chem. (2005) 382(8):1771-1782.
Dittrich et al., “Lab-on-a-chip: microfluidics in drug discovery”, Nat Rev Drug Discov. (2006) 5(3):210-218.
Dunnington et al., “Approaches to Miniaturized High-Throughput Screening of Chemical Libraries”, in Integrated Microfabricated Devices, (2002) Ch. 15, pp. 371-414, CRC Press.
Eddings et al., “A PDMS-based gas permeation pump for on-chip fluid handling in microfluidic devices”, J Micromech Microengin. (2006) 16(11):2396-2402.
Edwards, “Silicon (Si),” in “Handbook of Optical Constants of Solids” (Ghosh & Palik eds., 1997) in 24 pages.
Edwards et al., “Micro Scale Purification Systems for Biological Sample Preparation”, Biomed Microdevices (2001) 3(3):211-218.
Edwards et al., “A microfabricated thermal field-flow fractionation system”, Anal Chem. (2002) 74(6):1211-1216.
Ehrlich et al., “Microfluidic devices for DNA analysis”, Trends Biotechnol. (1999) 17(8):315-319.
El-Ali et al., “Simulation and experimental validation of a SU-8 based PCR thermocycler chip with integrated heaters and temperature sensor”, Sens Actuators A: Physical (2004) 110(1-3):3-10.
Erickson et al., “Joule heating and heat transfer in poly(dimethylsiloxane) microfluidic systems”, Lab Chip (2003) 3(3):141-149.
Erickson et al., “Integrated Microfluidic Devices”, Analytica Chim Acta. (2004) 507:11-26.
Erill et al., “Development of a CMOS-compatible PCR chip: comparison of design and system strategies”, J Micromech Microengin. (2004) 14(11):1-11.
Fair R.B., Digital microfluidics: is a true lab-on-a-chip possible? Microfluidics Nanofluid. (2007) 3:245-281.
Fan et al., “Integrated Plastic Microfluidic Devices for Bacterial Detection”, in Integrated Biochips for DNA Analysis by Liu et al. [Eds], (2007) Chapter 6, pp. 78-89.
Fiorini et al., “Disposable microfluidic devices: fabrication, function, and application”, Biotechniques (2005) 38(3):429-446.
Frazier et al., “Integrated micromachined components for biological analysis systems”, J Micromech. (2000) 1(1):67-83.
Gale et al., “Micromachined electrical field-flow fractionation (mu-EFFF) system”, IEEE Trans Biomed Eng. (1998) 45(12):1459-1469.
Gale et al., “Geometric scaling effects in electrical field flow fractionation. 1. Theoretical analysis”, Anal Chem. (2001) 73(10):2345-2352.
Gale et al., “BioMEMS Education at Louisiana Tech University”, Biomed Microdevices, (2002) 4:223-230.
Gale et al., “Geometric scaling effects in electrical field flow fractionation. 2. Experimental results”, Anal Chem. (2002) 74(5):1024-1030.
Gale et al., “Cyclical electrical field flow fractionation”, Electrophoresis. (2005) 26(9):1623-1632.
Gale et al., “Low-Cost MEMS Technologies”, Elsevier B.V. (2008), Chapter 1.12; pp. 342-372.
Garst et al., “Fabrication of Multilayered Microfluidic 3D Polymer Packages”, IEEE Proceedings Electronic Components & Tech, Conference May/Jun. 2005, pp. 603-610.
Gärtner et al., “Methods and instruments for continuous-flow PCR on a chip”, Proc. SPIE 6465, Microfluidics, BioMEMS, and Medical Microsystems V, (2007) 646502; 8 pages.
Giordano et al., “Toward an Integrated Electrophoretic Microdevice for Clinical Diagnostics”, in Integrated Microfabricated Biodevices: Advanced Technologies for Genomics, Drug Discovery, Bioanalysis, and Clinical Diagnostics (2002) Chapter 1; pp. 1-34.
Goldmeyer et al., “Identification of Staphylococcus aureus and Determination of Methicillin Resistance Directly from Positive Blood Cultures by Isothermal Amplification and a Disposable Detection Device”, J Clin Microbiol. (Apr. 2008) 46(4): 1534-1536.
Graff et al., “Nanoparticle Separations Using Miniaturized Field-flow Fractionation Systems”, Proc. Nanotechnology Conference and Trade Show (NSTI) (2005); pp. 8-12.
Greer et al., “Comparison of glass etching to xurography prototyping of microfluidic channels for DNA melting analysis”, J Micromech Microengin. (2007) 17(12):2407-2413.
Grunenwald H., “Optimization of Polymerase Chain Reactions,” in Methods in Molecular Biology, PCR Protocols., Second Edition by Bartlett et al. [Eds.] Humana Press (2003) vol. 226, pp. 89-99.
Guijt et al., “Chemical and physical processes for integrated temperature control in microfluidic devices”, Lab Chip. (2003) 3(1):1-4.
Gulliksen A., “Microchips for Isothermal Amplification of RNA”, Doctoral Thesis (2007); Department of Mol. Biosciences-University of Oslo; 94 pages.
Guttenberg et al., “Planar chip device for PCR and hybridization with surface acoustic wave pump”, Lab Chip. (2005) 5(3):308-317.
Haeberle et al., “Microfluidic platforms for lab-on-a-chip applications”, Lab Chip. (2007) 7(9):1094-1110.
Hale et al., “Optical constants of Water in the 200-nm to 200-μm Wavelength Region”, Applied Optics, 12(3): 555-563 (1973).
Handal et al., “DNA mutation detection and analysis using miniaturized microfluidic systems”, Expert Rev Mol Diagn. (2006) 6(1):29-38.
Handique et al., “Microfluidic flow control using selective hydrophobic patterning”, SPIE, (1997) 3224: 185-194.
Handique et al., “On-Chip Thermopneumatic Pressure for Discrete Drop Pumping”, Anal. Chem., (2001) 73(8):1831-1838.
Handique et al., “Nanoliter-vol. discrete drop injection and pumping in microfabricated chemical analysis systems”, Solid-State Sensor and Actuator Workshop (Hilton Head, South Carolina, Jun. 8-11, 1998) pp. 346-349.
Handique et al., “Mathematical Modeling of Drop Mixing in a Slit-Type Microchannel”, J. Micromech. Microeng., 11:548-554 (2001).
Handique et al., “Nanoliter Liquid Metering in Microchannels Using Hydrophobic Patterns”, Anal. Chem., 72(17):4100-4109 (2000).
Hansen et al., “Microfluidics in structural biology: smaller, faster . . . better”, Curr Opin Struct Biol. (2003) 13(5):538-544.
Harding et al., “DNA isolation using Methidium-Spermine-Sepharose”, Meth Enzymol. (1992) 216: 29-39.
Harding et al., “Rapid isolation of DNA from complex biological samples using a novel capture reagent—methidium-spermine-sepharose”, Nucl Acids Res. (1989) 17(17):6947-6958.
He et al., Microfabricated Filters for Microfluidic Analytical Systems, Analytical Chemistry, American Chemical Society, 1999, vol. 71, No. 7, pp. 1464-1468.
Heid et al., “Genome Methods—Real Time Quantitative PCR”, Genome Res. (1996) 6(10):986-994.
Henry C.S. [Ed], “Microchip Capillary electrophoresis”, Methods in Molecular Biology, Humana Press 339 (2006) Parts I-IV in 250 pages.
Herr et al., “Investigation of a miniaturized capillary isoelectric focusing (cIEF) system using a full-field detection approach”, Solid State Sensor and Actuator Workshop, Hilton Head Island (2000), pp. 4-8.
Herr et al., “Miniaturized Isoelectric Focusing (μIEF) as a Component of a Multi-Dimensional Microfluidic System”, Micro Total Analysis Systems (2001) pp. 51-53.
Herr et al., Miniaturized Capillary Isoelectric Focusing (cIEF): Towards a Portable High-Speed Separation Method. In Micro Total Analysis Systems (2000) Springer, Dordrecht; pp. 367-370.
Holland et al., “Point-of-care molecular diagnostic systems—past, present and future”, Curr Opin Microbiol. (2005) 8(5):504-509.
Hong et al., “Integrated nanoliter systems”, Nat Biotechnol. (2003) 21(10):1179-1183.
Hong et al., “Molecular biology on a microfluidic chip”, J Phys.: Condensed Matter (2006) 18(18):S691-S701.
Hong et al., “Integrated Nucleic Acid Analysis in Parallel Matrix Architecture”, in Integrated Biochips for DNA Analysis by Liu et al. [Eds], (2007) Chapter 8, pp. 107-116.
Horsman et al., “Forensic DNA Analysis on Microfluidic Devices: A Review”, J Forensic Sci. (2007) 52(4):784-799.
Hsieh et al., “Enhancement of thermal uniformity for a microthermal cycler and its application for polymerase chain reaction”, Sens Actuators B: Chemical. (2008) 130(2):848-856.
Huang et al., “Temperature Uniformity and DNA Amplification Efficiency in MicromachinedGlass PCR Chip”, TechConnect Briefs; Tech Proc. of the 2005 NSTI Nanotechnology Conference and Trade Show. (2005) vol. 1:452-455.
Huebner et al., “Microdroplets: A sea of applications?”, Lab Chip. (2008) 8(8):1244-1254.
Ibrahim, et al., Real-Time Microchip PCR for Detecting Single-Base Differences in Viral and Human DNA, Analytical Chemistry, American Chemical Society, 1998, 70(9):2013-2017.
International Preliminary Report on Patentability and Written Opinion dated Jan. 19, 2010 for Application No. PCT/US2008/008640, filed Jul. 14, 2008.
International Search Report and Written Opinion dated Sep. 11, 2008 for International Patent Application No. PCT/US2007/084730, filed Nov. 14, 2007.
International Search Report dated Jun. 17, 2009 for Application No. PCT/US2008/008640, filed Jul. 14, 2008.
Iordanov et al., “PCR Array on Chip—Thermal Characterization”, IEEE Sensors (2003) Conference Oct. 22-24, 2003; pp. 1045-1048.
Irawan et al., “Cross-Talk Problem on a Fluorescence Multi-Channel Microfluidic Chip System,” Biomed Micro. (2005) 7(3):205-211.
Ji et al., “DNA Purification Silicon Chip”, Sensors and Actuators A: Physical (2007) 139(1-2):139-144.
Jia et al., “A low-cost, disposable card for rapid polymerase chain reaction”, Colloids Surfaces B: Biointerfaces (2007) 58:52-60.
Kaigala et al., “An inexpensive and portable microchip-based platform for integrated RT-PCR and capillary electrophoresis”, The Analyst (2008) 133(3):331-338.
Kajiyama et al., “Genotyping on a Thermal Gradient DNA Chip”, Genome Res. (2003) 13(3):467-475.
Kang et al., “Simulation and Optimization of a Flow-Through Micro PCR Chip”, NSTI—Nanotech (2006) vol. 2, pp. 585-588.
Kantak et al., “Microfluidic platelet function analyzer for shear-induced platelet activation studies”, 2nd Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Med and Biol. (May 2002) 5 pages.
Kantak et al., “Microfabricated cyclical electrical field flow fractionation”, 7th International Conference on Miniaturized Chomical and Biochem Analysis Sys. (2003) pp. 1199-1202.
Kantak et al., “Platelet function analyzer: Shear activation of platelets in microchannels”, Biomedical Microdevices (2003) 5(3):207-215.
Kantak et al., “Characterization of a microscale cyclical electrical field flow fractionation system”, Lab Chip. (2006) 6(5):645-654.
Kantak et al., “Effect of carrier ionic strength in microscale cyclical electrical field-flow fractionation”, Anal Chem. (2006) 78(8):2557-2564.
Kantak et al., “Improved theory of cyclical electrical field flow fractions”, Electrophoresis (2006) 27(14):2833-2843.
Karunasiri et al., “Extraction of thermal parameters of microbolometer infrared detectors using electrical measurement”, SPIE's Inter'l Symposium on Optical Science, Engineering, and Instrumentation; Proceedings (1998) vol. 3436, Infrared Technology and Applications XXIV; (1998) 8 pages.
Kelly et al., “Microfluidic Systems for Integrated, High-Throughput DNA Analysis,” Analytical Chemistry, (2005), 97A-102A, Mar. 1, 2005, in 7 pages.
Khandurina et al., Microfabricated Porous Membrane Structure for Sample Concentration and Electrophoretic Analysis, Analytical Chemistry American Chemical Society, 1999, 71(9): 1815-1819.
Khandurina et al., “Bioanalysis in microfluidic devices,” J Chromatography A, (2002) 943:159-183.
Kim et al., “Reduction of Microfluidic End Effects in Micro-Field Flow Fractionation Channels”, Proc. MicroTAS 2003, pp. 5-9.
Kim et al., “Multi-DNA extraction chip based on an aluminum oxide membrane integrated into a PDMS microfluidic structure”, 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Med and Biol. (May 2005).
Kim et al., “Electrohydrodynamic Generation and Delivery of Monodisperse Picoliter Droplets Using a Poly(dimethylsiloxane) Microchip”, Anal Chem. (2006) 78: 8011-8019.
Kim et al., “Geometric optimization of a thin film ITO heater to generate a uniform temperature distribution”, (2006), Tokyo, Japan; pp. 293-295; Abstract.
Kim et al., “Micro-Raman thermometry for measuring the temperature distribution inside the microchannel of a polymerase chain reaction chip”, J Micromech Microeng. (2006) 16(3):526-530.
Kim et al., “Patterning of a Nanoporous Membrane for Multi-sample DNA Extraction”, J Micromech Microeng. (2006) 16:33-39.
Kim et al., “Performance evaluation of thermal cyclers for PCR in a rapid cycling condition”, Biotechniques. (2008) 44(4):495-505.
Kim et al., “Quantitative and qualitative analysis of a microfluidic DNA extraction system using a nanoporous AlO(x) membrane”, Lab Chip. (2008) 8(9):1516-1523.
Kogi et al., “Microinjection-microspectroscopy of single oil droplets in water: an application to liquid/liquid extraction under solution-flow conditions”, Anal Chim Acta. (2000) 418(2):129-135.
Kopf-Sill et al., “Creating a Lab-on-a-Chip with Microfluidic Technologies”, in Integrated Microfabricated Biodevices: Advanced Technologies for Genomics, Drug Discovery, Bioanalysis, and Clinical Diagnostics (2002) Chapter 2; pp. 35-54.
Kopp et al., Chemical Amplification: Continuous-Flow PCR on a Chip, www.sciencemag.org, 1998, vol. 280, pp. 1046-1048.
Kricka L.J., “Microchips, Bioelectronic Chips, and Gene Chips—Microanalyzers for the Next Century”, in Biochip Technology by Cheng et al. [Eds]; (2006) Chapter 1, pp. 1-16.
Krishnan et al., “Polymerase chain reaction in high surface-to-vol. ratio SiO2 microstructures”, Anal Chem. (2004) 76(22):6588-6593.
Kuo et al., “Remnant cationic dendrimers block RNA migration in electrophoresis after monophasic lysis”, J Biotech. (2007) 129: 383-390.
Kuswandi et al., “Optical sensing systems for microfluidic devices: a review”, Anal Chim Acta. (2007) 601(2):141-155.
Kutter et al., Solid Phase Extraction on Microfluidic Devices, J. Microcolumn Separations, John Wiley & Sons, Inc., 2000, 12(2): 93-97.
Labchem; Sodium Hydroxide, 0,5N (0.5M); Safety Data Sheet, 2015; 8 pages.
Lagally et al., Single-Molecule DNA Amplification and Analysis in an Integrated Microfluidic Device, Analytical Chemistry, American Chemical Society, 2001, 73(3): 565-570.
Lagally et al., “Genetic Analysis Using Portable PCR-CE Microsystem”, Proceedings 7th International Conference on Miniaturized Chemical and Biochemical Analysis Systems (2003) pp. 1283-1286.
Lagally et al., “Integrated portable genetic analysis microsystem for pathogen/infectious disease detection”, Anal Chem. (2004) 76(11):3152-3170.
Lauerman L.H., “Advances in PCR technology”, Anim Health Res Rev. (2004) 5(2):247-248.
Lawyer et al., “High-level Expression, Purification, and Enzymatic Characterization ofFull-length Thermus aquaticus DNA Polymerase and a Truncated Form Deficient in 5′to 3′Exonuclease Activity.” Genome research (1993) 2(4):275-287.
Lee et al., “Submicroliter—volume PCR chip with fast thermal response and very power consumption”, 7th International Conference on Miniaturized Chemical and Biochemical Analysis Systems, (2003) pp. 187-190.
Lee et al., “Bulk-micromachined submicroliter-vol. PCR chip with very rapid thermal response and low power consumption”, Lab Chip. (2004) 4(4):401-407.
Lewin et al., “Use of Real-Time PCR and Molecular Beacons to Detect Virus Replication inHuman Immunodeficiency Virus Type 1-infected Individuals on Prolonged Effective Antiretroviral Therapy”. J Virol. (1999) 73(7), 6099-6103.
Li et al., “Effect of high-aspect-ratio microstructures on cell growth and attachment”, 1st Annual Inter'l IEEE-EMBS Special Topic Conference on Microtechnologies in Med and Biol. Proceedings Cat. No. 00EX451; (Oct. 2000) Poster 66, pp. 531-536.
Li PCH., “Micromachining Methods et al.” in Microfluidic Lab-on-a-Chip for Chemical and Biological Analysis and Discovery, CRC Press (2005), Chapter 2-3 to 2-5; pp. 10-49.
Li PCH., “Microfluidic Flow” in Microfluidic Lab-on-a-Chip for Chemical and Biological Analysis and Discovery, CRC Press (2005), Chapter 3, pp. 55-99.
Li PCH., “Detection Methods” in Microfluidic Lab-on-a-Chip for Chemical and Biological Analysis and Discovery, CRC Press (2005), Chapter 7, pp. 187-249.
Li PCH., “Applications to Nucleic Acids Analysis” in Microfluidic Lab-on-a-Chip for Chemical and Biological Analysis and Discovery, CRC Press (2005), Chapter 9; pp. 293-325.
Li et al., “A Continuous-Flow Polymerase Chain Reaction Microchip With Regional Velocity Control”, J Microelectromech Syst. (2006) 15(1):223-236.
Liao et al., “Miniature RT-PCR system for diagnosis of RNA-based viruses,” Nucl Acids Res. (2005) 33(18):e156 in 7 pages.
Lien et al., “Integrated reverse transcription polymerase chain reaction systems for virus detection”, Biosens Bioelectron. (2007) 22(8):1739-1748.
Lien et al., “Microfluidic Systems Integrated with a Sample Pretreatment Device for Fast Nucleic-Acid Amplification”, J Microelectro Sys. (2008) 17(2):288-301.
Lifesciences et al., “Microfluidics in commercial applications; an industry perspective.” Lab Chip (2006) 6:1118-1121.
Lin et al., “Thermal Uniformity of 12-in Silicon Wafer During Rapid Thermal Processing by Inverse Heat Transfer Method,” IEEE Transactions on Semiconductor Manufacturing, (2000) 13(4):448-456.
Lin et al., “Simulation and experimental validation of micro polymerase chain reaction chips”, Sens Actuators B: Chemical. (2000) 71(1-2):127-133.
Linder et al., “Microfluidics at the Crossroad with Point-of-care Diagnostics”, Analyst (2007) 132:1186-1192.
Liu et al., “Integrated portable polymerase chain reaction-capillary electrophoresis microsystem for rapid forensic short tandem repeat typing”, Anal Chem. (2007) 79(5):1881-1889.
Liu et al. [Eds], Integrated Biochips for DNA Analysis—Biotechnology Intelligence Unit; Springer/Landes Bioscience (2007) ISBN:978-0-387-76758-1; 216 pages.
Livache et al., “Polypyrrole DNA chip on a Silicon Device: Example of Hepatitis C Virus Genotyping”, Analytical Biochemistry, (1998) 255: 188-194.
Locascio et al., “ANYL 67 Award Address—Microfluidics as a tool to enable research and discovery in the life sciences”, Abstract; The 236th ACS National Meeting (Aug. 2008); 2 pages.
Mahjoob et al., “Rapid microfluidic thermal cycler for polymerase chain reaction nucleic acid amplification”, Inter'l J Heat Mass Transfer. (2008) 51(9-10):2109-2122.
Malitson, “Interspecimen Comparison of the Refractive Index of Fused Silica,” J Optical Society of America, 55:1205-1209 (1965).
Manz et al., “Miniaturized Total Chemical Analysis Systems: a Novel Concept for Chemical Sensing,” Sensors and Actuators B1, (1990) 244-248.
Marcus et al., “Parallel picoliter rt-PCR assays using microfluidics”, Anal Chem. (2006) 78(3):956-958.
Mariella R.P. Jr., “Microtechnology”, Thrust Area Report FY 96 UCRL-ID-125472; Lawrence Livermore National Lab., CA (Feb. 1997) Chapter 3 in 44 pages.
Mariella R., “Sample preparation: the weak link in microfluidics-based biodetection”, Biomed Microdevices. (2008) 10(6):777-784.
Mastrangelo et al., Microfabricated Devices for Genetic Diagnostics. Proceedings of the IEEE (1998) 86(8):1769-1787.
Mascini et al., “DNA electrochemical biosensors”, Fresenius J. Anal. Chem., 369: 15-22, (2001).
McMillan et al., “Application of advanced microfluidics and rapid PCR to analysis of microbial targets”, In Proceedings of the 8th international symposium on microbial ecology (1999), in 13 pages.
Melin et al., “Microfluidic large-scale integration: the evolution of design rules for biological automation”, Annu Rev Biophys Biomol Struct. (2007) 36:213-231.
Merugu et al., “High Throughput Separations Using a Microfabricated Serial Electric Split System” (2003), Proceedings of μTAS 2003, 7th International Conference on Miniaturized Chemical and Biochemical Analysis Systems, Oct. 5-9, 2003, Squaw Valley, California; 1191-1194, in 3 pages.
Meyers, R.A., Molecular Biology and Biotechnology: A Comprehensive Desk Reference; VCH Publishers, Inc. New York, NY; (1995) pp. 418-419.
Miao et al., “Low cost micro-PCR array and micro-fluidic integration on single silicon chip”, Int'l J Comput Eng Science (2003) 4(2):231-234.
Miao et al., “Flip-Chip packaged micro-plate for low cost thermal multiplexing”, Int'l J Comput Eng Science. (2003) 4(2):235-238.
Micheletti et al., “Microscale Bioprocess Optimisation”, Curr Opin Biotech. (2006) 17:611-618.
MicroTAS 2005., “Micro Total Analysis Systems”, Proceedings 9th Int. Conference onMiniaturized Systems for Chemistry and Life Sciences; Presentations/Posters/Articles for Conference; Boston, MA in Oct. 10-12, 2005 in 1667 pages.
MicroTAS 2007., “Micro Total Analysis Systems”, Proceedings 11th Int. Conference onMiniaturized Systems for Chemistry and Life Sciences; Presentations/Posters/Articles for Conference; Paris, France in Oct. 7-11, 2007 in 1948 pages.
MicroTAS 2007., “Micro Total Analysis Systems”, Advance Program for the Proceedings 11th Int. Conference on Miniaturized Systems for Chemistry and Life Sciences; Presentations/Posters/Articles for Conference; Paris, France in Oct. 7-11, 2007 in 42 pages.
Minco, “Conductive Heating Technologies for Medical Diagnostic Equipment,” (2006) in 13 pages.
Mitchell et al., “Modeling and validation of a molded polycarbonate continuous-flow polymerase chain reaction device,” Microfluidics, BioMEMS, and Medical Microsystems, Proc. SPIE (2003) 4982:83-98.
Myers et al., “Innovations in optical microfluidic technologies for point-of-care diagnostics”, Lab Chip (2008) 8:2015-2031.
Nakagawa et al., Fabrication of amino silane-coated microchip for DNA extraction from whole blood, J of Biotechnology, Mar. 2, 2005, 116: 105-111.
Namasivayam et al., “Advances in on-chip photodetection for applications in miniaturized genetic analysis systems”, J Micromech Microeng. (2004) 14:81-90.
Narayanan et al., “A microfabricated electrical SPLITT system,” Lab Chip, (2006) 6:105-114.
Neuzil et al., “Disposable real-time microPCR device: lab-on-a-chip at a low cost, ” Mol. Biosyst., (2006) 2:292-298.
Neuzil et al., “Ultra fast miniaturized real-time PCR: 40 cycles in less than six minutes,” Nucleic Acids Research, (2006) 34(11)e77, in 9 pages.
Nguyen et al. [Eds], “Microfluidics for Internal Flow Control: Microfluidics” in Fundamentals and Applications of Microfluidics; 2nd Edition (2006) Introduction Chapter 1, pp. 1-9.
Nguyen et al. [Eds], “Microfluidics for Internal Flow Control: Microvalves” in Fundamentals and Applications of Microfluidics; (2006) 2nd Edition, Chapter 6, pp. 211-254.
Nguyen et al. [Eds], “Microfluidics for Internal Flow Control: Micropumps” in Fundamentals and Applications of Microfluidics; (2006) 2nd Edition, Chapter 7, pp. 255-309.
Nguyen et al. [Eds], “Microfluidics for Life Sciences and Chemistry: Microdispensers” in Fundamentals and Applications of Microfluidics; (2006) , Chapter 11, pp. 395-418.
Nguyen et al. [Eds], “Microfluidics for Life Sciences and Chemistry: Microreactors” inFundamentals and Applications of Microfluidics; (2006) 2nd Edition, Chapter 13, pp. 443-477.
Ning et al., “Microfabrication Processes for Silicon and Glass Chips”, in Biochip Technology, CRC-Press (2006) Chapter 2, pp. 17-38.
Northrup et al., “A MEMS-based Miniature DNA Analysis System,” Lawrence Livermore National Laboratory, (1995), submitted to Transducers '95, Stockholm, Sweden, Jun. 25-29, 1995, in 7 pages (Prepublication).
Northrup et al., “Advantages Afforded by Miniaturization and Integration of DNA Analysis Instrumentation,” Microreaction Technology, (1998) 278-288.
Northrup et al., A Miniature Analytical Instrument for Nucleic Acids Based on Micromachined Silicon Reaction Chambers, Analytical Chemistry, American Chemical Society, 1998, 70(5): 918-922.
Northrup et al., “A New Generation of PCR Instruments and Nucleic Acid ConcentrationSystems,” in PCR Applications: Protocols for Functional Genomics, (1999), Chapter 8, pp. 105-125.
Northrup, “Microfluidics, a few good tricks,” Nature materials (2004), 3:282-283.
Northrup et al., “Microfluidics-based integrated airborne pathogen detection systems,” Abstract, Proceedings of the SPIE, (2006), vol. 6398, Abstract in 2 pages.
Oh et al., “World-to-chip microfluidic interface with built-in valves for multichamber chip-based PCR assays,” Lab Chip, (2005), 5:845-850.
Oh K.W. et al., “A Review of Microvalves”, J Micromech Microeng. (2006) 16:R13-R39.
Ohno et al., “Microfluidics: Applications for analytical purposes in chemistry and biochemistry,” Electrophoresis (2008), 29:4443-4453.
Oleschuk et al., Trapping of Bead-Based Reagents within Microfluidic Systems: On-Chip Solid-Phase Extraction and Electrochromatography, Analytical Chemistry, American Chemical Society, 2000, 72(3): 585-590.
Pal et al., “Phase Change Microvalve for Integrated Devices”, Anal Chem. (2004) 76:3740-3748.
Pal et al., “An integrated microfluidic for influenza and other genetic analyses,” Lab Chip, (2005), 5:1024-1032.
Palina et al., “Laser Assisted Boron Doping of Silicon Wafer Solar Cells Using Nanosecond and Picosecond Laser Pulses,” 2011 37th IEEE Photovoltaic Specialists Conference, pp. 002193-002197, IEEE (2011).
Pamme, “Continuous flow separations in microfluidic devices,” Lab Chip, (2007), 7:1644-1659.
Pang et al., “A novel single-chip fabrication technique for three-dimensional MEMS structures,” Institute of Microelectronics, Tsinghua University, Beijing, P.R. China, (1998), IEEE, 936-938.
Pang et al., “The Study of Single-Chip Integrated Microfluidic System,” Tsinghua University, Beijing, P.R. China, (1998), IEEE, 895-898.
Papautsky et al., “Effects of rectangular microchannel aspect ratio on laminar friction constant”, in Microfluidic Devices and Systems II (1999) 3877:147-158.
Paulson et al., “Optical dispersion control in surfactant-free DNA thin films by vitamin B2 doping,” Nature, Scientific Reports 8:9358 (2018) published at www.nature.com/scientificreports, Jun. 19, 2018.
Petersen, Kurt E., “Silicon as a Mechanical Material.” Proceedings of the IEEE, (May 1982) 70(5):420-457.
Petersen et al., “Toward Next Generation Clinical Diagnostic Instruments: Scaling and New Processing Paradigms,” Biomedical Microdevices (1998) 1(1):71-79.
Picard et al., Laboratory Detection of Group B Streptococcus for Prevention of Perinatal Disease, Eur. J. Clin. Microbiol. Infect. Dis., Jul. 16, 2004, 23: 665-671.
Plambeck et al., “Electrochemical Studies of Antitumor Antibiotics”, J. Electrochem Soc.: Electrochemical Science and Technology (1984), 131(11): 2556-2563.
Poser et al., “Chip elements for fast thermocycling,” Sensors and Actuators A, (1997), 62:672-675.
Pourahmadi et al., “Toward a Rapid, Integrated, and Fully Automated DNA Diagnostic Assay for Chlamydia trachomatis and Neisseria gonorrhea,” Clinical Chemistry, (2000), 46(9):1511-1513.
Pourahmadi et al., “Versatile, Adaptable and Programmable Microfluidic Platforms for DNA Diagnostics and Drug Discovery Assays,” Micro Total Analysis Systems, (2000), 243-248.
Raisi et al., “Microchip isoelectric focusing using a miniature scanning detection system,” Electrophoresis, (2001), 22:2291-2295.
Raja et al., “Technology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical Testing,” Clinical Chemistry, (2005), 51(5):882-890.
Reyes et al., “Micro Total Analysis Systems. 1. Introduction, Theory, and Technology”, Anal Chem (2002) 74:2623-2636.
Roche et al. “Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells” Faseb J (2005) 19: 1341-1343.
Rodriguez et al., “Practical integration of polymerase chain reaction amplification and electrophoretic analysis in microfluidic devices for genetic analysis,” Electrophoresis, (2003), 24:172-178.
Rohsenow et al. [Eds.], Handbook of Heat Transfer, 3rd Edition McGraw-Hill Publishers (1998) Chapters 1 & 3; pp. 108.
Roper et al., “Advances in Polymer Chain Reaction on Microfluidic Chips,” Anal. Chem., (2005), 77:3887-3894.
Ross et al., Analysis of DNA Fragments from Conventional and Microfabricated PCR Devices Using Delayed Extraction MALDI-TOF Mass Spectrometry, Analytical Chemistry, American Chemical Society, 1998, 70(10): 2067-2073.
Ross et al., “Scanning Temperature Gradient Focusing for Simultaneous Concentration and Separation of Complex Samples,” Micro Total Analysis Systems 2005, vol. 2, (2005), Proceedings of μTAS 2005, Ninth International Conference on Miniaturized Systems for Chemistry and Life Sciences, Oct. 9-13, 2005, Boston, Massachusetts; 1022-1024.
Ross et al., “Simple Device for Multiplexed Electrophoretic Separations Using Gradient Elution Moving Boundary Electrophoresis with Channel Current Detection,” Anal. Chem., (2008), 80(24):9467-9474.
Sadler et al., “Thermal Management of BioMEMS: Temperature Control for Ceramic-Based PCR and DNA Detection Devices,” IEEE Transactions on Components and Packaging Technologies, (2003) 26(2):309-316.
Sanchez et al., “Linear-After-The-Exponential (LATE)-PCR: An advanced method of asymmetric PCR and its uses in quantitative real-time analysis”, PNAS (2004) 101(7):1933-1938.
Sant et al., “An Integrated Optical Detector for Microfabricated Electrical Field Flow Fractionation System,” Proceedings of μTAS 2003, 7th International Conference on Miniaturized Chemical and Biochemical Analysis Systems, Oct. 5-9, 2003, Squaw Valley, California; pp. 1259-1262.
Sant et al., “Geometric scaling effects on instrumental plate height in field flow fractionation”, J Chromatography A (2006) 1104:282-290.
Sant H.J., “Reduction of End Effect-Induced Zone Broadening in Field-Flow Fractionation Channels”, Anal Chem. (2006) 78:7978-7985.
Sant et al., “Microscale Field-Flow Fractionation: Theory and Practice”, in Microfluidic Technologies for Miniaturized Analysis Systems. (2007) Chapter 12, pp. 4710521.
Schäferling et al., “Optical technologies for the read out and quality control of DNA and protein microarrays,” Anal Bioanal Chem, (2006), 385: 500-517.
Serpengüzel et al., “Microdroplet identification and size measurement in sprays with lasing images”, Optics express (2002) 10(20):1118-1132.
Shackman et al., “Gradient Elution Moving Boundary Electrophoresis for High-Throughput Multiplexed Microfluidic Devices,” Anal. Chem. (2007), 79(2), 565-571.
Shackman et al., “Temperature gradient focusing for microchannel separations,” Anal Bioanal Chem, (2007), 387:155-158.
Shadpour et al., “Multichannel Microchip Electrophoresis Device Fabricated inPolycarbonate with an Integrated Contact Conductivity Sensor Array,” Anal Chem., (2007), 79(3), 870-878.
Shen et al., “A microchip-based PCR device using flexible printed circuit technology,” Sensors and Actuators B (2005), 105:251-258.
Shoffner et al., Chip PCR.I. Surface Passivation of Microfabricated Silicon-Glass Chips for PCR, Nucleic Acids Research, Oxford University Press, (1996) 24(2): 375-379.
Sia et al., “Microfluidic devices fabricated in poly(dimethylsiloxane) for biological studies,” Electrophoresis, (2003), 24:3563-3576.
Sigurdson M., “AC Electrokinetic Enhancement for Assay Enhancement”, ProQuest LLC (2008) Doctoral Thesis UMI Microform 3319791 in 24 pages.
Singh et al., “PCR thermal management in an integrated Lab on Chip,” Journal of Physics: Conference Series, (2006), 34:222-227.
Situma et al., “Merging microfluidics with microarray-based bioassays”, Biomol Engin. (2006) 23:213-231.
Smith, K. et al., “Comparison of Commercial DNA Extraction Kits for Extraction of Bacterial Genomic DNA from Whole-Blood Samples”, Journal of Clinical Microbiology, vol. 41, No. 6 (Jun. 2003), pp. 2440-2443.
Smith et al., “(576d) Micropatterned fluid lipid bilayers created using a continuous flow microspotter for multi-analyte assays,” (2007), Biosensors II, 2007 AIChE Annual Meeting, Nov. 8, 2007, Abstract in 2 pages.
Sommer et al., “Introduction to Microfluidics”, in Microfluidics for Biological Applications by Tian et al. [Eds] (2008) Chapter 1, pp. 1-34.
Spitzack et al., “Polymerase Chain Reaction in Miniaturized Systems: Big Progress in Little Devices”, in Methods in Molecular Biology—Microfluidic Techniques, Minteer S.D. [Ed.] Humana Press (2006), Chapter 10, pp. 97-129.
Squires et al., “Microfluidics: Fluid physics at the nanoliter scale”, Rev Modern Phys. (2005) 77(3):977-1026.
Sundberg et al., “Solution-phase DNA mutation scanning and SNP genotyping by nanoliter melting analysis,” Biomed Microdevices, (2007), 9:159-166, in 8 pages.
Tabeling, P. [Ed.], “Physics at the micrometric scale,” in Introduction to Microfluidics (2005) Chapter 1, pp. 24-69.
Tabeling, P. [Ed.], “Hydrodynamics of Microfluidic Systems”, in Introduction to Microfluidics; (2005) Chapter 2, pp. 70-129.
Tabeling, P. [Ed.], Introduction to Microfluidics; (2005) Chapters 5-7, pp. 216-297.
Tanaka et al., “Improved Method of DNA Extraction from Seeds Using Amine-Dendrimer Modified Magnetic Particles”, Proceedings of the 74th Annual Meeting of the Electrochemical Society of Japan; Abstract #2E09 on p. 149, Mar. 29, 2007; Faculty of Engineering, Science University of Tokyo; 4 pages.
Taylor et al., Fully Automated Sample Preparation for Pathogen Detection Performed in a Microfluidic Cassette, in Micro Total Analysis Systems, Springer (2001), pp. 670-672.
Taylor et al., “Lysing Bacterial Spores by Sonication through a Flexible Interface in a Microfluidic System,” Anal. Chem., (2001), 73(3):492-496.
Taylor et al., “Microfluidic Bioanalysis Cartridge with Interchangeable MicrochannelSeparation Components,” (2001), The 11th International Conference on Solid-State Sensors and Actuators, Jun. 10-14, 2001, Munich, Germany; 1214-1247.
Taylor et al., “Disrupting Bacterial Spores and Cells using Ultrasound Applied through a Solid Interface,” (2002), 2nd Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Medicine & Biology, May 2-4, 2002, Madison, Wisconsin; 551-555.
Thorsen et al., “Microfluidic Large-scale integration,” Science, (2002), 298:580-584.
Toriello et al., “Multichannel Reverse Transcription-Polymerase Chain Reaction Microdevice for Rapid Gene Expression and Biomarker Analysis,” Anal. Chem., (2006) 78(23):7997-8003.
Ugaz et al., “Microfabricated electrophoresis systems for DNA sequencing and genotyping applications,” Phil. Trans. R. Soc. Lond. A, (2004), 362:1105-1129.
Ugaz et al., “PCR in Integrated Microfluidic Systems”, in Integrated Biochips for DNA Analysis by Liu et al. [Eds]; (2007) Chapter 7, pp. 90-106.
Ullman et al., “Luminescent oxygen channeling assay (LOCI™): sensitive, broadly applicable homogeneous immunoassay method”. Clin Chem. (1996) 42(9), 1518-1526.
Velten et al., “Packaging of Bio-MEMS: Strategies, Technologies, and Applications,” IEEE Transactions on Advanced Packaging, (2005) 28(4):533-546.
Vinet et al., “Microarrays and microfluidic devices: miniaturized systems for biological analysis,” Microelectronic Engineering, (2002), 61-62:41-47.
Wang, “Survey and Summary, from DNA Biosensors to Gene Chips”, Nucleic Acids Research, 28(16):3011-3016, (2000).
Wang et al., “From biochips to laboratory-on-a-chip system”, in Genomic Signal Processing and Statistics by Dougherty et al. [Eds]; (2005) Chapter 5, pp. 163-200.
Wang et al., “A disposable microfluidic cassette for DNA amplification and detection”, Lab on a Chip (2006) 6(1):46-53.
Wang et al., “Micromachined Flow-through Polymerase Chain Reaction Chip Utilizing Multiple Membrane-activated Micropumps,” (2006), MEMS 2006, Jan. 22-26, 2006, Istanbul, Turkey; 374-377.
Waters et al., Microchip Device for Cell Lysis, Multiplex PCR Amplification, and Electrophoretic Sizing, Analytical Chemistry, American Chemical Society, 1998, 70(1):158-162.
Weigl, et al., Microfluidic Diffusion-Based Separation and Detection, www.sciencemag.org, 1999, vol. 283, pp. 346-347.
Woolley A.T., “Integrating Sample Processing and Detection with Microchip Capillary Electrophoresis of DNA”, in Integrated Biochips for DNA Analysis by Liu et al. [Eds]; (2007) Chapter 5, pp. 68-77.
Wu et al., “Polycationic dendrimers interact with RNA molecules: polyamine dendrimers inhibit the catalytic activity of Candida ribozymes”, Chem Commun. (2005) 3: 313-315.
Xiang et al., “Real Time PCR on Disposable PDMS Chip with a Miniaturized Thermal Cycler,” Biomedical Microdevices, (2005), 7(4):273-279.
Xuan, “Joule heating in electrokinetic flow,” Electrophoresis, (2008), 298:33-43.
Yang et al., “High sensitivity PCR assay in plastic micro reactors,” Lab Chip, (2002), 2:179-187.
Yang et al., “An independent, temperature controllable-microelectrode array,” Anal. Chem., (2004), 76(5):1537-1543.
Yang et al., “Cost-effective thermal isolation techniques for use on microfabricated DNA amplification and analysis devices,” J Micromech Microeng, (2005), 15:221-230.
Yobas et al., Microfluidic Chips for Viral RNA Extraction & Detection, (2005), 2005 IEEE, 49-52.
Yobas et al., “Nucleic Acid Extraction, Amplification, and Detection on Si-Based Microfluidic Platforms,” IEEE Journal of Solid-State Circuits, (2007), 42(8):1803-1813.
Yoon et al., “Precise temperature control and rapid thermal cycling in a micromachined DNA polymer chain reaction chip,” J. Micromech. Microeng., (2002), 12:813-823.
Yoza et al., “Fully Automated DNA Extraction from Blood Using Magnetic Particles Modified with a Hyperbranched Polyamidoamine Dendrimer”, J Biosci Bioeng, 2003, 95(1): 21-26.
Yoza et al., DNA extraction using bacterial magnetic particles modified with hyperbranched polyamidoamine dendrimer, J Biotechnol., Mar. 20, 2003, 101(3): 219-228.
Zhang et al., “Temperature analysis of continuous-flow micro-PCR based on FEA,” Sensors and Actuators B, (2002), 82:75-81.
Zhang et al., “PCR Microfluidic Devices for DNA Amplification,” Biotechnology Advances, 24:243-284 (2006).
Zhang et al., “Continuous-flow PCR Microfluidics for Rapid DNA Amplification Using Thin Film Heater with Low Thermal Mass,” Analytical Letters, (2007), 40:1672-1685, in 15 pages.
Zhang et al., “Direct Adsorption and Detection of Proteins, Including Ferritin, onto Microlens Array Patterned Bioarrays,” J Am Chem Soc., (2007), 129:9252-9253.
Zhang et al., “Micropumps, microvalves, and micromixers within PCR microfluidic chips: Advances and trends,” Biotechnology Advances, (2007), 25:483-514.
Zhang et al., “Miniaturized PCR chips for nucleic acid amplification and analysis: latest advances and future trends,” Nucl Acids Res., (2007) 35(13):4223-4237.
Zhao et al., “Heat properties of an integrated micro PCR vessel,” Proceedings of SPIE, (2001), International Conference on Sensor Technology, 4414:31-34.
Zhou et al., “Cooperative binding and self-assembling behavior of cationic low molecular-weight dendrons with RNA molecules”, Org Biomol Chem. (2006) 4(3): 581-585.
Zhou et al., “PAMAM dendrimers for efficient siRNA delivery and potent gene silencing”, Chem Comm.(Camb.) (2006) 22: 2362-2364.
Zou et al., “A Micromachined Integratable Thermal Reactor,” technical digest from International Electron Devices Meeting, IEEE, Washington, D.C., Dec. 2-5, 2001 (6 pages).
Zou et al., “Micro-assembled multi-chamber thermal cycler for low-cost reaction chip thermal multiplexing,” Sensors and Actuators A, (2002), 102:114-121.
Zou et al., “Miniaturized Independently Controllable Multichamber Thermal Cycler,” IEEE Sensors Journal, (2003), 3(6):774-780.
Petition for Inter Partes Review of U.S. Pat. No. 7,998,708 (Paper 1 in IPR2019-00488) dated Dec. 20, 2018 (94 pages).
Declaration of Bruce K. Gale, Ph.D. (Exhibit 1001 in IPR2019-00488 and IPR2019-00490) dated Dec. 20, 2018 (235 pages).
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 7,998,708 and Exhibit List (Papers 5 and 6 in IPR2019-00488) dated Apr. 18, 2019 (79 pages).
Decision instituting Inter Partes Review of U.S. Pat. No. 7,998,708 (Paper 8 in IPR2019-00488) dated Jul. 16, 2019 (20 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,323,900 (Paper 1 in IPR2019-00490) dated Dec. 20, 2018 (85 pages).
Declaration of Michael G. Mauk, Ph. D. in Support of Patent Owner Preliminary Responses in IPR2019-00488 and IPR2019-00490 dated Apr. 18, 2019 (43 pages).
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,323,900 and Exhibit List (Papers 5 and 6 in IPR2019-00490) dated Apr. 18, 2019 (73 pages).
Decision instituting Inter Partes Review of U.S. Pat. No. 8,323,900 (Paper 8 in IPR2019-00490) dated Jul. 16, 2019 (23 pages).
Patent Owner's Response in Inter Partes Review of U.S. Pat. No. 8,323,900 and Exhibit List (Paper 25 in IPR2019-00490) dated Oct. 16, 2019 (80 pages).
Patent Owner's Response in Inter Partes Review of U.S. Pat. No. 7,998,708 and Exhibit List (Paper 25 in IPR 2019-00488) dated Oct. 16, 2019 (93 pages).
Transcript of Deposition of Bruce K. Gale, Ph.D., in Support of Patent Owner's Responses (Exhibit 2012 in IPR2019-00488 and IPR2019-00490), taken Sep. 24, 2019 (124 pages).
Declaration of M. Allen Northrup, Ph.D. in Support of Patent Owner's Responses (Exhibit 2036 in IPR2019-00488 and IPR2019-00490) dated Oct. 16, 2019 (365 pages).
Petitioner's Reply to Patent Owner's Response to Petition in Inter Partes Review of UnitedStates Patent No. 7,998,708 and Exhibit List (Paper 32 in IPR 2019-00488) dated Jan. 31, 2020 (34 pages).
Petitioner's Reply to Patent Owner's Response to Petition in Inter Partes Review of U.S. Pat. No. 8,323,900 and Exhibit List (Paper 32 in IPR 2019-00490) dated Jan. 31, 2020 (35 pages).
Second Declaration of Bruce K. Gale, Ph.D. (Exhibit 1026 in IPR2019-00488 and IPR2019-00490) dated Jan. 31, 2020 (91 pages).
Transcript of Deposition of M. Allen Northrup, Ph.D., (Exhibit 1027 in IPR2019-00488 and IPR2019-00490), taken Dec. 19, 2019 (109 pages).
Patent Owner's Sur-Reply in Inter Partes Review of U.S. Pat. No. 8,323,900 (Paper 42 in IPR2019-00490) dated Mar. 12, 2020 (39 pages).
Patent Owner's Sur-Reply in Inter Partes Review of U.S. Pat. No. 7,998,708 (Paper 43 in IPR 2019-00488) dated Mar. 12, 2020 (41 pages).
Transcript of Second Deposition of Bruce K. Gale, Ph.D., (Exhibit 2068 in IPR2019-00488 and IPR2019-00490), taken Feb. 19, 2020 (352 pages).
Complaint filed by Becton, Dickinson et al., v. NeuModx Molecular, Inc. on Jun. 18, 2019 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS, Infringement Action involving U.S. Pat. Nos. 7,998,708; 8,273,308; 8,323,900; 8,415,103; 8,703,069; and 8,709,787 (29 pages).
Answer to Complaint filed by NeuModx Molecular, Inc. on Aug. 9, 2019 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (24 pages).
Amended Answer to Complaint filed by NeuModx Molecular, Inc. on Oct. 4, 2019 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (31 pages).
Anderson et al., “Microfluidic biochemical analysis system” Proc. 1997 IEEE Int. Conf. Solid-State Sens. Actuat. (1997) pp. 477-480.
Anderson et al., “Advances in Integrated Genetic Analysis” Micro Total Analysis Systems '98 Conference Proceedings, D. Kluwer Academic Publishers (1998) in 6 pages.
Anderson et al., “A Miniature Integrated Device for Automated Multistep Genetic Assays” Nucleic Acids Research (2000) 28(12), i-vi.
BDProbeTec™ ET Neisseria gonorrhoeae Amplified DNA Assay Package Insert, Jul. 2010 (13 pages).
BDProbeTec™ ET System Brochure, Aug. 2010 (9 pages).
Benters et al., “Dendrimer-Activated Solid Supports for Nucleic Acid and Protein Microarrays”, ChemBioChem (2001) 2(9): 686-694.
Burns et al., “Microfabricated Structures for Integrated DNA Analysis” Proc. Natl. Acad. Sci. USA (May 1996) 93: 5556-5561.
Devarakonda et al., “The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine”, Int J Pharma. 284(1-2): 133-140.
Gill et al., “Nucleic Acid Isothermal Amplification Technologies—A Review”, Nucleosides Nucleotides Nucleic Acids, (2008) 27(3): 224-243.
Harrison et al., “Capillary Electrophoresis and Sample Injection Systems Integrated on a Planar Glass Chip”, Anal. Chem., (1992) 64: 1926-1932.
Hsueh et al., “A microfabricated, electrochemiluminescence cell for the detection of amplified DNA” Proc. 1995 IEEE Int. Conf. Solid-State Sens. Actuators (1995) pp. 768-771.
Hsueh et al., “DNA quantification with an electrochemiluminescence microcell” Proc. 1997 IEEE Int. Conf. Solid-State Sens. Actuators (1997) pp. 175-178.
Jiang et al., “Directing cell migration with asymmetric micropatterns” Proc. Natl. Acad. Sci. USA (2005) 102, 975-978.
Lagally et al., “Monolithic integrated microfluidic DNA amplification and capillary electrophoresis analysis system” Sensors and Actuators B (2000) 63:138-146.
Manz et al., “Design of an open-tubular column liquid chromatograph using silicon chip technology” Sensors and Actuators B (1990) 1:249-255.
Manz et al., “Planar chips technology for miniaturization and integration of separationtechniques into monitoring systems: Capillary electrophoresis on a chip” Journal of Chromatography A (1992) 593:253-258.
Northrup et al., “A MEMS-based Miniature DNA Analysis System.” Transducers '95—Eurosensors in Proc. 1995 (8th) IEEE Int. Conf. Solid-State Sens. Actuators, pp. 764-767.
Rhee et al., “Drop Mixing in a Microchannel for Lab-on-a-Chip Applications” Langmuir (2008) 24 (2): 590-601.
Rush et al., “Dispersion by Pressure-Driven Flow in Serpentine Microfluidic Channels”, Ind Eng Chem Res., (2002) 41: 4652-4662.
Sammarco et al., “Thermocapillary Pumping of Discrete Drops in Microfabricated Analysis Devices” AlChE Journal (1999) 45(2): 350-366.
Taylor et al., “Optimization of the performance of the polymerase chain reaction in silicon-based microstructures” Nucleic Acids Res. (1997) vol. 25, pp. 3164-3168.
Terry et al., “A Gas Chromatographic Air Analyzer Fabricated on a Silicon Wafer” IEEE T Electron Dev (1979) 26:1880-1886.
U.S. Appl. No. 60/491,264, filed Jul. 31, 2003 (41 pages).
U.S. Appl. No. 60/491,269, filed Jul. 31, 2003 (52 pages).
U.S. Appl. No. 60/491,539, filed Aug. 1, 2003 (45 pages).
U.S. Appl. No. 60/553,553, filed Mar. 17, 2004 (49 pages).
U.S. Appl. No. 60/726,066, filed Oct. 11, 2005 (54 pages).
U.S. Appl. No. 60/786,007, filed Mar. 24, 2006 (223 pages).
U.S. Appl. No. 60/859,284, filed Nov. 14, 2006 (114 pages).
Walker et al., “Strand displacement amplification—an isothermal, in vitro DNA amplification technique”, Nucleic Acids Res. (1992) 20(7): 1691-1696.
Whitesides G.M., “The origins and the future of microfluidics” Nature (2006) 442(7101):368-373.
Woias P., “Micropumps—past, progress and future prospects” Sensors and Actuators B (2005) 105, 28-38.
Woolley et al., “Functional integration of PCR amplification and capillary electrophoresis in a microfabricated DNA analysis device” Anal. Chem. (1996) vol. 68, pp. 4081-4086.
Wu et al., “Fabrication of Complex Three-dimensional Microchannel Systems in PDMS” J. Am. Chem. Soc. (2003) 125, 554-559.
Zhang et al., “Parallel DNA amplification by convective polymerase chain reaction with various annealing temperatures on a thermal gradient device,” Analytical Biochemistry, (2009) 387:102-112.
Record of Oral Hearing in IPR2019 00488 and IPR2019 00490 held Apr. 21, 2020 (80 pages); Petitioner's Demonstratives for Oral Hearing in IPR2019-00488 and IPR2019-00490 held Apr. 21, 2020 (72 pages); Patent Owner's Demonstratives for Oral Hearing in IPR2019-00488 and IPR2019-00490 held Apr. 21, 2020 (88 pages); Patent Owner's Objections to Petitioner's Oral Hearing Demonstratives in IPR2019-00488 and IPR2019-00490 dated Apr. 16, 2020 (4 pages).
Judgment/Final Written Decision Determining No Challenged Claims Unpatentable in InterPartes Review of U.S. Pat. No. 7,998,708 (Paper No. 52 in IPR2019-00488) dated Jul. 14, 2020 (43 pages).
Judgment/Final Written Decision Determining No. Challenged Claims Unpatentable in Inter Partes Review of U.S. Pat. No. 8,323,900 (Paper No. 51 in IPR2019-00490) dated Jul. 14, 2020 (43 pages).
Petitioner's Notice of Appeal in Inter Partes Review of U.S. Pat. No. 7,998,708 (Paper No. 54 in IPR2019-00488) dated Sep. 9, 2020 (48 pages).
Petitioner's Notice of Appeal in Inter Partes Review of U.S. Pat. No. 8,323,900 (Paper No. 53 in IPR2019-00490) dated Sep. 9, 2020 (48 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,273,308 (Paper 2 in IPR2020-01083) dated Jun. 12, 2020 (104 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,273,308 (Paper 2 in IPR2020-01091) dated Jun. 12, 2020 (105 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,803,069 (Paper 2 in IPR2020-01095) dated Jun. 12, 2020 (84 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,803,069 (Paper 3 in PR2020-01100) dated Jun. 12, 2020 (83 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,709,787 (Paper 2 in IPR2020-01132) dated Jun. 18, 2020 (96 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,415,103 (Paper 2 in IPR2020-01133) dated Jun. 18, 2020 (96 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,709,787 (Paper 2 in IPR2020-01137) dated Jun. 19, 2020 (86 pages).
Petition for Inter Partes Review of U.S. Pat. No. 8,415,103 (Paper 2 in IPR2020-01136) dated Jun. 19, 2020 (85 pages).
Declaration of Mark A. Burns, Ph.D. (Exhibit N1001 in IPR2020-01083, IPR2020-01091, IPR2020-01095 and IPR2020-01100) dated Jun. 12, 2020 (378 pages).
Declaration of Mark A. Burns, Ph.D. (Exhibit N1101 in IPR2020-01132 and IPR2020-01133) dated Jun. 17, 2020 (253 pages).
Declaration of Mark A. Burns, Ph.D. (Exhibit N1201 in IPR2020-01136 and IPR2020-01137) dated Jun. 19, 2020 (205 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,703,069 (Paper 13 in IPR2020-01095) dated Sep. 17, 2020 (77 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,273,308 (Paper 13 in IPR2020-01091) dated Sep. 17, 2020 (70 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,703,069 (Paper 14 in IPR2020-01100) dated Sep. 17, 2020 (59 pages).
Declaration of M. Allen Northrup, Ph.D. in Support of Patent Owner Preliminary Responsesin IPR2020-01091, IPR2020-01095 and IPR2020-01100 (Exhibit H2003) dated Sep. 16, 2020 (137 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,273,308 (Paper 13 in IPR2020-01083) dated Oct. 22, 2020 (88 pages).
Declaration of M. Allen Northrup, Ph.D. in support of Patent Owner Preliminary Responses in IPR2020-01083, IPR2020-01091, IPR2020-01095 and IPR2020-01100 (Exhibit H2003) dated Oct. 21, 2020 (171 pages).
Petition for Inter Partes Review of U.S. Pat. No. 10,625,262 (Paper 2 in IPR2021-00250) dated Nov. 25, 2020 (107 pages).
Petition for Inter Partes Review of U.S. Pat. No. 10,625,261 (Paper 2 in IPR2021-00251) dated Nov. 25, 2020 (117 pages).
Petition for Inter Partes Review of U.S. Pat. No. 10,632,466 (Paper 2 in IPR2021-00253) dated Nov. 25, 2020 (121 pages).
Declaration of Mark A. Burns, Ph.D. (Exhibit N1001 in IPR2021-00250, IPR2021-00251 and IPR2021-00253) dated Nov. 24, 2020 (311 pages).
Declaration of James L. Mullins, Ph.D. (Exhibit N1029 in IPR2021-00250, IPR2021-00251, and IPR2021-00253) dated Nov. 18, 2020 (54 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,273,308 (Paper 14 in IPR2020-01091) dated Dec. 4, 2020 (21 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,703,069 (Paper 14 in IPR2020-01095) dated Dec. 4, 2020 (22 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,703,069 (Paper 15 in IPR2020-01100) dated Dec. 4, 2020 (19 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,273,308 (Paper 14 in IPR2020-01083) dated Jan. 7, 2021 (24 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,415,103 (Paper 20 in IPR2020-01133) dated Jan. 20, 2021 (67 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,709,787 (Paper 19 in IPR2020-01132) dated Jan. 20, 2021 (78 pages).
Declaration of M. Allen Northrup, Ph.D. in support of Patent Owner Preliminary Responses in IPR2020-01132 and IPR2020-01133 (Exhibit H2016) dated Jan. 20, 2021 (154 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,415,103 (Paper 19 in IPR2020-01136) dated Jan. 20, 2021 (77 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,709,787 (Paper 19 in IPR2020-01137) dated Jan. 20, 2021 (69 pages).
Declaration of M. Allen Northrup, Ph.D. in support of Patent Owner Preliminary Responsesin IPR2020-01136 and IPR2020-01137 (Exhibit H2016) dated Jan. 20, 2021 (111 pages).
Opening Brief [Corrected] of Appellants Qiagen North American Holdings, Inc. and NeuMoDx Molecular Inc. in Appeals to IPR2019-00488, IPR2019-00490, IPR2019-01493 and IPR2019-01494 filed Jan. 22, 2021 in U.S. Court of Appeals for the Federal Circuit Case Nos. 20-2249, 20-2250, 20-2273 and 20-2276 (82 pages).
Decision Granting Institution of Inter Partes Review of U.S. Pat. No. 8,709,787 (Paper 20 in IPR2020-01132) dated Apr. 19, 2021 (33 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,415,103 (Paper 21 in IPR2020-01133) dated Apr. 19, 2021 (24 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,415,103 (Paper 20 in IPR2020-01136) dated Apr. 19, 2021 (19 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,709,787 (Paper 20 in IPR2020-01137) dated Apr. 19, 2021 (14 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 10,625,262 (Paper 6 in IPR2021-00250) dated Apr. 19, 2021 (71 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 10,625,261 (Paper 6 in IPR2021-00251) dated Apr. 19, 2021 (82 pages).
Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 10,632,466 (Paper 6 in IPR2021-00253) dated Apr. 19, 2021 (66 pages).
Declaration of James P. Landers, Ph.D. in support of Patent Owner Preliminary Responsesin IPR2021-00250, IPR2021-00251, and IPR2021-00253 (Exhibit H2003) dated Apr. 19, 2021 (189 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 10,625,262 (Paper 7 in IPR2021-00250) dated Jul. 15, 2021 (15 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 10,632,466 (Paper 7 in IPR2021-00253) dated Jul. 15, 2021 (22 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 10,625,261 (Paper 7 in IPR2021-00251) dated Jul. 15, 2021 (24 pages).
Patent Owner's Response in Inter Partes Review of U.S. Pat. No. 8,709,787 and Exhibit List (Paper 29 in IPR 2020-01132) dated Jul. 15, 2021 (87 pages).
Decision Granting Institution of Inter Partes Review of U.S. Pat. No. 8,415,103 on Rehearing (Paper 23 in IPR2020-01133) dated Aug. 6, 2021 (20 pages).
Decision of U.S. Court of Appeal for the Federal Circuit Affirming Inter Partes Review Final Written Decisions Determining No Challenged Claims of U.S. Pat. Nos. 7,998,708 and 8,323,900 are Unpatentable (IPR2019-00488, IPR2019-00490, IPR2019-01493, and IPR2019-01494) dated Oct. 29, 2021 (12 pages).
Joint Motion to Terminate Inter Partes Review of U.S. Pat. No. 8,709,787 (Paper 37 in IPR 2020-01132) dated Nov. 15, 2021 (8 pages).
Joint Motion to Terminate Inter Partes Review of U.S. Pat. No. 8,415,103 (Paper 35 in IPR 2020-01133) dated Nov. 15, 2021 (8 pages).
Brief for Appellee HandyLab, Inc. in Appeals from the USPTO, PTAB, in Nos. IPR2019-00488, IPR2019-00490, IPR2019-01493, and IPR2019-01494 filed May 24, 2021 in U.S. Court of Appeals for the Federal Circuit Case Nos. 20-2249, 20-2250, 20-2273 and 20-2276 (74 pages).
Reply Brief of Appellants Qiagen North American Holdings, Inc. and NeuMoDx Molecular, Inc. in Appeals from the USPTO, PTAB, in Nos. IPR2019-00488, IPR2019-00490, IPR2019-01493, and IPR2019-01494 filed Jun. 21, 2021 in U.S. Court of Appeals for the Federal Circuit Case Nos. 20-2249, 20-2250, 20-2273 and 20-2276 (44 pages).
First Amended and Supplemental Complaint filed by Becton, Dickinson and Company et al. on Jun. 25, 2020 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS, Infringement Action involving U.S. Pat. Nos. 7,998,708; 8,273,308; 8,323,900; 8,415,103; 8,703,069; 8,709,787; 10,494,663; 10,364,456; 10,443,088; 10,604,788; 10,625,261; 10,625,262; and 10,632,466 (55 pages).
Answer to First Amended and Supplemental Complaint filed by NeuModx Molecular, Inc. on Jul. 16, 2020 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (42 pages).
Defendant NeuModx's Initial Invalidity Contentions filed Sep. 30, 2020 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (47 pages).
Defendant NeuModx's Joint Claim Construction Chart [Exhibit N1023] filed Oct. 21, 2020 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (25 pages).
Defendant NeuModx's Amended Answer, Affirmative Defenses, and Counterclaims to Plaintiffs' First Amended and Supplemental Complaint filed Dec. 11, 2020 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (43 pages).
Second Amended and Supplemental Complaint filed by Becton, Dickinson and Company et al. on Feb. 25, 2021 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (75 pages).
Defendant NeuMoDx's First Supplemental Invalidity Contentions filed Mar. 17, 2021 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (55 pages).
Defendant NeuModx's Answer, Affirmative Defenses, and Counterclaims to Plaintiffs'Second and Supplemental Complaint filed Mar. 18, 2021 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (67 pages).
Plaintiffs' Answer and/or Reply to Defendants' Counterclaims and Counterclaims-In-Reply filed Apr. 22, 2021 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (127 pages).
Claim Construction (Markman) Order dated May 10, 2021 in in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (30 pages).
Stipulation of Dismissal filed by Plaintiffs Becton, Dickinson and Company, Geneohm Sciences Canada, Inc. and HandyLab, Inc. and Defendants NeuMoDx Molecular, Inc., Qiagen GmbH, and Qiagen North American Holdings, Inc. on Nov. 12, 2021 in U.S. District Court, Delaware, Case # 1:19-cv-01226-LPS (3 pages).
Davis et al., “Surface vibrational sum frequency and Raman studies of PAMAM G0, G1 and acylated PAMAM G0 dendrimers”. Anal Chimica Acta. Oct. 3, 20031;496(1-2): 117-131.
Related Publications (1)
Number Date Country
20210299663 A1 Sep 2021 US
Provisional Applications (2)
Number Date Country
60859284 Nov 2006 US
60959437 Jul 2007 US
Continuations (3)
Number Date Country
Parent 15809248 Nov 2017 US
Child 17089426 US
Parent 14263208 Apr 2014 US
Child 15809248 US
Parent 11940310 Nov 2007 US
Child 14263208 US